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Abstract 
Plant polyphenols are reported to have bioactive properties, which may be used for 
protection against diseases. Therefore, the aim of this research was to investigate the 
bioactive activities of a pomegranate tannin polyphenol compound, punicalagin. In 
particular, the antioxidant, antihypertensive and anticancer mechanisms were 
investigated. 
Punicalagin was found in pomegranate husk but not in pomegranate juice when 
analysed by HPLC and LC-MS. Antioxidant mechanisms involved hydrogen peroxide 
scavenging, ferrous chelating and reducing ability. Higher hydrogen peroxide 
scavenging activity was achieved by 0.1 mg/ml from both punicalagin and pomegranate 
juice when compared with butylated hydroxytoluene (BHT) or trolox (p ::;0.05). 
Punicalagin and pomegranate juice exhibited ferrous chelating ability significantly 
lower than Ethylenediaminetetraacetic acid. 
Cell toxicity induced by tert-butylhydroperoxide (3 mM) was significantly inhibited by 
punicalagin (5 and 10 IlM) in Caco-2 cells; these results were confirmed by cell 
morphology. Punicalagin protection was achieved by inhibiting cellular reactive oxygen 
species (ROS) as well as malondialdehyde levels. Glutathione level was significantly 
increased in stressed cells pretreated with both concentration of punicalagin, indicating 
good antioxidant activity for punicalagin. 
Punicalagin (1-60 IlM) increased nitric oxide production in endothelial cells 
(EA.hy926) through decreased ROS levels and increased endothelial nitric oxide 
synthase enzyme (eNDS) activation. Activation of eNOS enzyme was achieved by an 
II 
increase of cellular calcium concentration. At the same examined concentration of 
punicalagin (1-60 ~M), the activity of angiotensin converting enzyme (ACE) was 
significantly inhibited. The dual action of punicalagin as nitric oxide synthase inducer 
and ACE inhibitor showed antihypertensive effect. 
Punicalagin (50 and 75 ~M) showed toxic effects on the colon cancer cell line (Caco-2) 
but not on a nonnal colon cell line (HCEC); both results were confinned by 
morphological studies. In the presence of punicalagin, cytoplasmic ROS production 
decreased, indicating antioxidant activity whereas superoxide radicals released from 
mitochondria increased due to mitochondrial dysfunction. Annexin V and caspase 
family (caspase 9, 8 and 3) activation confinned that cell death occurred via apoptosis 
pathway by both concentrations of punicalagin. The cell cycle was arrested by 
punic ala gin in the G liS-phase at the concentrations tested. The above findings 
indicating that punicalagin has antioxidant, antihypertensive and anticarcinogenic 
activity. 
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1 Introduction 
1.1 Polyphenols 
Plant foods like (fruits, vegetables and chocolate) and drinks like (tea, coffee and wine) 
contain several phenolic compounds which are secondary plant metabolites that exhibit 
nutritional quality (Ziccarelli and Basu, 2003; Crozier et al., 2009). Phenolic 
compounds are a large group of molecules with a variety of functions in plant growth, 
development and defence. Over the past decade, there has been a growing interest in 
identifying and developing phenolic compounds from plant extracts, as they are 
reported to have substantial benefits on human health (ail et al., 2000; Zhang et al., 
2005; Cvorovic et al., 2010). Polyphenol compounds have different biological 
activities like anti-carcinogen (Ahmad et al., 1997; Zhao et al., 2004; Kasimsetty et al., 
2010b), anti-atherosclerosis (Aviram and Domfeld, 2003; Adams et al., 2006), anti-
oxidant (Kulkami et al., 2004; Wolfe et al., 2008; Kunyanga et al., 2011), improvement 
of endothelial cell line and inhibition of cell proliferation (Leikert et al., 2002; Huang et 
al., 2004; Persson et al., 2009). Plant polyphenols can scavenge reactive oxygen species 
(ROS) and activate endogenous defence systems such as increasing glutathione level 
(Ziccarelli and Basu, 2003; Lima et al., 2006), activating antioxidant enzyme (Alia et 
al., 2006b; Lima et al., 2007), activating caspases (Li et al., 2003; Larrosa et al., 
2006a) and increasing the activity of nitric oxide synthase enzyme (Martin et al., 2003; 
Appeldoom et al., 2009). 
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1.1.1 Structure of Polyphenols 
Phenolic compounds have one or more hydroxyl groups attached directly to an aromatic 
ring and their structures may range from simple phenolic molecules to high molecular 
mass complexes. Most phenolic compounds are present as esters or glycosides rather 
than free compounds (Balasundram et al., 2006). 
1.1.2 Classification 
Polyphenols are divided into several classes according to the phenol ring number they 
consist of, and to the structural elements that bind these rings to each other (see Figure 
1.1). Flavonoids, phenolic acids, tannins, stilbenes and lignans are the main groups of 
polyphenols (D'Archivio et al., 2007). Different classes of polyphenols are present in 
the human diet like fruits (apple, raspberry, pomegranate and orange), vegetables 
(onion, tomatoes and broccoli), beverages (tea, coffee and red wine) and spices 
(tunneric, cinnamon and hot pepper) (Murcia et al., 2001; Bajpai et al., 2005). An 
example of a phenolic acid class is caffeic acid, which has antioxidant activity via 
scavenging ROS in endothelial cell line (EA.hy926) (Huang et al., 2004). Quercetin is 
another phenolic compound (subclass of flavonoids), which has a significant effect on 
increasing the activity of antioxidant enzymes such as catalase, superoxide dismutase, 
glutathione reductase and glutathione peroxidase in mouse liver (Shen et al., 2007) and 
liver cell line (HepG2) (Molina et al., 2003). Apoptosis in colon cancer cell line (HT29 
and HeT 116) can be induced by tannic acid, a component in the tannin class (Seeram 
et al., 2005). Resveratrol is a type of stilbene that has the ability to inhibit the 
proliferation of cardiac fibroblasts in rat cardiac fibroblast cell line (Wang et al., 2007), 
as well as inhibiting the cell proliferation of human colon cell line (Fuggetta et al., 
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2006). Moreover, it can increase nitric oxide and the nitric oxide synthase enzyme level 
in rat cardiac fibroblast cell line (Wang et al., 2007). 
Phmolic acids I 
~O~ , OH HO 
t1allH1! erxrol 
I l,n'J 
# , OH HO OH I AI' AI' 
OH OH 
OH 
Figure 1.1: Phenolic compounds classification. Source: Han et 01. ,2007 
1.1.3 Flavonoids 
Flavonoids are one of the phenolic compound classes that are found in the human diet. 
Flavanoids are low molecular weight and have 15 carbon atoms arranged in a C6-C3-C6 
configuration; there are 2 aromatic rings A and B connected by a 3-carbon bridge into a 
heterocyclic ring (see Figure 1.2). 
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OH 
OH 
Figure 1.2: General structure of flavonoid. Source: Kar et al., 2006 
Flavonoids comprise anthocyanins, flavones, isoflavones, flavanones, flavonols and 
flavanols. The chemical structures of the main classes of flavonoids are depicted in 
Figure 1.3 (Merken and Beecher, 2000). 
OH 
OH 
HO 
OH 0 
OUtrctItm 
F1av~non .. 
OH 
HO 
OH 0 
NarlngtJnIn 
OH 
An1hocyanlns 
OH 
HO 
OH 
Cyanidin 
HO 
HO 
HO 
Flavone. 
OH 0 
Ap/fJcnJn 
lcoOavaruts 
Flavanols 
OH 
Catochins 
OH 
OH 
OH 
Figure 1.3: Subclasses of the flavonoids family. Source: Gamet-Payrastre et al. , 1999 
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1.1.4 Tannins 
Tannins are one of the major polyphenol groups present in the human diet. Tannins are 
divided in two groups: hydrolysable tannin (ellagitannins and gallotam1ins) and 
condensed tannin (proanthocyanidins). Their chemical structures are illustrated in 
Figure 1.4. 
Tannins 
Gallotannins Ellagitannins Complex Tannins Condensed 
Tannins 
HO 
0 i/O' OH 0 HO ij:~ 
" 
OH 
RO 1 HO OH o OR 
..-:; C-O 
O.."C .... RO C . OR 
"O*"IGI 
~_O HO 
I " RO HO 
/. 
OH R = Galloy! moiety (G) 
OH OH 0( other substituents (Catedlin moiety) n 
2 3 4 
Figure 1.4: Tannins phenolic compound structures. Source: Khanbabaee and van Ree, 2001 
Flavonoids and tannins are antioxidants as they have a high redox potential, permitting 
them to perform as reducing agents, hydrogen donors and single oxygen quenchers. 
They also have a metal ch elating ability (Yen and Dub, 1994; Tsao and Yang, 2003; 
Gii19in et al., 2010). All tbese features are due to their phenolic structure (Passamonti et 
al., 2003; Crozier et al., 2009). Due to their presence in our diet and their protective 
effect from several diseases associated with oxidative stress, several studies on 
polyphenols activity were performed (Young and Woodside; 2001, Mertens-TaIcott et 
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al., 2006; Bao and Lou, 2006; Kasimsetty et al., 20 lOb) (Figure 1.5). Epidemiological 
studies suggest that an intake of flavonoids and tannins is beneficial for prevention of 
cardiovascular, inflanunatory and cancer diseases (Noda et al., 200 I; Mertens-Talcott et 
al., 2006; Kunyanga et al. , 2011). Pomegranates contain flavonoids (delphinidine, 
cyanindin, and peralgonidin) and tannin (punicaJagin ellagic acid and gallic acid) 
(Malik et al., 2005). Therefore, the therapeutic effects of punicalagin as one of 
pomegranate phenolic compounds will be investigated in this research. 
Impacting cell cycle 
.... 
Scavenging free A ~ Inducing endogenous 
radicals ~..:.:.~:.J antioxidant enzymes ~ Dietary 
.,.. 
Inhibiting oxidant Polyphenols 
... Modulation of signal ~ .. ..., transduction enzymes .... .,.. 
V I Bioactive effects I 
! 1 1 
Anti- Gastrointestinal Anti- Hormone 
inflammation health allergy modulation 
Neuro- Endothelial Anti- Other 
protection protection diabetes effects 
Cardio- Anti- Immune 
protection Turnor protection 
Figure 1.5: Bioactive properties of polypbenol compounds. Source: Han et al. , 2007 
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1.2 Pomegranate 
Pomegranate is grown in the Mediterranean region, Afghanistan, Iran, India, China, 
Japan, Russia, Saudi Arabia and United States, particularly in Arizona and California. 
The history of pomegranates dates back to 800 years ago and it has been used 
worldwide as a folk medicine. In India (Nagaraju and Rao, 1990), Tunisia (Boukef et 
al., 1982) and Guatemala (Caceres et al., 1987), the pomegranate peels are dried and 
boiled in water and used both internally and externally as astringents and! or 
germicides especially for diarrhoea and ulcers. A mixture of pomegranate seed, juice 
and peel products paradoxically has been reported, not only to prevent abortion 
(Ramirez et al., 1988), but also conception (Gujral et al., 1960; Jochle, 1971; Zhan, 
1995). Recent uses of pomegranate-derived products include hormone replacement 
therapy (Lansky, 2000) and cardiovascular protection (Shiraishi et al., 2002; Aviram 
and Dornfeld, 2003). People normally consume pomegranate as fresh fruit and drink or 
as food products e.g. (jams) and as dietary supplements (Lanskya and Newman, 2007). 
The antioxidant capacity of different pomegranate cultivars reflected a significant 
concentration difference of some individual phenolic compounds (Arai et al., 1999). 
1.2.1 Structure of Pomegranate 
The pomegranate fruit can be divided anatomically into three compartments: 
• Seeds: pomegranate seed oil contains punicic acid. It is an omega-5 long chain 
polyunsaturated fatty acid. It has be~n reported to have an anticancer effect because it 
contains a large number of potential bioactive substances (Lanskya and Newman, 
2007). 
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• Juice: Pomegranate is a rich source of anthocyanin. Delphinidin-3,5-diglucoside is 
a major anthocyanin in pomegranate juice. The juice also contains delphinidin-3-
glucoside, cyanidin-3-glucoside, cyanidin-3,5-diglucoside, pelargonidin-3-glucoside 
and pelargonidin-3,5-diglucoside (Gil et al., 2000). The juice also contains glucose, 
ascorbic acid, ellagic acid, gallic acid, caffeic acid, catechin, epigallocatechin gallate, 
quercetin, rutin, numerous minerals and amino acids. 
• Peels (pericarp or husk): pomegranate husk has been reported to have higher 
antioxidant activity than its seeds. Flavonoids and tannins are more abundant 
components in the peel (Ozcal and Dine, 1993). 
Pomegranate, as described previously, contains different classes of polyphenols that 
enables it to act as an antioxidant compound. Consequently, its bioactive compounds 
can scavenge reactive oxygen species (ROS) that are generated from normal metabolic 
functions and are responsible for several diseases. 
1.3 Reactive Oxygen Species and Lipid Oxidation 
1.3.1 Reactive Oxygen Species (ROS) 
Radicals are molecules with unpaired electrons that are highly reactive e.g. hydroxyl 
radical OH· and superoxide radical 02··. Radicals are formed in all living organisms in 
normal metabolic pathways during the oxidation. The free radical level increases under 
certain circumstances e.g. environmental stress, wounding and pathogen attack. ROS 
can damage living organisms, such as cell membranes, protein, lipid and nucleic acids 
(Halliwell, 1991), when left unchecked Figure 1.6. 
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Reactive oxygen species are molecules that contain an oxygen atom and are highly 
reactive as a result of the presence of a free radical, or a configuration of the oxygen 
atom whereby there are more electrons than usual e.g. peroxide ions 0 2-2. Hydrogen 
peroxide (H202) is also considered as a ROS because of its reactivity. In fact, it is 
regarded as the most reactive radical known with an ability to react with a very wide 
range ofbio-molecules (Halliwell, 1991). 
Increased 
ROS 
Figure 1.6: Illustration of diseases related to ROS production. Source: Brieger et al., 2012 
It has been demonstrated that the unsaturated lipids in cell membranes are susceptible to 
damage from free radical molecules that lead to uncontrolled chain reactions producing 
further oxidation products. Furthermore, other biological molecules like RNA, DNA 
and protein enzymes can also be damaged (Hanahan and Weinberg, 2000). 
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1.3.2 Lipid Peroxidation 
Lipid peroxidation can be defined as the oxidative damage to lipids comprising one or 
more carbon-carbon double bonds. The peroxidation of lipids produces free radicals 
which damage the cell membrane (Catala, 2006). 
1.3.2.1 Types of Lipid Oxidation 
Lipid oxidation occurs when free radicals attack the unsaturated lipids through 
different pathways: autoxidation, photoxidation and enzymatic oxidation. 
a) Autoxidation: The process of autoxidation is triggered off when free 
radicals present in living cells interact with polyunsaturated and 
monounsaturated fatty acids, and result in the production of intermediate 
substances such as alkyl and peroxyl radicals (Kolakowska, 2002). 
b) Photoxidation: In this process, light including ultraviolet light works as a 
source of energy which raises the oxygen from a ground state (02) to an 
excited energy state e02). The latter reacts with the unsaturated fatty acids 
to form free radicals (Kolakowska, 2002). 
c) Enzymatic oxidation: The enzymatic oxidation reaction is determined by 
the presence of lip oxygenase enzyme system that catalyses the reaction 
between oxygen and the unsaturated fatty acids in order to produce 
hydroperoxides (Wang et al., 1991). 
1.3.2.2 Mechanism of Lipid Peroxidation in Cell l\fembrane 
The process of lipid peroxidation is associated with several diseases linked with the 
undesirable effect produced in the cell. The mechanism of lipid peroxidation is 
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illustrated in Figure 1.7. The hydroxyl group removes a hydrogen atom from the carbon 
adjacent to the double bond, producing a fatty acid radical with a free electron on the 
carbon atom. The radical rearranges to give a stable conjugated structure. The free 
radicals can either crosslink with adjacent fatty acid radicals or react with oxygen to 
give a peroxyl radical. This subsequently starts a chain reaction, creating new peroxyl 
radicals. Lipid peroxidation can alter the fluidity of the membrane and transfer radicals 
onto the membrane proteins, especially receptors (Vermerris and Nicholson, 2006). 
The mechanism of lipid peroxidation comprises of three steps: initiation, propagation 
and termination. 
Initiation: The initiation step of lipid peroxidation starts with the production of free 
radicals. This initiation process occurs slowly as the reaction between oxygen and the 
unsaturated fatty acids is difficult. A number of factors activate the initiation of lipid 
oxidation of PUF A like oxygen, metal ions, and ultraviolet light. Several enzymes have 
the ability to promote lipid oxidation such as lip oxygenase, and peroxidase. 
Lipoxygenase enzyme is the main cause of PUF A peroxidation as it is usually found in 
food (Halliwell and Gutteridge, 1984). 
Through the initiation of lipid oxidation, a reactive species like the hydroxyl radical 
(OH') extracts a hydrogen atom from PUFA (the methylene group). Therefore, a 
conjugated diene is produced as a result of the rearrangement of the double bonds of the 
carbon radical that is subsequently combined with an oxygen atom to form a peroxy 
radical (ROO') (Niki et al., 2005). Photosensitisation is responsible for the production 
of the fIrst few radicals in the reaction between a fatty acid double bond and an excited 
oxygen molecule. Pre-existing lipid hydroperoxide (ROOH) that has low reactivity 
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levels can be cleaved to produce alkoxy radicals (RO·). The new radical product is 
highly reactive and reacts with the aUylic hydrogen atom of the unsaturated fatty acid to 
produce additional ROOH (Niki et al., 2005). 
Propagation: Radicals such as alkoxyl and peroxyl abstract H atoms from the 
methylene group next to the double bond of the allylic position of the unsaturated fatty 
acids. Therefore, the autocatalytic chain reaction of lipid oxidation would proceed. The 
rate of propagation is based on the quantity of the double bonds present in the 
membrane (Niki et al., 2005). 
Lipid hydroperoxides, which are products of ROS oxidation on polyunsaturated fatty 
acids, are heat labile and break down to produce secondary metabolite products like 
hydroxyl-fatty acids, epoxides and cleavage products like aldehydes including 
malondialdehyde (MDA). These radicals then bind and react with another unsaturated 
fatty acid to propagate the reaction. Consequently, the propagation step continues as 
long as the unsaturated fatty acid molecules are available (Niki et al., 2005). 
Termination: Lipid oxidation can be terminated by the reaction of two free radicals to 
form non-radical products. The termination steps occur at low oxygen concentrations 
(Niki et al., 2005). For example, alkoxyl radicals via a radical recombination 
mechanism bind with another radical to form a stabilised ketone or a secondary alcohol 
through radical transfer. On the other hand, ifno binding occurs, free radicals may react 
with protein molecules. This produces protein cross-linking and, therefore, severely 
damages the protein. 
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Figure 1.7: Mechanism of lipid peroxidation. Source: OaJrympJe et al., 2010 
1.3.2.3 Defence System against Lipid Peroxidation 
Since lipid peroxidation plays a key role in the pathogenesis of many diseases such as 
cancer, coronary heart disease and Alzheimer's disease, several studies have suggested 
that free radical scavenging and antioxidant activity can help to prevent the above 
diseases (Noda et al., 2001). In fact , the living organism has developed various ways to 
deal with ROS by endogenous defence systems (antioxidant enzymes) and the 
exogenous antioxidants (provided from the diet) (Hayes and McLellan, 1999; Masella et 
al. , 2005). 
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1.3.2.3.1 Enzymatic Defence System 
The important antioxidant enzymes in the tissue are catalase, superoxide dismutase and 
glutathione peroxidase. H202, ROS, and superoxide radicals that are present in the cell 
environment can be scavenged by these defence system enzymes and prevent lipid 
oxidation in cells and cell membranes (Halliwell, 1991). The defence system enzymes 
are described below: 
Superoxide Dismutase (SOD) 
SOD is responsible for the elimination of superoxide (02.-) by converting it to hydrogen 
peroxide (H20 2), which is less harmful to the tissue as compared to (02'-). 
• + 202 -+2H 
In humans, this enzyme is found in the cytoplasm, mitochondria and extracellular 
fluids. The location of SOD depends on the metal ion cofactors that are bound to the 
enzyme. Copper-zinc SOD is found in the cytoplasm and extracellular fluids, while 
manganese- SOD exists in the mitochondria (Halliwell and Gutteridge, 1990). 
Catalase (CAT) 
CAT can convert H202 to water and oxygen using a manganese or iron cofactor. This 
enzyme is found in all eukaryotic cells in peroxisomes organelle (del Rio et al., 1992). 
Catalase enzyme is activated at high concentrations of H202. Two molecules of H20 2 
are needed in the active site of catalase to convert them to H20 (Halliwell and 
Gutteridge, 1990). 
14 
Chapter 1: Introduction 
CAT 
> 
Glutathione Peroxidase (GPx) 
Glutathione peroxidase enzyme is responsible for the conversion of hydrogen peroxide 
to water using glutathione (GSH) in its reduced form as substrate. This reduced form of 
GSH converts to oxidized glutathione form (GSSG) (HalliweU and Gutteridge, 1990). 
----->~ 2 H20 + GSSG 
The oxidized form (GSSG) is reduced by glutathione reductase to GSH. Therefore, the 
ratio GSHlGSSG should be maintained (Halliwell and Gutteridge, 1990). 
GSSG + NADPH + W -----~> 2 GSH + NADP+ 
GPx enzyme is present in the cytoplasm and the matrix of mitochondria. Selenium is 
found in the active site of this enzyme (Brigelius-Flohe, 1999). 
Both catalase and glutathione peroxidase take part in the breakdown of H202 to H20 . 
The concentration ofHz0 2 determines which enzyme will be activated. At higher levels 
of H20 2, it is metabolised by catalase enzyme while, at lower concentrations, it is 
converted by GPx enzyme (Chance et al., 1979). 
1.3.2.3.2 Antioxidant Defence System 
Antioxidants are compounds that can scavenge free radicals and convert them to non-
reactive molecules; these compounds are stable in the presence of free radical electrons 
(Young and Woodside, 2001). Antioxidants are classified into synthetic antioxidant like 
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butylated hydroxyltoluene (BHT) and natural antioxidant such as vitamin C and plant 
polyphenols. One of the most important subjects in human health and nutrition is the 
role of antioxidants to reduce lipid oxidation that form secondary oxidation products, 
which have harmful effects on the human body as they are linked with several diseases 
(Halliwell and Gutteridge, 1990; Niki et al., 2005; Lobo et al., 2010). Antioxidants such 
as vitamin E (tocopherols) and vitamin C (ascorbic acid) are commercially added to 
food products to retard lipid oxidation. Based on their structures, both components have 
the ability to prevent fat oxidation processes and therefore prevent ROS production 
(Flora, 2009). 
A. Synthetic Antioxidants 
Synthetic antioxidants are cheaper to produce and are more stable than natural 
antioxidants. Butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) are 
the most used synthetic antioxidants in the food industry (Iverson, 1999), although their 
use is restricted in some countries due to the possible effects on some enzymes in the 
human body (Nakatani, 1997). Therefore, research on natural antioxidants has 
witnessed an increase due to these safety concerns (Pokorny, 2007). 
Butylated hydroxy toluene (BHT) 
Butylated hydroxytoluene (BHT) (Figure 1.8) is a hydrophobic synthetic antioxidant 
that minimises lipid oxidation by donating on hydrogen atom to a free radical made 
during the initiation or the propagation step to produce a stable, unreactive molecule. 
Although, BHT is used as food an additive to prevent food spoilage, there are many 
safety concerns (Williams et al., 1999). 
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OH 
Figure 1.8: The chemical structure of butylated hydroxy toluene (2,6 - bis (l,1-
dimethylethyl) - 4 methylphenoI. Source: GilI~in et al., 2009 
B. Natural Antioxidants 
The concern about using natural antioxidants in food has increased over the past 20 
years due to consumer concern of using synthetic antioxidants in food. Plant products 
like vegetables e.g. (broccoli, onion and tomato) (D'Archivio et aI., 2007), fruits (e.g. 
strawberry, apple and pomegranate), herbs (oregano, thyme and rosemary) (Viuda-
Martos et al., 2010) and spices (cinnamon, cloves and chilly pepper) contain natural 
antioxidants (Dai and Mumper, 2010). Consumption of these antioxidants (polyphenols 
and flavonoids) may have a role in the prevention of chronic diseases like hypertension, 
cardiovascular diseases (A viram and Domfeld, 200 I) and cancer (Ames et al., 1993). 
The phenolic compounds often exhibit similar or greater activity than synthetic 
antioxidants, for example, ethanolic extract from peanut hulls (1.2 mg/ml) showed 
significant antioxidant activities similar to BHA and catechin (Yen and Duh, 1994). 
Moreover, tannic acid showed the highest scavenging activity for H20 2 compared with 
a-tocopherol , BHT and trolox (Giil~in et al., 2010). The most common and effective 
antioxidant used in food products is ascorbate (Figure 1.9). Ascorbate is a very reactive 
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compound that acts as a reducing agent and, therefore, has the ability to scavenge 
oxygen (McGregor and Biesalski, 2006). It binds with an unpaired electron in the free 
radical and forms stable molecule; it also chelates metal ions (McGregor and Biesalski, 
2006). 
HO 
o 
HO OH 
Figure 1.9: Chemical structure of ascorbic acid. Source: Dragsted, 2008 
The other natural antioxidant that has been used as a food additive is trolox, (Figure 
1.10). It is a water-soluble analogue of vitamin E as the presence of hydroxyl groups 
reduces the hydrophobicity of the compound. The hydroxyl group can stop lipid 
autooxidation by interfering with either the chain propagation or the decomposition 
processes. Due to its powerful antioxidant activity, it is usually used as a positive 
control standard during any experiment in order to investigate the antioxidant activity of 
other substances (Poljsak and Raspor, 2008). 
OH 
Figure 1.10: Illustration of the chemical structure of trolox. Source: Menichetti et al., 2005 
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Antioxidants can induce their effect via different mechanisms, which can be classified 
as: 
1. Antioxidants having one or more hydroxyl groups have the ability to donate 
hydrogen atom or electron to the lipid oxidation species and produce stable 
molecules (Flora, 2009) . 
2. Antioxidants have the ability to chelate metals such as Fe2+ that can initiate 
free radical formation (Flora, 2009). 
Antioxidants are normally added to food for two reasons: 
1. To avoid food taste changes by delaying lipid oxidation caused by processing or 
long storage (Pokorny, 2007). 
2. To reduce free radical concentration in the body after food ingestion and, 
therefore, controlling any cellular changes that may lead to diseases, such as 
strokes, atherosclerosis and cancer (Pokomy, 2007). 
Polyphenols are antioxidants from plant foods that react in the body to enhance health 
and protect the human body from different diseases by different mechanisms. In fact, 
polyphenols are used as food additives because they are rich sources of natural 
antioxidants such as vitamin E, C and ~-carotene. One of the important mechanisms 
of antioxidants as protective agents is their ability to inhibit lipid peroxidation. 
Several studies showed the ability of phenolic compounds to prevent lipid 
peroxidation (Dinis et al., 1994; Murcia and Martinez-Tome, 2001; Peng and Kuo, 
2003). To this end, the focus of this research is to investigate these mechanisms 
further. Pomegranate is a fruit that has different phenolic compounds such as 
punicalagin as mentioned earlier. The cyto-protective effect of punic ala gin against 
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lipid peroxidation and other mechanisms was examined in order to investigate the 
antioxidant properties of this compound. 
1.4 Antioxidant Activity of Pomegranate 
Antioxidants are compounds that have the ability to delay or inhibit the oxidation of 
oxidisable molecules through scavenging free radicals and reducing the oxidative stress 
(Ames et al., 1993). 
Pomegranate contains high levels of flavonoids and polyphenols that have potent 
antioxidant protection against heart disease and cancer (Aviram et al., 2000). 
Anthocyanidins cyanidin, pelargonidin and delphinidin are three antioxidant types 
found in pomegranate, which have shown inhibitory effects on H20 2- induced lipid 
peroxidation in rat brain homogenate with delphinidin being the most potent and 
pelargonidin the least (Halvorsen et al., 2002). 
The ability of dietary flavonoids to prevent lipid peroxidation in Caco-2 cell lines has 
been investigated by Peng and Kuo, (2003a). Quercetin, myricetin, luteolin and 
epigallocatechin gallate (EGCG) inhibited lipid peroxidation in Caco-2 cell lines 
whereas kaempferol, genistein and daidzein did not. Seeram et al., (2005) described the 
antioxidant activities of punicalagin, ellagic acid (EA), total pomegranate tannin (TPT) 
and pomegranate juice (PJ) on human oral (KB, CAL27), colon (HT-29, HCTI16, 
SW480, SW620) and prostate (RWPE-l,22Rvl) tumor cells. The trend of antioxidant 
activity was highest for PI then TPT, followed by punicalagin and EA had the lowest 
activity (Seeram et al., 2005). Alia et al., (2006) studied the catalase and SOD levels in 
liver cells (HepG2) pretreated with 50 and 100 J..tM of quercetin and rutin and then 
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incubated for 3 hours with 3 mM T -BOOH; there were no significant changes in both 
enzyme levels. Similar results were found for oral cell line (NHEK., OSC-2 and OSC-4) 
treated with 100 !AM epigallocatechin gallate (green tea polyphenol)(Yamamoto et al., 
2004). Lima et al., (2006) indicated that polyphenol showed experimental protective 
effect against oxidative damage induced by T-BOOH. Luteolin (200 !AM), 45 !AM 
quercetin, 370 !AM caffeic acid and 180 !AM rosmarinic acid inhibited the glutathione 
depletion caused by 2 mM T-BOOH in liver cell line (HepG2) (Lima et al., 2006). 
Further, when oxidative stress was induced by 2 mM T -BOOH for 5 hours in liver cell 
line HepG2 (Lima et al., 2007), the addition of methanolic and water polyphenol 
extracts from Salvia plant significantly prevented glutathione depletion. Pomegranate 
fruit extract PFE showed higher antioxidant activity than tea polyphenol 
epigallocatechin-3-gallate, in human lung carcinoma A549. The PFE extract showed a 
dose-dependent decrease in A549 cancer cell viability and smaller effects on normal 
human bronchial cells (Khan et al., 2007). 
In this thesis, human colon carcinoma cell line (Caco-2) was used to investigate the 
antioxidant activity of pomegranate compound (punicalagin) under oxidative stress 
caused by tert-butylhydroperoxide (T -BOOH). Caco-2 monolayer cell line exhibits 
features closely resembling intestinal epithelial cells such as tight junctions and brush 
border microvilli when grown under normal conditions (Pinto et al., 1983). Therefore, 
Caco-2 cell line has been used as a model to study the transportation of compounds like 
fatty acids, polyphenols and flavonoids through the intestinal epithelium (Meaney and 
O'Driscoll, 2000; Aheme and O'Brien, 2000; Tian et al., 2009). In addition, Caco-2 
cells are used as an in-vitro model for many other purposes such as studying the 
potential absorption of drugs (van Breemen and Li, 2005), investigating the 
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biotransfonnation of compounds (Dai et al., 2008) and investigating the protective 
effects of natural antioxidants against oxidative stress (Aherne and O'Brien, 2000). 
Tert-butyl hydroperoixde (T-BOOH) is an organic peroxide that can be converted to 
other alkoxyl and peroxyl radicals by cytochrome P450 enzymes and by free metal ions 
that can produce ROS. Consequently, these free radicals initiate lipid peroxidation 
chain reactions, produce cell toxicity by reducing glutathione level, damage the DNA 
and affect the membrane potential of mitochondria, and consequently cause cell death 
(apoptosis) (Kim et al., 1998; Aherne and O'Brien, 2000; Lima et al., 2006). 
Several studies have shown that high intakes of polyphenols may protect the human 
body from cardiovascular diseases (Aviram and Dornfeld, 2003; Adams et al., 2006). 
The possible protective mechanism against heart diseases could be related to the 
polyphenols effect, namely anti-platelet aggregation, vasodilator properties and prevent 
LDL oxidation. In this study, the effect of punicalagin as an antihypertensive agent has 
been studied via different mechanistic pathways. 
1.5 Cardiovascular Disease (CVD) 
1.5.1 Cardiovascular Disease Epidemiology 
Cardiovascular disease affects the circulatory system (heart, artery and blood vessels). 
This disease is a leading cause of death all over the world (Heidenreich et al., 2011). In 
the USA, according to the American Heart Association report in 2013, cardiovascular 
disease (CVD) deaths were 21.42% (Go et al., 2013). According to the World Health 
Orgnization (WHO., 2013), in the United Kingdom, CVD was one of the main causes 
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of death in 2011 reaching about 19.77%, while in Saudi Arabia the death rate from 
CVD was 23.98% in the same year (Finegold et al., 2012). 
1.5.2 Risk Factors Related to CVD 
There are several factors related to this disease such as age, gender (Jousilahti et al., 
1999), high blood pressure (hypertension), family history, high level of serum 
cholesterol, smoking, extreme alcohol consumption, being overweight, lack of physical 
activity, and high blood glucose level (diabetes mellitus). In addition, the cardiovascular 
function in healthy people can be altered due to some physiological and morphological 
changes related to aging (Kurian and Cardarelli, 2007). Each factor has individual 
contributions in every country, based on people's life styles. 
Cardiovascular disease can be reduced by avoiding some risk factors like increasing 
physical activity, eating healthily, managing weight, avoiding smoking and stopping or 
decreasing alcohol consumption. 
One important factor associated with increasing cardiovascular disease is high blood 
pressure (hypertension) (Lin et al., 2004) which has increased the number of deaths 
worldwide. According to WHO, in 2011 the mortality rate by this disease was 11, 3 
and 109 per 100,000 of population in the United State, the United Kingdom, and Saudi 
Arabia, respectively. This rate ranks US, UK and Saudi Arabia number 152, 183 and 4 
respectively in the world (WHO., 2013). Regulating blood pressure can be achieved by 
physical exercise, losing weight, and minimising salt consumption (Devi et al., 2013). 
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1.5.3 Cardiovascular Disease and ROS 
Oxidative stress that initiates increased ROS level leads to heart disease (Paravicini and 
Touyz, 2006). One of the ROS production pathways in endothelial cells is through the 
stimulation of the redox signaling cascade like NADPH oxidase. This enzyme is 
stimulated by angiotensin II (Rey et al., 2001). High levels of superoxide radical ot 
and low levels of endogenous antioxidant enzymes were observed in the blood of 
hypertension patients (Paravicini and Touyz, 2006). 
1.5.4 Angiotensin Converting Enzyme (ACE) 
In the human body, blood pressure is regulated by several mechanisms, one of which is 
the renin-angiotensin system (RAS) (Hall, 1991). Angiotensin converting enzyme 
(ACE) is one of the key elements of this system. This enzyme is found in many tissues 
including lung, endothelial cells, epithelia kidney cells and brain tissues. The ACE 
enzyme has two active sites; the N domain and the C domain. Both of these catalytic 
domains are zinc dependent (Hubert et al., 1991) as illustrated in Figure 1.11. 
ACE enzyme converts the inactive biological molecule decapeptide (angiotensin I) to 
the potent octapeptide (angiotensin II) by removing the dipeptide His-Leu from the C-
terminal in angiotensin I (Hubert et al., 1991). 
Angiotensin-I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) 
~ 
Angiotensin-11 (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) - His-Leu 
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Figure 1.11: Depiction of angiotensin converting enzyme structure. Source: Dzau et al., 
2001 
Angiotensin 11 acts as a vasoconstrictor leading to blood pressure increase, as well as 
prothrombotic action via adhesion on the aggregation of platelets (Benigni et al., 2010) 
(Figure 1.12). Therefore, inhibiting the activity of ACE enzyme is a target for 
pharmacologists to treat hypertension patients. Several ACE inhibitor mechanisms on 
the market are based on the strong binding between the zinc atom present in the active 
site of the enzyme and the strong chelating group on the inhibitor (Acharya et al., 
2003). 
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Figure 1.12: Illustration of rennin angiotensin system. Source: Gradman and Papademetriou , 
2009 
Several studies have concluded that the inhibition of ACE by synthetic drug likes 
captopril or natural inhibitors like polyphenols provide antihypertensive effect in 
hypertension patients (A viram et al., 2000). The synthetic inhibitors of ACE enzyme 
such as captopril and lisinopril cause side effects like headaches, dizziness and cough in 
hypertension patients (Rossetto, 1987). In contrast, the natural ACE inhibitors like 
polyphenols do not exert any undesirable effects on the human body (Tabassum and 
Ahmad, 2011). Therefore, extensive research has been performed on natural products 
for use as alternative treatments for hypertension disease. The powerful effect of 
pomegranate juice on hypertension patients was studied by A viram on ACE enzyme 
inhibitor, in 2001. A two-week consumption of pomegranate juice (50 ml) inhibits 
about 36% of the ACE enzyme activity (A viram and Dornfeld, 2001). 
26 
Chapter 1: Introduction 
Numerous studies were conducted on polyphenols to examine their effects as inhibitors 
of ACE activity, for example flavan-3-ols (epicatechin and catechin) inhibited ACE 
enzyme in rabbit lung (Actis-Goretta et al., 2003). A significant inhibition on ACE 
enzyme activity was observed in endothelial cell line treated with green tea and black 
tea and their flavanols (epicatechin, epigallocatechin, epicatechingallate and 
epigallocatechingallate) (Persson et al., 2006). 
1.5.5 Effect of Polyphenols on Nitric Oxide (NO) Production 
In cardiovascular systems, nitric oxide plays an important role in human health, such as 
vasodilation of the arteries and decrease in the stickiness of platelets (Dejam et al., 
2004). The generation of NO in blood vessels is involved in the regulation of vessel 
functions. L-arginine (amino acid) is a source of NO due to the action of nitric oxide 
synthase in the presence of 02 (Andrew and Mayer, 1999). Nitric oxide synthase 
enzyme has three isoforms: inducible (iNOS) isoform, which is independent of calcium 
ion; neuronal (nNOS) and endothelial (eNOS) are both calcium-dependent enzymes 
(Andrew and Mayer, 1999). 
nNOS 
Neuronal nitric oxide synthase (nNOS) generates NO in nervous tissues. It is located in 
the plasma membrane and has a role in cell communication. It is a calcium-dependent 
enzyme (Andrew and Mayer, 1999). 
iNOS 
Inducible nitric oxide synthase (iNOS) produces NO in an oxidative environment. The 
large amount of NO can react with superoxide and form peroxynitrite, which induces 
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cell toxicity. It is a calcium-independent enzyme (Andrew and Mayer, 1999). 
Endothelial nitric oxide synthase (eNOS) enzyme is localised in caveolae (small 
invagination of the plasma membrane). This enzyme is bound with fatty acids; one 
molecule of myristate and two molecules of palmitate. The enzyme remains inactive 
until calcium calmodulin replaces caveolin and binds to eNOS, thus activating the 
enzyme as illustrated in Figure 1.13 (An drew and Mayer, 1999). 
Figure 1.13: Endothelial nitric oxide synthase cell location. Source: MicheI and Feron, 1997 
For several years, researchers investigated the antioxidant activity of polyphenol 
compounds such as cyanidin, catechin and gallic acid for human health protection from 
cardiac disease (Morton et al., 2000; Actis-Goretta et al., 2003; Wang et al., 2007). 
Red wine polyphenols have the ability to increase the activity and the expression of 
eNOS enzyme as well as increasing calcium concentration in cytoplasm leading to 
increased levels of NO (Leikert et al., 2002). Additional research on pomegranate juice 
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found that NO level was increased without any significant effect on eNOS enzyme 
activity or expression. The researchers explained the significant increase of NO to be 
due to the antioxidant property of pomegranate juice that protects NO from ROS 
destruction (Ignarro et al., 2006). Resveratrol, epicatechingallate and epigallocatechin 
have significant effects on eNOS expression and, therefore, the level of NO was found 
to increase in EA.hy926 cell line (Appeldoom et al., 2009). 
In the present study, human endothelial immortalised cell line EA.hy926 has been used 
as a model for endothelial cell line to investigate the effect of pomegranate compound 
(punicalagin) as an angiotensin converting enzyme inhibitor and nitric oxide synthase 
enzyme activator. The EA.hy926 cell line is derived from the invasion of HUVEC 
(human umbilical vein endothelial cells) with lung carcinoma cell line A549 (Edgell et 
al., 1983). In the endothelial cell line, ROS are generated from NADPH oxidase 
enzyme system. The activation of this enzyme and the high level of ROS are implicated 
in angiotensin II-dependent hypertension associated with endothelial dysfunction 
(Rajagopalan et al., 1996). EA.hy926 cells were used as a model to measure the 
expression of eNOS enzyme after exposure to different phenolic compounds 
(Appeldoom et al., 2009). 
Chronic disease prevention and aging can be partly controlled through the dietary 
intakes of plant polyphenols. Therefore, it is crucial to improve our knowledge of 
polyphenol availability from diet. Although pomegranate components may offer ways 
of treatment and health benefits, extensive studies are still required before they can be 
recommended for regular human consumption. 
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As described previously, under the hannful effect of oxidative stress, high levels of 
ROS are produced in living cells, thus causing chronic diseases like cancer. Therefore, 
ROS scavenging is necessary in order to prevent cancer and protect the human body 
from ROS damage. Dietary antioxidants such as polyphenols are reported to have anti-
carcinogenic activity (Malik et al., 2005, Zhang et al., 2008) and cardiovascular 
diseases prevention properties (lgnarro et al., 2006; Edirisinghe et al., 2011; Hidalgo et 
al., 2012) due to their antioxidant effects. In this research, the anti-carcinogenic effect 
of pomegranate punicalagin has been investigated through different mechanistic 
pathways. 
1.6 Reactive Oxygen Species and Cancer Disease 
Oxidative stress is a phenomenon resulting from the damage caused by free radicals on 
biological macromolecules like lipid, protein and nucleic acids (Florence, 1995; Becker, 
2004). Free radicals are nonnally generated in the cell during metabolic processes. The 
imbalance in ROS production and degradation leads to initiation of several diseases 
such as cancer (Florence, 1995). 
1.6.1 Cancer Definition 
Cancer disease can be defined as uncontrolled cell growth and division. These cells can 
migrate and invade other tissues through the lymphatic system or bloodstream and 
affect any part of the body (Hanahan and Weinberg, 2000). Cancer occurs in several 
steps (Figure 1.14). The first is the initiation step when chemicals, metabolic, 
environmental factors and genetic factors, damage the DNA. Promotion is the second 
long step, which starts with the proliferation of the defected cells in the initiation 
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process. The final step is progression described as the metastasis of tumor cells 
developed in the proliferation step (Doll and Peto, 1981). 
Normal Cell 
Carcinogenic agents 
(dlemicals, radiation and 
viruses) 
Initiation 
1 
DNA damage and ce ll 
mutati on 
Promotion (Tumor) 
1 
Progression (Carcinoma CeU) 
1 
Diseas,e Development 
J 
Cancer 
Figure 1.14: Illustration of the process of carcinogenesis. Source: Dai and Mumper, 20 I 0 
1.6.2 Cancer Incidence and Morbidity 
Globally, cancer is a leading cause of death, and was responsible for approximately 
13% of deaths in 2008. The most conmlon types of cancer globally are lung (1.37 
million deaths), stomach (736 000 deaths), liver (695 000 deaths), colon (608 000 
deaths), and breast (458 000 deaths) (Ferlay et al., 2011). All over the world, the 
incidence of colorectal cancer is the third most common type and it is the fourth most 
common type of death (Ferlay et al., 2011). Worldwide, there are several causes of this 
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disease such as ultraviolet radiation (Armstrong and Kricker, 2001), smoking (Secretan 
et al., 2009), drinking alcohol (Secretan et al., 2009), unhealthy diet (high calories 
intake and low fiber supply) (La Vecchia, 1992), and chronic infection from hepatitis B 
(HBV) (Buendia, 1992). 
1.6.3 Treatment and Prevention Strategies 
Several types of cancer can be treated if detected in the early stages (Duffy et al., 2010). 
The awareness of some cancer signs and symptoms helps in early diagnosis and can be 
treated before the disease metastases. Regular screening programmes for some organs 
(colon, breast, stomach and cervix) can be effective for preventing this disease (Smith et 
al., 2007). The treatment of this disease depends on the stages; the treatment can be 
either surgical, chemotherapy or radiotherapy, or in combination in advanced stages 
(Samee and Selvasekar, 2011). There are several side effects of these treatments such as 
appetite loss, hair loss or thinning, fatigue, nausea, vomiting, skin and nail problems, 
diarrhoea or constipation and effects on some organs like kidney, heart and sexual 
organs (Shapiro and Recht, 200 I). 
Risk of cancer can be reduced by avoiding risk factors such as smoking, increasing 
intake of fruits and vegetables, performing physical activities, reducing exposure to 
sunlight and decreasing the amount of alcoholic drinks (Anton-Culver, 1995). 
1.6.4 Dietary Polyphenols and Cancer Prevention 
Life style and diet are closely linked to the incidence of colon cancer. One of the 
prevention strategies of this disease is increasing fruit and vegetable intakes as they are 
rich in bioactive compounds (Potter et al., 1993). These bioactive compounds, which 
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are found in plant food (vegetables and fruit) or drink (tea, coffee and wine), are 
phenolic compounds that have beneficial health effects in addition to their basic 
nutrition effect (Hollman et al., 1997; Hartman et al., 2006; Kasimsetty et al., 201Oa). 
They have the ability to change some biochemical processes involved in cancer disease 
(Pozo-Guisado et al., 2004; Afaq et al., 2005; Gonzalez-Sarrias et al., 2009). 
These polyphenols may inhibit cell proliferation in different cancer cell types through 
induced apoptosis by arresting cell cycle in a specific phase (Seeram et al., 2005; 
Hafeez et al., 2008). The antioxidant activity of these compounds can inhibit the 
oxidative damage done by ROS scavenging (Lima et al., 2006). Several studies 
propose that the mechanisms used by these anticancer compounds include antioxidant 
and anti-proliferative activities by stimulating apoptosis and arresting the cell cycle 
through the activation of subcellular signaling pathways, (Yang et al., 2001). 
1.6.5 Cell Cycle Process 
Cancer cell growth and metastases can be prevented by specific cell cycle regulation. 
There are groups of proteins such as cyclin-dependent kinase groups that act in specific 
pathways to determine whether the cell cycle will go forward or remain between stages 
(Nigg, 1995). The cell cycle is a sequential process, which takes place in a cell, leading 
to its division and duplication. There are three stages for cell division; the first called 
the interphase, the second is the mitotic phase (M), and the final stage is cytokinesis 
(Alberts et al., 2002). The precise completion of one stage leads to activation of the 
following stage. 
Interphase is the longest phase; it consists of four steps: Gap 0 phase (GO), Growth 
phase 1 (GI), S phase (synthesis) phase, and Growth phase 2 (G2). These steps take 
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around 12 to 24 hours in mammalian tissues by which the cell produces protein 
synthesizing RNA, and grows in size (Alberts et al., 2002). 
GO phase is the arresting time when the cell leaves the cycle and stops dividing. 
Gl-phase is when the cell size increases and starts producing RNA and synthesises 
protein. G 1 checkpoint is an important control mechanism activated in this step to 
ensure that everything is prepared for DNA synthesis (Alberts et al., 2002). 
S-phase is where the replication of DNA starts. The aim of this duplication is to 
produce exactly two identical chromosomes in the new daughter cells. Accuracy is 
important in this step to prevent any genetic abnormalities that often lead to cell death 
or disease (Alberts et al., 2002). 
G2-phase is one in which cells remain growing and produce new proteins. By the end 
of this step another control checkpoint (G2 checkpoint) is used to check whether the 
cells are ready to enter the new stage, the mitosis phase (M), and divide (Alberts et al., 
2002). 
Mitosis-phase is the where the chromosomes split between the two daughter cells this 
phase is shorter than the interphase. Similar to Gland 02, there is a checkpoint in the 
middle of this phase to ensure that the cell is ready to complete division (Alberts et al., 
2002). -
Cytokinesis is the final stage in the cell cycle initiated at the late stage of mitosis 
(Alberts et al., 2002). The whole cell cycle process is illustrated in Figure 1.15. 
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Figure 1.15: Illustration of cell cycle process in eukaryotic. Source: Secko, 2003 
1.6.6 Cell Death Mechanisms 
There are several cell death mechanisms, as illustrated in Figure 1.16. Apoptosis is a 
type of cell death programmed process, characterised by changing cell morphology 
leading to cell death (Rowan and Fisher, 1997). The apoptosis pathway is induced by 
anticancer therapy through the induction of the intracellular cysteine family (caspase 
family) (Persson et al., 2009). Cell apoptosis is controlled via intrinsic or extrinsic 
pathways. Caspase activation protein, which is released from mitochondria, is 
responsible for the intrinsic pathway. The extrinsic pathway is controlled by trans-
membrane death receptors like turnor necrosis factor (TNF-R) (Seeram et al., 2005). 
The other cell death type, called necrosis, is characterised by cell swallowing and 
injury. The cells spill all their contents in the intracellular cell space and induce 
inflammation around the dying cell (Edinger and Thompson, 2004a). Another noo-
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apoptotic cell death is autophagy meaning eat oneself. In autophagy, during the period 
of nutrient stress, the cell components are degraded to produce energy referred to as the 
catabolic metabolic programme (Edinger and Thompson, 2004a). 
Figure 1.16: Representation of different cell death mechanism. Source: Zappavigna et al. , 
2013 
1.6.7 Pharmacological Effect of Pomegranate on Mammalian Cell 
Line 
1.6.7.1 Proliferation 
The chemical components of pomegranate seeds, juice and peels are reported to have 
pharmacological effect in mammalian cells that may prevent or be used in the treatment 
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of cancer as discussed below. Epidemiological studies suggest a protective role of 
pomegranate as anticancer and anti-proliferative activities (inhibit cell growth). In 
2006, Larrosa and colleagues found that ellagic acid (EA) produced from hydrolysable 
tannin and dietary ellagitannins (pomegranate punicalagin "PUNI") both inhibit the 
proliferation of Caco-2 cell line in a dose-and time-dependent manner at level of 30 
Jlmol/L and 100 Jlmol/L, respectively. Cell viability decreased at 24 hours, especially 
in the presence of PUNI (100 JlM) (Larrosa et al., 2006b) and a further decrease was 
shown when a mixture of EA and PUNI was added (Larrosa et al., 2006b). Another in 
vitro study done by (Seeram et al., 2005) evaluated anti-proliferative activities of 
punicalagin, ellagic acid (EA), total pomegranate tannin (TPT) and pomegranate juice 
(PJ). The effects of these components were studied on human oral (KB, CAL27), colon 
(HT-29, HCTl16, SW480, SW620) and prostate (RWPE-l,22Rvl) tumor cells. 
Pomegranate juice showed the greatest anti-proliferative effect against all cell lines. 
1.6.7.2 Apoptosis 
Several cancer research studies have focused on the types of cancer cell death 
mechanisms. A study of the apoptotic effect of punicalagin, ellagic acid (EA), total 
pomegranate tannin (TPT) and pomegranate juice (PJ) on (HT-29 and HCTl16) colon 
cancer cell lines showed that apoptosis was induced by PJ, EA, punicalagin and TPT in 
HT-29 colon cells at 100 Jlg/ml. However, EA, punicalagin and TPT (but not PJ) 
induced the apoptosis in HCT1l6 colon cells (Seeram et al., 2005). PUNI and EA 
significantly increased apoptosis in Caco-2 cells; the highest early apoptotic cell 
population was at 24 and 48 h in the presence of EA and PUNI, respectively (Larrosa et 
al., 2006b). In addition, the anti-carcinogenic effect is mainly due to the pomegranate 
ellagitannins hydrolysis product, EA that induces apoptosis in human colon cancer cell 
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line, via activating caspase 9 and effector caspase 3 due to the release of cytochrome C 
into the cytosol. The cell cycle of Caco-2 cells was arrested in the S phase (Larrosa et 
al., 2006b). 
From previous studies it is clear that pomegranate may have a cancer-chemo-preventive 
effect as well as a cancer chemotherapeutic effect against colon cancer. It has also been 
found that pomegranate has an effect against prostate (Malik et al., 2005), breast (Kim 
et al., 2002) and lung (Khan et 01., 2007) cancer. Pomegranate extraction showed a 
significant anti-proliferative and pro-apoptotic activity against highly aggressive human 
prostate cancer PC3 cells at (10-100 Ilglml, 48 hours) and resulted in a dose-dependent 
inhibition of cell growth/cell viability and apoptosis induction (Li et al., 2002). Also, it 
depicted alteration in the regulatory molecules arresting in the G 1 phase of the cell 
cycle (Malik et al., 2005). Furthermore, it has been speculated that EA, caffeic acid, 
luteolin and punicic acid are important components of pomegranate that significantly 
inhibit in-vitro invasion of human PC3 when employed individually (Lansky et al., 
2005). 
Punicalagin is an ellagitannin (type of phenolic compound). It is considered to be the 
main compound in pomegranate husk (Chen and Li, 2006; Kulkami et 01.,2007; Lee et 
al., 2008). Punicalagin is reported to have anti-cancer, anti-inflammatory and anti-
atherosclerotic properties (Chen et al., 2000; Seeram et al., 2005; Kulkami et al., 2007). 
Therefore, some bioactive properties of punicalagin were investigated in this research. 
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Figure 1.17: The chemical structure of punicalagin. Source: Larrosa et al., 2006a 
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1.7 Aim and Objectives 
To this end, it is clear that there is a growing interest in plant products such as 
polyphenols because of their bioactive properties that may be used for disease 
protection. In the present study, more attention was focused on the mechanistic that 
promote antioxidant, anti-carcinogenic and antihypertensive activity. For this reason, 
the aim of this research was to investigate some of the bioactive properties of 
ellagitannin "punicalagin" class of polyp he no Is through different in-vitro mechanisms. 
To achieve this goal the following was carried out: 
1. The radical scavenging and antioxidant activity of pomegranate and punicalagin 
was determined. 
2. The protective effects of punic ala gin under oxidative stress conditions caused by 
tert-butyl hydroperoxide treatment in a Caco-2 intestine cell line were studied. 
3. The inhibitory effect of punicalagin on angiotensin converting enzyme (ACE) 
and induction of nitric oxide (NO) production in the EA.hy926 endothelial cell 
line was examined. 
4. The effect of the active component of pomegranate punicalagin on human colon 
cancer Caco-2 cells was investigated. 
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2 Antioxidant Activity of Pomegranate Juice and 
Punicalagin 
2.1 Introduction 
Antioxidants are compounds that scavenge free radicals and convert them to non-
reactive molecules. These compounds are converted to stable molecule after quenching 
or scavenging free radical (Young and Woodside, 2001). 
Antioxidants are essential components of the human diet and recently there has been a 
great interest in using rich sources of natural antioxidants such as plants and food 
additives as they consist of vitamins (vitamin E, C and ~-carotene) and plant 
polyphenols. Natural antioxidants found in nutraceuticals and functional food plants are 
more advantageous than synthetic antioxidants like butylated hydroxytoluene (BHT) 
because of their ability to protect food against free radicals and reactive oxygen species 
(ROS) damage and reduce risk of chronic disease (Finley et al., 2011). 
It is well known that human health condition is partly controlled through the dietary 
intake of plant polyphenols. Antioxidants prevent food degradation and thus are used as 
food additives (Gulcin, 2012). It is, therefore, vital to improve our knowledge of 
polyphenol availability from diet. 
Pomegranate fruit contains many phenolic compounds including flavonoids-
anthocyanins, and other complex flavanoids and hydrolyzable tannins (punicalagin, 
gallic and ellagic acid), which are compounds with high antioxidant activity that may 
offer beneficial health properties. Around 92 % of pomegranate antioxidant activity was 
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comes from hydrolysable tannins (Passamonti et al., 2003). Punicalagin, ellagic acid 
and gallic acid are the polyphenols found in pomegranate (Gil et al., 2000). The main 
component of pomegranate husk is punicalagin (Chen and Li, 2006; Kulkami et al., 
2007; Lee et al., 2008). Punicalagin is reported to have anti-inflammatory, anti-cancer 
and anti-atherosclerotic properties (Chen et al., 2000; Seeram et al., 2005; Kulkami et 
01.,2007). 
Investigations on pomegranates show high antioxidant and anti-proliferative, anti-
cancer and pro-apoptotic activity in various cancer cell lines and animal models (Chen 
et al., 2000; Seeram et al., 2005; Kulkami et al., 2007). Pomegranate polyphenols are 
thus considered as agents capable of restraining the effect of ROS on the body (Chen et 
al., 2000, Seeram et al., 2005). 
Radicals are molecules with unpaired electrons that are highly reactive, e.g. hydroxyl 
radical OH
e 
and superoxide radical 0 20 -. Radicals form in all living organisms in 
nonnal metabolic pathways during oxidation reactions. The free radical concentration 
level increases under certain circumstances e.g. environmental stress, wounding and 
pathogen attack, and can damage the living organisms when left unchecked. Where cell 
membranes consist of unsaturated lipids (Halliwell, 1991), free radicals are reactive 
molecules that have the ability to react and damage all types of bio-molecules-lipid, 
proteins, carbohydrates and DNA. This damaging effect could lead to several diseases 
e.g. coronary heart disease, inflammation and cancer (Wolfe et al., 2008). 
Pomegranate juice was, nevertheless, found to exert potent antioxidant activity against 
lipid peroxidation (Malik et al., 2005). 
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The objectives of this chapter are: 
• To detennine the total polyphenol and flavonoid content in pomegranate 
JUIce. 
• 
• 
To detennine the presence of punic algin in pomegranate seed and husk. 
To detennine the antioxidant activities of punicalagin and pomegranate 
juice by using four methods: 
1) Radical scavenging method detennined by DPPH and H20 2 
scavenging for punicalagin and pomegranate juice at various 
concentrations. 
2) Ferrous chelating activity of punicalagin and pomegranate juice at 
different concentrations. 
3) Detennining the reducing power for each compound at several 
concentration levels. 
2.2 Materials and Methods 
2.2.1 Materials 
Trolox, 2,2-Diphenyl-l-picrylhydrazyl (DPPH), FeChAH2, Ethylenediaminetetraacetic 
acid (EDTA), Butylated hydroxytoluene (BHT), ferrozine ascorbate, H20 2, potassium 
ferricyanide, phosphate buffer, ferric chloride, gaIlic acid, catechin, Folin-Ciocalteu 
reagent, sodium nitrite, aluminum chloride, glacial acetic acid, acetonitrile, and fonnic 
acid were obtained from Sigma-Aldrich Chemical Co, (Pool, UK). Ethanol, methanol, 
trichloroacetic acid (TCA), sodium carbonate and sodium hydroxide were purchased 
from Fisher Scientific (Loughborough, UK). Phenomenex Synergi 4 Jlm Hydro-RP 
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80A column (250 mm x 4.6 mm x 5 Jlm) and Phenomenex C 18 5 Jlm column (250 mm 
x 3.0 mm) were obtained from Torrance, CA, USA. 
UVIKontron 860 spectrophotometer (Zurich, Switzerland) was used in all the 
experiments, described in this chapter, to measure the specific wave length for each 
experiment. 
2.2.2 Methods 
2.2.2.1 Sample Preparation 
Fresh pomegranates were harvested in Spain in September, 2011 were purchased from 
the local store and peeled, and the edible portions (seeds and arils) were juiced then 
stored at -80°C overnight. The resulting pomegranate juice (P J) was then freeze-dried 
for 7 days. The freeze-dried pomegranate (powder) was stored at -80°C until analysed. 
2.2.2.2 Determination of Total Phenolic and Total Flavonoid Content 
The total phenolic content of pomegranate juice was determined using the Folin-
Ciocalteu method described by Kim et al., (2003). A sample of I ml pomegranate juice 
(40 mg/ml) was mixed with 10 ml of deionised water and Iml Folin-Ciocalteu reagent. 
After 5 minutes, 2 ml of 2% sodium carbonate (w/v) was added to the solution. The 
mixture was incubated in a dark place at room temperature for 1 hour, whereby the 
absorbance of the solution was measured at 750 nm. The standard curve was 
determined with gallie acid (0, 50, 100, 150,200,250 and 500 Jlg/ml) (w/v) dissolved in 
50% methanol (v/v). The results were expressed as gallic acid equivalents. Zhishen et 
al., (1999) used an aluminum chloride colorimetric assay to determine the total 
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flavonoid. A sample (250 Ill) from (60 mg/ml pomegranate juice) or from the standard 
(0, 50, 100, 150, 200, 250, 300 and 500 Ilg/ml of catechin) was added to 1.25 ml 
deionised water and 75 J.lI of 5% NaN02 (w/v). After 5 minutes, 150 J.lI of 10% AIC!) 
was added to the mixture and 0.5 ml of 1 M NaOH (w/v) and 275 III deinoised water 
were added to make up the total volume of the solution to 2.5 ml and measure the 
absorbance at 510 nm. The total flavonoid content of pomegranate juice was expressed 
in terms of catechin equivalents. Each set of the three separate experiments was 
repeated three times in order to verify the results obtained from the determination of 
both total phenolic and flavonoid contents of pomegranate. 
2.2.2.3 Extraction of Sample for HPLC and LC-MS 
HPLC and LC-MS were carried out in North Carolina State University, United State. 
Freeze dried pomegranate samples (lg) were extracted with 25 ml 50% methanol in 
water, vigorously vortexed at room temperature. Extracted samples were centrifuged at 
1500 x g for 3 minutes using a Beckman GRP centrifuge. The supernatants were filtered 
through a Whatman No.1 filter paper in to a 50 ml volumetric flask. The precipitate 
was re-extracted with another 25 ml of 50% methanol then centrifuged, and the 
supernatant was added to the previously collected solution. In order to make up the 
volume of the volumetric flask, 50% methanol was used. Subsequently, I ml of the 
extracted solution was filtered through 0.2 mm PTFE filters in HPLC umber vial. 
Punicalagin standard was prepared by dissolving 0.5 mg in I ml of 100 % methanol. 
Samples were then filtered through 0.2 mm PTFE filters into HPLC amber vial for 
HPLC and LC-MS analysis. 
46 
Chapter 2: Antioxidant Activity of Pomegranate Juice and Punicalagin 
2.2.2.4 HPLC Analysis 
HPLC analyses were conducted using Agilent Technologies 1200 series HPLC (Santa 
Clara, CA, USA) with a photo diode array (PDA) detector and an auto sampler. 
Chemstation software was used to control the experiment and for quantification of 
phenolic compounds. Hydrolysable tannin separation was undertaken using a 
Phenomenex Synergi 4 Jlm Hydro-RP 80A column (250 mm x 4.6 mm x 5 Jlm, 
Torrance, CA, USA). The mobile phase was 2% acetic acid in distilled H20 (solvent A) 
and 0.5% acetic acid in 50% acetonitrile in water (solvent B). The flow rate was 
1 mLlmin with a step gradient of 10%, 55%, 100%, 10% and 10% of solvent B at 0, 10, 
13, 15 and 20 min, respectively. Samples, filtered through 0.2 mm PTFE filters, were 
injecting (10 JlL) on the HPLC column (25°C). Peak areas recorded at 280 run were 
quantified using a calibration curve obtained with punicalagin reference standard. 
(Gonzalez-Barrio et al., 2010). 
2.2.2.5 LC-MS Analysis 
Following HPLC analysis, the samples were injected on to the LC-MS Electrospray 
ionization ion-trap time-of-flight mass spectrometry (Shimadzu Scientific Instruments, 
Columbia, MD, USA) system for structural elucidation. PJE and standards were 
analysed on Phenomenex C18 column (250 mm x 3.0 mm x 5 Jlm, Torrance, CA, 
USA). The mobile phase consisted of 0.1 % formic acid in distilled H20 (solvent A) and 
0.1 % formic acid in methanol (solvent B). The flow rate was set at 0.4 mLlmin with a 
step gradient of 5%, 8%, 14%, 14%, 25%, 85% and 5% of solvent B at 0, 5, 15, 25, 30, 
32, and 40 min, respectively. Samples were filtered through 0.2 mm PTFE filters before 
injecting 5 J.lL on the LC-MS column (25°C). Quantification of the compound was 
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performed from the peak areas recorded at 250 run to the calibration curve obtained 
with reference standards punicalagin (Lu et al., 20 I 0). 
2.2.2.6 DPPH Radical Scavenging Activity 
The total radical scavenging capacity of pomegranate juice and punicalagin was 
determined by the Bersuder et al., (1998) method; this method was used to measure the 
reducing ability of antioxidants. Trolox and BHT were prepared with a concentration of 
0.1 mglml dissolved in deionised water whereas alcoholic DPPH concentration was set 
to 0.02% (w/v) in 99.5% ethanol. Different concentrations of 0.05, 0.1 and 0.15 mglml 
were prepared from pomegranate juice and punicalagin. Both control and blank samples 
were prepared in triplicate. A sample/control of 500 III was added to 500 III 99.5% 
ethanol, and 125 III of DPPH was then added to the solution and vortexed thoroughly. 
All samples were incubated in the dark for one hour; the absorption of the solution was 
read in the spectrometer calibrated with a phosphate buffer at 517 run. A blank was also 
prepared where 500 III of deionised water was used instead. The DPPH radical 
scavenging activity was then calculated as follows: 
ACDPPH - ASDPPH Radical Scavenging Activity(%) = AC xl00 
DPPH 
Where: ACDPPH represents the absorbance of the control which contains DPPH, and 
ASDPPH refers to the absorbance pomegranate / punicalagin in the presence of DPPH. 
2.2.2.7 Scavenging of Hydrogen Peroxide (HzOz) 
The ability of pomegranate juice and punicalagin to scavenge hydrogen peroxide was 
determined by the Gulcin et al., (2005) method. Different concentrations from 
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experimental samples have been studied (0.05, 0.1 and 0.15 mg/ml water). H20 2 (40 
mM) was prepared in phosphate buffer saline at pH 7.4 (v/v), and 0.6 ml was added to 
1 ml of each pomegranate and punicalagin concentration (0.05, 0.1 and 0.15 mg/ml). 
The solutions were then incubated for 10 minutes and read at 230 nm. The absorbance 
of the positive controls of 0.0.1 mg/ml BHT and trolox were measured. The percentage 
inhibition activity was calculated as follows: 
Where ACH202 is the absorbance of the control with H202 and ASH202 is the absorbance 
of testing sample in the presence of H202. 
2.2.2.8 Ferrous Chelating Activity 
Ferrous ion was measured by inhibiting the formation offerrous-ferrozine complex after 
adding the components under test (pomegranate juice and punicalagin) following a 
modified method (Dinis et al., 1994). The ch elating activity of substances was 
measured at 562 nm. Concentrations of 0.05, 0.1 and 0.15 mg of pomegranate juice and 
punicalagin were investigated. Slight modifications were made to the published method, 
wherein 1.5 ml of deionised water and 50 JlI of 2 mM FeCh (w/v) were added to 500 JlI 
of sample then vortexed. After 30 seconds, 100 JlI of 5 mM of ferrozine (w/v) was 
added to the solution. The final solution was incubated for 10 minutes at room 
temperature, and its absorption was read at 562 nm. Each sample of the above 
concentrations was prepared in triplicates with a blank for each concentration. A 0.01% 
EDT A solution was used as a positive control in this experiment. The chelating activity 
of the pomegranate juice and punicalagin for Fe2+ were calculated as: 
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Ao -Al 
Chelating rate(%) = Ao xlOO 
Where, Ao is the absorbance of the control that contains FeCh and ferrozine complex 
and Al is the treated sample in the presence of Fe Ch and ferrozine complex. 
2.2.2.9 Reducing Power Assay 
The reducing power of pomegranate juice and punicalagin were quantified by the 
Yildirim et al., (2000) method. This method is based on determining the ability of the 
tested material to reduce Fe3+ (CN)6 to Fe2+ (CN)6, in which the formed Perl's Prussian 
Blue complex was measured at 700 nm. A solution of 1 ml from each sample (with 
concentrations of 0.05, 0.1 and 0.15 mg/ml of water) was added to 2.S ml of 0.2 M 
pH 6.6-phosphate buffer (w/v) and 2.S ml of 1 % potassium ferricyanide (w/v). This 
mixture was incubated at SO °C for 30 minutes in a water bath. The reaction mixture 
was subsequently acidified by adding 2.S ml of 10% TCA (w/v) and centrifuged 
at 1600 rpm for 10 minutes at 10°C. Finally, 2.5 ml of supematant was mixed with 
2.5 ml deionised water and 0.5 ml of 1 % ferric chloride (w/v). The resultant mixture 
was then incubated for 10 minutes at room temperature, after which its absorbance was 
read at 700 nm; higher absorbance of the reaction mixtures indicates a higher reducing 
power. This experiment was repeated three times to verify the results. 
2.2.2.10 Statistical Analysis 
All experiments were presented as mean ± SD. All measurements were replicated three 
times. The data were statistically analysed using Graph Pad Prism. Differences 
between pomegranate arils and punicalagin were assessed by unpaired Hest. A one-
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way analysis of variance followed by Bonferroni's test testing between treatments and 
controls was performed. Values ofp S 0.05 were considered significant. 
2.3 Results and Discussion 
2.3.1 Total Phenol and Flavonoid Contents 
Standard curves of gallic acid and catechin were produced, as depicted in Figure 2.1 and 
Figure 2.2, respectively, to estimate the total polyphenols and flavonoid contents In 
pomegranate juice and punicalagin. 
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Figure 2.1: Gallic acid standard curve. Standard curve represented as mean ± SO of gallic 
acid (0-500 !!g/ml) for a total polyphenol content determination. R2 = 0.996. 
51 
Chapter 2: Antioxidant Activity of Pomegranate Juice and PunicaJagin 
1.5 
E 
= Q 
..... 1.0 I£l 
.... 
eo: 
~ 
~ 
= eo: 
..Q 0.5 l.. 
0 
'" ..Q 
< 
0.0 
0 200 400 600 
Concentration J..tg/ml 
Figure 2.2: Catechin standard curve. Standard curve represented as mean ± SD of catechin 
(0-500 !!g/ml) for total tlavonoids content determination. R2 = 0.993 . 
The quantitative detennination of the total phenolic content was expressed in mg of 
gallic acid corresponding to 40 mg dry weight of pomegranate arils. The content of 
polyphenols was 118.56 ~g of gallic acidl40 mg and the total flavonoid content of th 
pomegranate juice was 31.5 ~g of catechinl60 mg of dry weight of pomegranate ari l . 
2.3.2 HPLC and LC-MS Analysis 
Methanol extracts of pomegranate husk acquired from a local store in the United State 
and freeze-dried pomegranate arils from United States and United Kingdom were 
applied to HPLC. The Le-MS analysis was undertaken for pomegranate husk, 
pomegranate juice methanol extracts and compared with punicalagin standard . The 
HPLC and LC-MS chromatograms are illustrated in Figures 2.3, 2.4 and 2.5, 
respectively. There was a high degree of similarity found between the punicalagin 
standard and methanol extract from pomegranate husk. 
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Figure 2.3: HPLC a nalysis of punicalagin and pomegr anate husk. A= punicalagin standard, 
B= US pomegranate husk in 50% methanol. Separation conditions were: column Phenomenex 
Synergi 4 !-lm Hydro-RP 80A (250 mm x 4.6 mm x 5 !-lm, Torrance, CA, USA). Column 
temperature: 25 °C. Mobile phase: Solvent A= 2% acetic acid in distill ed H20 , Solvent B= 0.5% 
acetic acid in 50% acetonitri le in water. Grad ient condition: 10, 55 , J 00, 10 and 10 % at 0, 10, 
13, 15 and 20 min, respectively. The flow rate: I mLlmin, recorded at 280 nm. A= 
punicaJagin standard and B= methanol extract for pomegranate husk. 
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Figure 2.4: HPLC analysis of punicalagin a nd pomegra nate juice. A= punicalagin standard, 
B= US handy pomegranate juice and C= UK handy pomegranate juice extracted in 50% 
methanol. Separation conditions were: column Phenomenex Synergi 4 !-lm Hydro-RP 80A (250 
mm x 4.6 mm x 5 !lm, Torrance, CA, USA). Column temperature: 25 °C. Mobi le phase: 
Solvent A= 2% acetic acid in distilled H20, Solvent B= 0.5% acetic acid in 50% acetonitrile in 
water. Gradient condition: 10, 55, 100, 10 and 10 % at 0, 10, 13,15 and 20 min , respectively. 
The flow rate: 1 mLlmin, recorded at 280 nm. 
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Figure 2.5: Identification of punicalagin in methanol extract of pomegranate husk by LC-
MS. Identification conditions were: column C 18 (250 mm x 3.0 mm x 5)lm Torrance, A, 
USA). Column temperature : 25 DC. Mobile phase: Solvent A= 0.1 % formic acid in di tilled 
H20 , Solvent B= 0.1 % formic acid in methanol. Gradient conditions: 5-85% olvent B 
followed by 10 min re-equilibration. Flow rate: 0.4 mllmin monitord at 250 nm. A= 
punicalagin standard, B= methanol extract of pomegranate husk. 
The retention time was 17 minutes for the total run of 20 minutes in HPLC and 40 
minutes for a total run of 40 minutes. In contrast, the chromatograms resulting fro m the 
methanol extract for pomegranate juice from both countries did not show any peak for 
punicalagin. 
Several analytical reports on extracted pomegranate juice manually found that the 
concentrations of anthocyanin are higher than tannin compounds present In 
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pomegranate husk such as punic ala gin, gallic acid and ellagic acid (Gil et al., 2000; 
Fischer et al., 2011; Qu et al., 2012). These high concentrations of gallic acid, 
punicalagin and ellagic acid were found in both pomegranate husk and commercial 
juice because the majority of phenolic compounds were extracted during the pressing 
process (Gil et 01.,2000; Fischer et 01.,2011). 
2.3.3 DPPH Radical Scavenging Activity 
The mechanism of antioxidant action differs from one component to another; 
consequently it cannot be assumed that only one mechanism reflects the antioxidant 
activity of the compounds. For this reason, investigation of different antioxidant 
mechanisms has been adopted in this study. 
DPPH exists as a stabilised free radical, which has a deep violet colour with an 
absorbance wavelength of 520 nm. In the presence of antioxidants, the DPPH radical 
form is converted to a DPPH-H non-radical form. The ability to bleach the purple 
colour to yellow indicates the efficacy of the antioxidant component. When the odd 
electron in DPPH accepts a hydrogen atom or electron from the antioxidant, the 
absorbance decreased proportionally due to the increase in the non- radical form of 
DPPH. The changes in the DPPH radical scavenging effects of pomegranate juice and 
punicalagin at different concentrations (0.05, 0.1 and 0.15 mg/ml) are shown in 
Figure 2.6. 
The percentages of inhibition caused by pomegranate juice were 14.4, 27.5 and 37.9% 
for the concentrations (0.05, 0.1 and 0.15 mg/ml), respectively, while the scavenging 
activity in the presence of punicalagin at the same concentrations was (12.5, 23.9 and 
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30.8 %), respectively. The DPPH radical scavenging effects increased in proportion to 
the dose. It was noted that at 0.1 and 0.15 mg/ml pomegranate juice, radical scavenging 
was significant as compared with punicalagin at the same concentrations (p SO.05). 
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Figure 2.6: DPPH r adica l scavenging activity by pomegr anate juice and punicalagin. 
Concentrations of both components were 0.05 , 0.1 and 0.15 mg/mt. Each va lue is expre sed as 
mean ± SD (n=3) of triplicate measurements. Comparisons of means were made u ing unpaired 
t-test (* = p < 0.05). 
This radical scavenging activity of pomegranate juice and punicalagin at 0.1 mg/m) wa 
compared to 0.1 mg/ml of trolox and BHT individually. DPPH radical cavenging 
activity was significantly increased by trolox compared to 0.1 mg/ml of pomegranate 
juice and punicalagin (p S 0.0001 ) the percent of inhibition was 66, 27.5 and 23 .9 % 
respectively. However, there was no significant difference in DPPH radical scavenging 
activity between BHT, pomegranate juice and punicalagin (p > 0.05), the percent 
inhibition was 24, 27.5 and 23.9 % respectively (Figure 2.7 A and B). It is likely that 
pomegranate juice and punicalagin have the ability to scavenge DPPH radical due to the 
presence of multiple phenolic hydroxyl groups (Chen and Ho, 1997; Bouchet et al., 
1998). 
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Figure 2.7: Comparison between DPPH radical scavenging activity of pu nicalagin, 
pomegra nate juice, t rolox a nd BHT . Concentration was 0.1 mg/ml for all components. Value 
are mean ± SD of three determinations. Comparisons of means were made u ing a one-way 
ANOVA followed by Bonferroni's test (*** = p < 0.0001 ). 
In a research study conducted by Gulcin et al., (2010), tannic acid concentration 
between (15-45 ~g/ml) produced significant inhibition of DPPH. The scavenging effect 
for BHT was more significant than tannic acid, while the tannic acid DPPH cavenging 
activity was more than a-tocopherol and trolox . In contrast to our findin g, the 
scavenging effect of DPPH was not significant when compared BHT with punicalagin 
or pomegranate juice. In contrast, trolox showed a significant difference when 
compared with punicalagin (which is hydrolysable tannin) or pomegranate juice 
(containing tannin). Methanolic extracts of phenolic compounds from peanut hull s 
(1.5 mg/ml) produced a significant inhibition of DPPH of about 90% scavenging 
activity. This inhibition of DPPH radicals was similar to the scavenging ac tivity from 
BHA and catechin at 8 ~M and 240 ~M respectively (Yen and Duh, 1994). 
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2.3.4 Scavenging of Hydrogen Peroxide (H20 2) 
The ability of pomegranate juice and punicalagin to scavenge H20 2 was measured at 
320 run. The presence of phenolic groups in pomegranate juice and punicalagin give 
them the ability to donate an electron to H20 2 and convert it to H20 (Ebrahimzadeh et 
al., 2010). There was significant inhibition percent of pomegranate juice compared with 
punicalagin at the highest concentration (p < 0.001) as depicted in Figure 2.8. 
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Figure 2.8: H 20 2 scavenging activity of pomegranate juice and punicalagin. Concentrations 
were 0.05 , 0.1 and 0.15 mg/ml. Each value is expressed as mean ± SD of triplicate 
measurements. Comparisons of means were made using unpaired t- test (** = p < 0.00 I). 
The percent of inhibition activity of H20 2 was 14 %, 17% and 30% for 0.05 , 0.1 and 
0.15 mg/ml of pomegranate juice respectively. On the other hand, the percent of H20 2 
scavenging by 0.05, 0.1 and 0.15 mg/ml of punicalagin was 11 %, 17% and 18% 
respectively. Both compounds showed scavenging of H20 2 with increasing 
concentrations. 
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Figure 2.9 (A and B) illustrates the activity of 0.1 mg/ml trolox and BHT compared 
with 0.1 mg/ml pomegranate juice and punicalagin. Scavenging activity va lues for 
trolox, BHT, pomegranate juice and punicalagin were 19, 13 , 17 and 17.8% 
respectively. The pomegranate juice and punicalagin showed a sign ificant increase in 
the scavenging of H20 2 compared with BHT (p < 0.001). However, no sign ificant 
difference was observed between trolox, pomegranate juice and punicalagin. Although 
H20 2 itself is a weak oxidant, it is sometimes toxic to the cell because it may give ri se 
to a hydroxyl radical in the cell (Ebrahimzadeh et al. , 2009), which results in lipid 
peroxidation as described in the introduction chapter (1.3.2). 
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Figure 2.9: Comparison of H20 2 scavenging activity of pomegranate juice, punicaJagin, 
tro lox and BHT. Concentration was 0.1 mg/m!. Values are mean ± SO of three experiments. 
Comparisons of means were made using a one-way ANOV A followed by Bonferroni' test (** 
= p < 0.001). 
Oil et al., (2000) reported, that both experimental (hand pressing in the laboratory) and 
commercial pomegranate juice demonstrated antioxidant activity that was alway higher 
than that of red wine and green tea. The activity of experimental juice was, however, 
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lower than that of the commercial juice (Gil et al., 2000). Hydrogen peroxide was 
significantly scavenging by 15 Ilg/ml tannic acid (a type of tannin polyphenols). This 
tannic acid has higher scavenging activity compared to other standards, i.e.( Tannic acid 
> a-tocopherol> BHT > trolox) (Giil!yin et al., 2010). The above results are similar to 
our findings for HzOz scavenging activity, i.e. pomegranate juice (containing tannins) 
and punicalagin (which is a hydrolysable tannin) were significantly higher than BHT 
(p <0.001) and were similar to trolox (p >0.05). Moreover, the methanolic extract of 
peanut hulls showed the ability to scavenge HzOz at 1.2 mg/ml, similar to standards 
BHA and catechin (Yen and Duh, 1994). 
2.3.5 Ferrous Chelating Activity 
With regards to ferrous ion chelating ability, the formation of Fe2+-ferrozine complex is 
inhibited in the presence of antioxidant. The antioxidant that has the ability to inhibit 
the formation of this complex is expressed as Fe2+ chelatinon. The chelation of ferrous 
ions by pomegranate juice and punicalagin is shown in Figure 2.10. Both components 
chelater ferrous ion in a dose dependent-manner; at 0.15 mg/ml punicalagin was 
significantly higher than pomegranate juice as ferrous chelator (p ~ 0.05). A standard 
metal chelating agent used in this experiment was EDTA. Ferrous chelating activity of 
EDTA was 97% while, for pomegranate juice and punicalagin, chelating activity were 
lower at 14% and 18% respectively (Figure 2.11). 
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Figure 2.10: Ferrous ion chelating activity by pomegranate juice and punicalagin. 
Concentrations were 0.05, 0.1 and 0.15 mg/m!. Each value is the mean ± SD of three 
measurements. Comparisons of means were made using unpird t-test (* = p < 0.05). 
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Figure 2.11: Metal cheiating activity of pomegranate juice, punicalagin and EDT A. 
Concentration was 0.1 mg/m!. Values are mean ± SD of three experiments. Compari on of 
means were made using a one-way ANOVA followed by Bonferroni's test (*** = p < 0.000 I). 
Punicalagin and pomegranate juice that contain several OH groups are efficient to 
chelating ferrous ion. Yen and Duh (1994) found that, the methanolic extract of peanut 
hulls did not show any chelating activity for metal ions compared with EDT A. Gtil9in 
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et al., (2010) examined ferrous chelation activity of tannic acid, BHT and a-tocopherol. 
Tannic acid which is tannin polyphenols showed the ability to chelate ferrous ion at 15 
J.tglml, the chelation percentage was found to be similar to that of BHT and higher than 
a-tocopherol (Giil~in et al., 2010) which is similar to our finding since both 
pomegranate juice contain tannin and punicalagin is a type of hydrolysable tannin. 
2.3.6 Reducing Power Assay 
Reducing power reflects the electron donating capacity of bioactive compounds; a 
mechanism also known as antioxidant activity. It measures the reduction of Fe3+/ Fe2+ 
thiocyanide in the presence of antioxidants; the resulting ferrocyanids form a complex 
with ferric chloride. The results showed an increase in the absorbance at 700 nm and, 
therefore, an increase in the reductive ability of pomegranate juice and punicalagin 
(Gulcin et al., 2005). Figure 2.12 illustrates the reducing activities corresponding to the 
concentration range (0.05, 0.1 and 0.15 mg/ml) of pomegranate juice and punicalagin. 
The reducing activity for both treatments increased in a dose dependent manner. The 
reducing activity shown by punicalagin increased significantly compared with 
pomegranate juice (p ::s 0.05) at all concentrations. 
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D punicalagin 
Figure 2.12: Reducing power of different concentrations from pomegranate juice and 
punicalagin. Each value is expressed as mean ± SD. Each value is the means ± SO of three 
measurements. Comparisons of means were made using unpird t- test ( '" = p < 0.05). 
These results demonstrate that pomegranate juice and punicalagin have the ability to 
reduce ferric ions and donate electrons to neutralise free radicals by forming table 
products (Gulcin, 2012). Reducing power is a significant indicator that pomegranate 
juice and punicalagin demonstrate antioxidant activity. As reported from Gill et al. , 
(2000), punicalagin (type of tannin) contain 16 phenolic hydroxyls per molecule while 
the manually extracted pomegranate juice contains higher concentration of anthocyanin 
than tannin group. This could explain the higher reducing activity of punicalagin than 
that of pomegranate juice extract. 
2.4 Conclusion 
The study confmned that punicalagin was present in high concentrations 111 
pomegranate husk compared to pomegranate juice, as measured using a punicalagin 
standard. All experiments on pomegranate juice and punicalagin to determine the 
antioxidant mechanism concluded that pomegranate juice has a significantly higher 
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radical scavenging activity in comparison with punicalagin (p :5 0.05). However, 
punicalagin showed significant ferrous chelating activity ability as compared with 
pomegranate juice. Both of these tested samples had the ability to reduce Fe3+ ion to 
Fe2+. However, punicalagin showed significant reducing power ability in a dose 
dependent manner compared with pomegranate juice. Nonetheless, both the 
pomegranate juice and punicalagin depict the ability to scavenge H20 2. In addition, 
both punicalagin and pomegranate juice showed non- significant inhibition of DPPH 
radicals compared with BHT and significant scavenging of H202 compared with BHT. 
Although, the DPPH radicals significantly inhibited by trolox compared with 
punicalagin and pomegranate juice, there was no significant difference found in H20Z 
scavenging for both pomegranate juice and punic ala gin compared with trolox. 
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3 Protective Effects of Punicalagin on Caco-2 Intestine 
Cell Line under Oxidative Stress Caused by Tert-butyl 
hydroperoxide 
3.1 Introduction 
Oxidative damage to cellular components occurs if there is an imbalance between the 
antioxidant capacity of cellular antioxidants in a biological system and the 
quantity/activity of reactive oxygen species (ROS). Excessive ROS production leads to 
tissue injury and is the basis of several human diseases such as coronary heart disease 
and cancer (Wijeratne et al., 2005). Free radicals can alter the poly-unsaturated fatty 
acids present in the cell membrane and change the permeability of the membrane itself. 
The lipid bilayer exists in all cellular organisms and forms the plasma membrane, and 
the surrounding membrane of organelles such as the endoplasmic reticulum and 
mitochondria. In addition to causing direct cellular damage to the membrane, the lipid 
peroxidation products, such as malondialdehyde (MDA), are also very toxic 
(Devasagayam et al., 2003). For this reason, biological systems are normally protected 
from oxidation by their in-built antioxidant defence systems and by dietary antioxidant. 
One of the important antioxidant defence mechanisms at cellular level is the 
concentration of reduced glutathione (GSH). 
Glutathione is a tri-peptide of glutamic acid, cysteine and glycine. It has the ability to 
work as an antioxidant, protecting the cell from damage caused by ROS (Castell et al., 
1997). Reduced and oxidized forms of GSH are both present in the cell at the same 
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time. In healthy cells and tissues, the reduced form of GSH accounts for more than 
90%, while the oxidized form (GSSG) accounts for less than 10%. A severe decrease in 
GSH level in the cell leads to the susceptibility of the cell to oxidative damage by 
radicals (Castell et al., 1997). Previous studies have indicated a relationship between 
polyphenols and GSH levels in the cell. Polyphenols have the ability to prevent the 
decrease of GSH levels induced by tert-butylhydroperoxide (T-BOOH) (Kedderis, 
1996, Castell et al., 1997, Lima et al., 2006). Thus, natural products containing 
polyphenols have been proposed as antioxidants. 
Epidemiological studies have shown that the intake of polyphenol may reduce the risk 
of some diseases such as cancer and cardiovascular disease (Steinmetz and Potter, 1996; 
Arts et 01.,2001). Pomegranate juice has a high content of phenolic compounds (such as 
punicalagin isomers, ellagic acid) and anthocyan ins (such as delphinidin, cyanidin, and 
pelargonidin) (Gil et al., 2000). Gallic and ellagic acid link to glucose molecules to 
form punicalagin. The high antioxidant properties of pomegranate juice are due to the 
presence of punicalagin (Gil et al., 2000). Punicalagin is a yellow water-soluble 
compound that is mainly present in the pomegranate husk and is extracted in the juice 
during fruit processing (Gil et al., 2000). 
Previous studies on polyphenols and flavonoids demonstrate their ability to prevent 
lipid peroxidation in living cells by trapping free radicals (Cotelle et al., 1996; van 
Acker et al., 1996; Cao et al., 1997). The tissue with the highest exposure to dietary 
flavonoids and polyphenols is the intestine. For this reason, human intestinal Caco-2 
cells were used as a model to investigate the protective effects of punicalagin under 
oxidative conditions caused by T-BOOH by measure, GSH, ROS and MDA levels. 
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The aims of this chapter are: 
• To determine the cytotoxicity of dimethyl sulphoxide (DMSO) and methanol 
(MeOH) on Caco2 cells to choose an appropriate solvent for punicalagin. 
• To study the antioxidant activity of different concentrations (1-200 IlM) of 
punicalagin to determine if it is cytotoxic to Caco-2 cells by the MTT method. 
• To determine the cytotoxicity of T -BOOH at different concentrations (2, 3, 5 
and 10 mM) and to assess whether punic ala gin treatment decreases lipid 
oxidation in Caco-2 cells by measuring cell viability. 
• To determine MDA levels by the TBARS method. 
• To determine the antioxidant effect of punicalagin as a ROS scavenger 
• To determine the GSH level with treatments before and after induction by 
T-BOOH. 
• To assess cellular morphology with treatments before and after induction by 
T-BOOH. 
3.2 Materials and Methods 
3.2.1 Materials 
The Caco-2 cell line was obtained from the European Collection of Cell Cultures 
(ECACC) Salisbury, UK. Phosphate buffered saline (PBS) tablets were obtained from 
Oxoid, Hampshire, UK. Punicalagin, T -BOOH, 3-( 4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT dye), thiobarbituric acid (TB A), trichloroacetic acid 
(TCA), 1,1 ,3,3-tetraethoxypropane (TEP), DMSO, and cell lysis buffer were obtained 
from Sigma-Aldrich Chemical Co, Poole, UK. Foetal bovine serum (FBS), trypsin-
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EDTA solution, L-glutamine (200 mM), non-essential amino acids (NEAAs), 
Dulbecco's Modified Essential Medium (DMEM) and CM-H2DCFDA were purchased 
from Invitrogen, Paisley, UK. A total glutathione peroxidase kit was obtained from the 
Cell Biolabs, INC, Cambridge, UK. 
3.2.2 Methods 
3.2.2.1 Solutions and Buffers for Tissue Culture 
3.2.2.1.1 Phosphate Buffered Saline (PBS) 
One tablet was dissolved in 100 ml of Milli-Q water and autoclaved to sterilise. 
3.2.2.1.2 MTT Stock 
MTT (5 mg) was dissolved in 1 ml PBS solution, sterilised and filtered, and then stored 
at 4 °c. 
3.2.2.1.3 FBS DMEM Media (Complete Media) 
DMEM media was supplemented with 20% FBS, 1 % glutamate, 1 % NEAA and 1 % 
penicillin. 
3.2.2.1.4 Freezing Media 
FBS was supplemented with 10% DMSO. 
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3.2.2.2 Cell Culture 
3.2.2.2.1 Routine Cell Culture 
Caco-2 cells were grown in DMEM complete media. Cells were grown in a monolayer 
starting with a cell concentration of 1 x 106 cells/ml in 75cm2 flasks. Cells were sub-
cultured at 3 day intervals by trypsinisation. Caco-2 cells were maintained in a 
humidified atmosphere in 5% C02 at 37°C. 
3.2.2.2.2 Trypsinisation 
Media was removed from cells when 70%-90% confluent and cells were washed with 
PBS. The PBS was aspirated and 5 ml trypsin was added to the 75cm2 flask. Cells were 
incubated for 8 minutes in the incubator. Cells were then detached from the flask 
surface by tapping. Complete media (5 ml) was then added to inactivate the tyrpsin. 
Cells were then ready for counting, culturing and freezing. 
3.2.2.2.3 Cell Count 
A cell suspension (10 JlI) was placed on a haemocytometer slide with a depth of 0.2 
mm. The total cell number was counted in the four chambers using an inverted 
microscope. The number of cells in the chamber and the volume of suspension were 
used to calculate the cell concentration; this was then used to determine the volume of 
cell suspension required to seed cells at a particular density: 
C II 
Number of cells neededxI0 
e count = ------------------~----~~--------~~----~~~ Average number of counted cellsxl04 xl0 
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3.2.2.2.4 Cell Freezing 
Cells of 80% confluency were trypsinised and collected in a 50 ml centrifuge tube and 
centrifuged at 500 x g for 5 minutes. The media was removed and the cell pellet re-
suspended in the freezing media. Cell suspension (1.8 ml) was added to cryovial tubes. 
Vials were stored at 4 °C for 30 minutes, and then moved to a freezer at -80°C. On the 
following day, vials were transferred to a liquid nitrogen container for longer-term 
storage. 
3.2.2.2.5 Cell Thawing 
Cell vials to be thawed were immersed in a 37°C water bath and gently agitated until 
thawed. The contents of the vial were transferred to a 20 ml centrifuge tube containing 
complete media (8 ml) and the suspension was centrifuged at 500 x g for 5 minutes. 
The media was removed and the cell pellet re-suspended in 15 ml complete media. The 
cell suspension was then transferred to a 75cm2 flask. 
3.2.2.3 MTT Assay 
3.2.2.3.1 Principle 
The MTT assay is dependent on the conversion of the soluble, yellow MTT dye to the 
insoluble purple formazan by the mitochondrial enzyme, succinate dehydrogenase. This 
occurs in metabolically active cells. Succinate dehydrogenase cleaves the tetrazolium 
ring in the MTT structure and converts it to formazan. Water insoluble formazan is 
largely impermeable to cell membranes and, therefore, accumulates within healthy cells 
(Jouvet et al., 2000; Waterfield et al., 1998). When formazan is solubilised in DMSO it 
produces a purple colour, which is measured by simple colorimetric assay at 492 nm 
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using a plate reader (Boehring CO, Marburg, Gennany). The intensity of the colour is 
proportional to the amount of living cells present: 
Mean absorbance of samplexl00 
%Cell Viability = -------~---~----::-:­Mean absorbance of untreated cells 
3.2.2.3.2 Determination of Methanol (MeOH) and Dimethyl sulfoxide (DMSO) 
Cytotoxicity by MTT Assay 
Since the punic ala gin used in these investigations has the ability to dissolve in methanol 
and DMSO, the cytotoxicity of different concentrations of the solvents (0.1 % - 1 %) was 
tested on Caco-2 cells. Caco-2 cells were seeded into 96-well tissue culture plates with 
200 III DMEM complete media at a density of 1 xl 04 cells/ well. Cells were incubated 
for 24 hours at 37 QC to allow attachment. The plate was removed from the incubator 
after 24 hours and the media was aspirated. The plate was washed with 200 III PBS, 
which was then aspirated from the cells. Cells were then incubated with different 
concentrations of DMSO and methanol individually for 24 hours at 37 QC. The plate 
was removed from the incubator and the media was aspirated. The plate was then 
washed with 200 Jl1 with PBS. Following removal of the PBS, 20 JlI MTT dye was 
added to each well along with 50 III complete media to cover the MTT dye. The plate 
was incubated for 2 hours at 37 QC. At the end of the incubation time, the culture media 
was aspirated and 50 III of DMSO was added to each well. The fonnazan crystals 
produced were dissolved completely by shaking the plate for 30 seconds at room 
temperature. The colour intensity was measured at 492 nm using a plate reader 
(Boehring CO, Marburg, Gennany). 
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3.2.2.3.3 Determination the Cytotoxicity of Punicalagin 
The cytotoxic effect of different concentrations of punicalagin ranging from 1-200 IlM 
on Caco-2 cells was studied. A stock solution (10 mM) of punic ala gin was prepared in 
DMSO. Caco-2 cells were seeded into 96-well tissue culture plates at 
1 x 104 cells/200 III DMEM complete media. After 24 hours, punic ala gin was added to 
each well to give a final concentration of 1, 3, 5, 10, 50, 100, 150 and 200 J.lM. The 
MTT assay was performed after 24 hours incubation at 37°C and 5% C02. The plate 
was removed from the incubator and the media was aspirated. Following this, the plate 
was washed with 200 III with PBS. The buffer was aspirated and 20 III MTT dye was 
added to each well. A small volume (50 Ill) of complete media was then added to cover 
the MTT dye. The plate was incubated for 2 hours at 37°C. At the end of incubation 
time, the culture media was aspirated and 50 J.lI of DMSO was added to each well. The 
formazan crystals produced were dissolved completely by shaking the plate for 30 
seconds at room temperature. The colour was measured at 492 nm using a plate reader 
(Boehring CO, Marburg, Germany) 
3.2.2.3.4 Determination the ICso for Tert-butylhydroperoxide (T-BOOII) 
The effect of different concentrations of T-BOOH on Caco-2 cells was investigated to 
determine the ICso. Caco-2 cells were incubated with different concentrations of T-
BOOH (1, 3, 5 and 10 mM). The T-BOOH concentrations were prepared in complete 
media. Caco-2 cells were seeded into 96-well tissue culture plates at a density of 
1 x 104 cells/200 J.lI DMEM complete media. After 24 hours, each of the four 
experimental concentrations were incubated with Caco-2 cells for 2 hours. The MTT 
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assay (described above) was perfonned to detennine cell viability. Absorbance was read 
at 492 nm using a plate reader (Boehring CO, Marburg, Gennany). 
3.2.2.3.5 Determination the Protective Concentrations of Punicalagin in Caco-2 
Cells Treated with T-BOOH 
The antioxidant activity of punic ala gin in cells treated with T-BOOH was measured by 
MTT method. Caco-2 cells were seeded into 96-well tissue culture plates at a density of 
1 x 104 cells/200 Jll DMEM complete media. After 24 hours, the cells were incubated at 
37°C for 24 hours with 1, 3, 5 and 10 JlM punicalagin. Then the media was aspirated 
and the cells washed with 200 JlI ofPBS. T-BOOH (3 mM) was added to the pre-treated 
cells and incubated for 2 hours at 37°C and 5% C02. Cell viability was then 
detennined by the MTT assay (see section 3.2.4.2). Absorbance was read at 492 nm 
using a plate reader (Boehring CO, Marburg, Gennany). 
3.2.2.4 Determination of Thiobarbituric Acid Reactive Substances 
(TBARS) 
TBARS are considered a marker of lipid peroxidation (Liu et al., 1997; Devasagayam et 
al., 2003). The spectrophotometric method of Ohkawa et al., (1979) was used with 
some modifications to detect TBARS in the biological system. The oxidation of poly-
unsaturated fatty acid present in cell membranes produces MDA. Caco-2 cells at a 
density of 1 x 1 06 cells/ml were seeded in 25cm2 tissue culture flasks. Once 50% 
confluency was achieved, cells were treated with 5 and 10 JlM punicalagin and 
incubated for 24 hours. Trolox, at a concentration of 0.01%, was used as positive 
control. After 24 hours, the media was aspirated and the cells were washed with 5 ml 
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PBS. T-BOOH (3 mM) was added to the treated cells and incubated for 2 hours. At the 
end of incubation time, the cells were scraped with 3ml of 20% TCA. Cells were then 
collected with 2 ml of 0.7% TBA and incubated in a water bath at 100°C for 1 hour. 
After cooling, the tubes were centrifuged at 1500 x g for 10 minutes. The intensity of 
the pink colour was determined by reading the absorbance at 535 run using a 
spectrophotometer (UNICAM Spectronic, Leeds, UK). A stock solution of TEP 
(200 Ilg/ml) was prepared to obtain a standard curve with a range of 0-200 Ilglml. The 
MDA concentration was expressed in runol of MDAlmg protein. 
3.2.2.5 Measurement of Cellular Reactive Oxygen Species (ROS) 
Dichlorofluorescein dye (non-fluorescent CM-H2DCFDA) has the ability to diffuse 
through cell membranes. In the cytoplasm, this dye is hydrolysed enzymatically by 
intracellular esterases and in rapidly converted to fluoresce in dye (DCF) in the presence 
of ROS. The fluorescence intensity of DCF is proportional to the ROS content (Osseni 
et al., 1999). The ROS levels in Caco-2 cells incubated with 5 and 10 IlM punicalagin 
were measured by flow cytometry using the CM-H2DCFDA dye. Caco-2 cells were 
seeded in 25cm1 flasks at a density of 1 x 1 06 cells/ml. The treatments were applied for 
24 hours after the cells reached 60-70% confluence. Following incubation, the media 
was aspirated and the cells washed with 5 ml PBS. T -BOOH (3 mM) was added to the 
treated cells and incubated for 2 hours. At the end of the incubation time, the cells were 
trypsinised and the cell suspension centrifuged for 3 minutes at 150 x g using a 
Beckman GRP centrifuge. The supematant was discarded and the cells were washed 
and centrifuged with 3 ml PBS. Again the supematant was discarded and 1 ml PBS was 
added. The cells were incubated with 5 IlM ofCM-H2DCFDA (prepared in DMSO) for 
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30 minutes at 37°C and 5% C02. At the end of the incubation time, the cells were kept 
on ice under low light conditions due to the high susceptibility of the dye to photo-
oxidation. DCF florescence was measured using a BD F ACSCanto flow cytometer 
(California, USA). At least 10,000 events were acquired in the gated regions using an 
emission wavelength of 520 nm. Trolox, at a concentration of 0.01%, was used as 
positive control. 
3.2.2.6 Preparation of Cell Lysates 
Caco-2 cells at a density I x 106 cells/ml were seeded in 25cm2 tissue culture flasks. 
Once 50% confluency was achieved, cells were treated with 5 and 10 J.1M punic ala gin 
and incubated for 24 hours. Trolox (0.0 1%) was used as a positive control. After 
24 hours, the media was aspirated and the cells washed with 5 ml PBS. T-BOOH 
(3 mM) was added to the treated cells and incubated for 2 hours. At the end of the 
incubation period, the culture media was decanted and cells were washed with 5 ml 
PBS. The cells were trypsinised and the cell suspensions centrifuged at 1500 x g for 
3 minutes. Pellets were washed with 5 ml PBS. Supernatants were removed and the cell 
pellets were lysed by adding 300 J.11 of lysis buffer (Sigma-Aldrich Chemical Co, Poole, 
UK). The sample was then immersed in ice for 20 minutes and stored at -80°C until 
protein concentration was measured and total GSH was determined. 
3.2.2.6.1 Protein Quantification 
The protein concentration of each sample was measured by the Bradford, (1976) 
method using a BioRad assay following the manufacturer's instructions. Briefly, 
samples were diluted I: 1 0 and 50 III of each was added to 96-well plate. To each 
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sample,25 I-lI working solution (20 I-lI reagent S per ml reagent A) was added followed 
by 200 I-lI of reagent B into each well. The intensity of the blue colour fonned was 
measured at 690 nm using a plate reader (Boehring CO, Marburg, aennany). 
Bovine serum albumin (BSA) was used as a protein standard to generate a standard 
curve. Six dilutions of BSA prepared in reverse osmosis (Ra) water ranging from 0.1 to 
1 mg/ml were used. The standard samples were treated in the same way as the samples. 
The absorbance of the solutions was measured at 690 nm. 
3.2.2.7 Determination of Total Glutathione (GSH) 
A total aSH assay kit from Cell Biolabs was used to measure the total concentration of 
GSH. Oxidized GSH (GSSG) can be reduced to GSH in the presence of NADPH and 
the GSH reductase enzyme. Consequently, the thiol group of GSH reacts with the 
chromogen to produce a yellow colour that absorbs light at 405 nm. The aSH 
concentration in the sample is proportional to the absorbance value of the chromophore. 
The unknown concentration of aSH was detennined by generating a aSH standard 
curve. Briefly, 25 I-lI aSH reductase was added to a 96-well plate followed by the 
addition of25 I-llofNADPH. Samples and standards of volume 100 I-lI were applied to 
the mixture followed by adding 50 I-lI of chromogen. The absorbance was recorded 
immediately at 405 nm. 
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3.2.2.8 Morphology 
Cell morphology was assessed through microscopic observation of the Caco-2 cellline 
(treated with control, trolox, 5 and 10 ~M punicalagin) with and without incubation 
with 3 mM T-BOOH for 2 hours. Cells were seeded in T 25 flasks at a concentration 
1 x106 cells/ml. After 24 hours, treatments (trolox or punicalagin) were applied. Cells 
were then incubated with 3 mM T -BOOH for 2 hours. A photograph of the cells was 
taken using a Nikon Eclipse microscope at lOx magnification. 
3.2.2.9 Statistical analyses 
All experiments were performed at least three times. For the 96-well micro-titer tissue 
culture plates, 4 replicate wells were used per category. The data were analyzed using 
Graphpad Prism software version 6. Significant differences between control and 
experimental values were determined by one way analysis of variance followed by the 
Bonferroni test using a significance level of ::: 0.05. 
3.3 Results and Discussion 
3.3.1 Cell Viability by MTT Results 
3.3.1.1 Cytotoxicity of MeOH and Dl\ISO 
The cytotoxic effects of different concentrations of solvents ranging assay 0.1% - 1 % 
were determined. The maximum solvent concentrations used in the cell should not 
exceed 1 %. DMSO as a solvent was found to be non-toxic to the Caco-2 cells at all 
examined concentrations. In contrast, methanol showed a significant toxic effect that 
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started from 0.25% (p value :s 0.05). These results are illustrated in Figure 3.1. Based 
on this result DMSO has been used to dissolve punicalagin. 
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Figure 3.1: The viability of Caco-2 cells treated with methanol and DMSO at different 
concentrations. A) methanol and B) dimethyl sulfoxide (DMSO) concentrations were (0.1-
1% ). These data represent the mean ±SD of at least 3 independent experiments. Compari on of 
means were made using a one-way ANOV A followed by Bonferroni's test (* = p < 0.05 ** = P 
< 0.01 and *** = p < 0.0001). 
3.3.1.2 Cytotoxicity of Punicalagin on Caco-2 by MTT Assay 
The cytotoxicity of punicalagin at different concentrations (1-200 IlM) is di splayed in 
Figure 3.2. The average cell survival at concentrations between 1-10 IlM was more than 
95%, There was no significant difference between the viability of control Caco-2 cells 
and those incubated with punicalagin at 1, 3, 5 and 10 IlM. However, there was a 
significant decrease with higher pUl1icalagin concentrations compared to the control 
(P < 0,0001). The non- toxic dose was assessed to examine the protective effect of 
those doses under oxidative stress generated by T-BOOH. 
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Figur e 3.2 : Cell viability of Caco-2 cells treated with d ifferent concentrations of 
punicalagin (0-200 !J,M) fo r 24 hours. Viability ofCaco-2 cells treated with punicalagin 
concentrations (0-200 !J,M) for 24 hours were determined by MTT as ay. These data repre ent 
the mean ± SD of at least 3 independent experiments. Comparisons of mean were made u ing 
a one-way ANOVA followed by Bonferroni 's test (ns= non significant, ***= P <0.000 I). 
3.3.1.3 The ICso of T ·BOOH 
Different doses of T-BOOH (1 , 3, 5 and 10 mM) were incubated with Caco-2 cell fo r 
2 hours to detennine the ICso of T-BOOH. The dose response curve in Figure 3.3 
showed that the ICso of T-BOOH, when applied to Caco-2 cell s, was 3 mM. 
Consequently, this concentration was used to induce oxidative stress in Caco-2 cell and 
to measure the protective effect of punicalagin. 
80 
Chapter 3: Protective Effects of Punicalagin on Caco-2 Intestine Cell Line under Oxidative Stress 
caused by Tert-butylhydroperoxide 
150 
~ C> 
Co 100 
:5 
.Q 
c:s 
.;;;: 
= Q,l 50 U 
Ol~--------~------~--------~ 
o 5 10 15 
[T-BOOH] mM 
Figure 3.3: Dose-response curve for different concentrations of T -BOO" 
(1,3,5 and 10 mM) incubated for 2 hours with Caco-2 cells. Cell viabi li ty was measured by 
the MTT assay. Values represent the mean ± SD, n=3, the le 50 va lue was 3 mM T-BOOH. 
3.3.1.4 Protective Effect of Punicalagin Against the Cytotoxicity of T-
BOOH 
The protective effect of punicalagin (1, 3, 5 and 10 IlM) against the oxidative stre 
induced by 3 mM T-BOOH is illustrated in Figure 3.4. No significant diffe rence wa 
seen between the cells incubated with 3 mM T-BOOH (58% viability) and tho e 
pretreated with 1 )lM (55% viability) and 3 )lM (62% viability) of punicalagin. 
However, there was a significant difference between the cells incubated with 3 mM T-
BOOR and pretreated with 5 and 10 /lM punicalagin (p < 0.001 and p <0.000 I, 
respectively). Concentrations of punicalagin that have the ability to protect Caco-2 cells 
against 3 mM T-BOOH were 5 and 10 /lM; the cell viability with punicalagin wa 71.5 
and 64.4 % respectively, versus 58 % for 3 mM T-BOOH only. 
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Figure 3.4: The viability of Caco-2 cells treated with different concentrations of 
punicaJagin (1, 3, 5 and 10 !lM) with and without 3mM T-BOOH after 2 hour. ell 
viability of Caco-2 cells was assessed by MTT assay. These data represent the mean ± 0 of at 
least 3 independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's test (ns= non-significant , ** = p < 0.01 and *** * = p < 0.0001 ). 
3.3.2 Determination of MDA concentration 
The effect of different concentrations of punicalagin on the production of the secondary 
lipid oxidation product MDA was studied in Caco-2 cells. The MDA concentration wa 
expressed as !J.g/m1 using the standard curve shown in Figure 3.5 When trolox and 
different concentrations of punicalagin were incubated with Caco-2 cell s without T-
BOOH, non-significant differences in MDA concentration were observed in control 
cells compared with treated cells. Malondialdehyde concentrations were 37 !J.glml for 
control, 35.5 !J.g/ml for trolox, 35 !J,glml for 5 !J,M punicalagin and 34 !J,g/ml for 10 !J.M 
punicalagin respectively as presented in Figure 3.6 A. 
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There was a significant decrease in the production of MDA in cell s pretreated with 
trolox, or 5 and 10 ~M punicalagin following induction of oxidative stress using 
T-BOOH (Figure 3.6 B). The most protective cell concentration against oxidative stress 
was 10 ~M punicalagin followed by trolox and then 5 ~M punicalagin compared with 
cells treated with T-BOOR alone (p value ~ 0.05). Concentrations of MDA were 27.7, 
38.7, 41.4, and 64.6 10 ~g/ml after treatment with either 10 ~M, trolox, 5 ~M, or 3 mM 
T-BOOR alone, respectively. 
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Figure 3.5: Standard curve of MDA concentration. Data represent the mean ± SO of MOA 
standard concentrations (0-200 !!g/ml). Absorbance was measured at 532 nm. Linear regre ion 
performed in Grapbpad Prism version 6.0 yielded a correlation coeffi cient of R2 = 0.998. 
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Figure 3.6: Concentration of MDA in Caco-2 cells treated with punicalagin and trolox 
individually with/without 3 mM T-BOOH for 2 hours. A) Caco-2 cells were incubated with 
trolox and different punicalagin concentrations (5 and lO IlM); B) pretrea ted cells incubated 
with 3 mM T-BOOH for 2 hours. Values are the mean ± SO, n=3. Compari sons of means were 
made using a one-way ANOV A followed by Bonferroni's test (* **p < 0.000 1). Trolox 0.1 
mg/ml was used as antioxidant positive control. 
MDA is one of the main products of lipid peroxidation (Suttnar et al., 1997). It i 
produced in high quantities in various diseases and it is related to free radical damage 
(Suttnar et al., 2001). Quercetin (a flavonol from a class of flavonoids) of 5 and 10 !J.M 
incubated for 2 and 20 hours in HepG2 cells significantly inhibited the production of 
MDA under oxidative stress conditions induced by 200 !J.M T-BOOH after a 3 hour 
incubation period (Alia et al. , 2006b). Another study by Peng and Kuo in 2003 , 
discovered that 0.1 !lM quercetin, 10 !lM luteolin and I !J.M epigallocatechin gallate had 
the ability to inhibit lipid peroxidation in Caco-2 cells under 30 !J.M H20 2 + 30 !J.M 
FeS04 inductive conditions (Peng and Kuo, 2003). Results from a study by Lima et al., 
(2007) on phenolic compounds extracted from Salvia officinalis (an aromatic plant) 
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showed a significant inhibition in MDA concentration in HepG2 cells under oxidative 
stress. The water and methanolic extracts at 250 and 16 tAg/ml, respectively, incubated 
for 40 hours afforded protection to 80% of HepG2 cells and had the ability to prevent 
lipid peroxidation produced by 2 mM T -BOOH for 5 hours (Lima et al., 2007). The 
most abundant phenolic compounds present in the Salvia officinalis plant were 
rosmarinic acid and luteolin-7-glucoside (Lima et al., 2007). All of the previous 
findings discussed above are similar to our result that punicalagin has the ability to 
prevent production of MDA in the Caco-2 cell line when under stress from 3 mM of 
T-BOOH. The ability of phenolic compounds to scavenge peroxides and prevent chain-
breaking reaction of cell membrane could explain the observed reduction in MDA as 
lipid peroxidation marker (Brown et al., 1998). 
3.3.3 Measurement of Cellular ROS Levels 
The ROS levels in Caco-2 cells without T-BOOH in control and treated cells with 
trolox or punicalagin concentrations for 24 hours were measured using the CM-
H2DCFDA dye. There was no significant difference in ROS levels as illustrated in 
Figure 3.7 A between control and tested components. 
Punicalagin (5 and 10 tAM) reduced cellular ROS levels compared with control in 
24 hours in pretreated Caco-2 cells exposed to 3 mM T-BOOH for 2 hours (Figure 3.7 
B). ROS production was assessed by flow cytometric analysis using CM-H2DCFDA 
dye. Non-fluorescent CM-H2DCFDA dye was converted to fluorescent DCF in the 
presence of ROS, as described in the method section (3.2.6). The pre-treated cell line 
with trolox and punicalagin showed a significant decrease in fluorescence intensity 
compared with T-BOOH treated group (p <0.001). This result indicates that punicalagin 
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has the ability to scavenge ROS and thereby protect cellular macromolecules such as 
lipids and proteins from ROS-mediated damage. 
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Figure 3.7: Cellular ROS levels in Caco-2 cells treated with punicalagin and trolox 
individually with/without 3 mM T-BOOH for 2 hours. A) Caco-2 cell were incubated with 
trolox (0.01 %) or different punicalagin concentrations (5 and 10 !!M) for 24 hour ; B) pre-
treated Caco-2 cells for 24 hours were incubated with 3 mM T-BOOH for 2 hour. 
Measurement of cellular ROS was by flow cytometric method. Values are the mean ± SO, n=3. 
Comparisons of means were made using a one-way ANOV A followed by Bonferroni' te t (n = 
non-significant, ***P < 0.0001). 
Previous studies have shown that the antioxidant activity of phenolic compound occurs 
via ROS scavenging (Yokomizo and Moriwaki, 2006). The ability of di fferent 
flavonoids (quercetin, kaempferol and luteolin) to decrease the amount of ROS wa 
measured by Yokomizo and Moriwaki (2006). In their study, each flavonoid (50 !AM) 
was incubated for 1 hour with the Caco-2 cell line. The pre-treated cell line wa 
stressed by 50 !AM H20 2 for 1 hour. The three flavonoids caused a significant decrease 
in ROS levels. Quercetin (54%) was the most effective, followed by luteolin (34%) and 
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then kaempferol (26%) (Yokomizo and Moriwaki, 2006). ROS production was also 
significantly reduced in the HepG2 liver cell line when incubated with quercetin and 
rutin (1-100 IlM) for 24 hours when stressed with 200 IlM H20 2 or 3 hours compared 
with cells without pre-treatment (Alia et al., 2006a). 
The cellular ROS scavenging activity of apple juice extract and apple peal extract has 
also been examined in the Caco-2 cell line (Bellion et al., 2010). Different 
concentrations (1-100 Ilg/ml) of each apple-based sample were tested. The apple peel 
extract caused a significant inhibition in ROS production in a dose-dependent manner, 
while the apple juice extract showed a significant reduction of ROS levels at the highest 
concentration only (Bellion et al., 20 I 0). In agreement with previous results, the ability 
of examined phenolic compound (punicalagin) to decrease cellular ROS levels was 
observed. This finding may explain the importance of the presence of the phenolic 
hydroxyl group that scavenges radicals (Y okomizo and Moriwaki, 2006). The 
antiradical activity of punicalagin against DPPH and H20 2 is shown in the second 
chapter of this thesis (section 2.3.3 and 2.3.4). 
3.3.4 Determination of Total Glutathione (GSH) 
In Figure 3.8 B, the total GSH level was significantly increased in the pre-treated cells 
with trolox, 5 and 10 IlM punicalagin under 3 mM T-BOOH oxidative induction 
compared with cells exposed to 3 mM T-BOOH only. Levels of GSH were similar for 
all pre-treated cells (0.3 IlM). The GSH level of incubated cells with T-BOOH was 
only 0.18 IlM. In the case of the trolox, 5 and 10 IlM punicalagin treated cells without 
T-BOOH (Figure 3.8 A), the level of GSH was significantly higher with trolox 
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treatment (p <0.01) whereas no significant difference was observed with punica\agin 
treatment compared with the control. 
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Figure 3.8: Glutathione (GSH) level in Caco-2 cells treated with punicalagin and trolox 
individually with/without 3 mM T-BOOH for 2 hours. A) Caco-2 cell s were incubated with 
trolox (0.1 mg/ml) or different punicalagin concentrations (5 and 10 flM) for 24 hour ; B) pre-
treated Caco-2 cells for 24 hours were incubated with 3 mM T-BOOH for 2 hours. Value are 
the mean ± SD, n=3. Comparisons of means were made using a one-way ANOVA foll owed by 
Bonferroni's test (ns= non-significant, **p < 0.001 and ***p < 0.0001). 
Levels of GSH in Caco-2 cells decreased under oxidative stress conditions induced by 3 
mM T-BOOH for 2 hours. This depletion was significantly reduced by 5 and 10 ~M of 
punicalagin (p < 0.0001). Research by Lima et al. ,(2006) indicates that polyphenols 
provide protection against oxidative damage induced by T-BOOH. Luteolin 200 ~M, 45 
flM quercetin, 370 ~M caffeic acid and 180 ~M rosmarinic acid all had the ability to 
inhibit the GSH depletion in the HepG2 liver cell line (Lima et al. , 2006). Lima et al. , 
(2007) reported the protective effect of polyphenols extracted from the Salvia plant, 
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using the same liver cell line. aSH depletion was significantly prevented by pre-
treating cells with methanolic and water extract of salvia. In all of Lima's research, the 
oxidative stress induced in the liver cell line was caused by treatment with 2 mM T-
BOOH for 5 hours (Lima et al., 2007). aSH has an important role in the protection of 
cells against ROS and free radicals. A severe reduction in aSH levels increases the 
susceptibility of cell damage by free radicals. Depletion of aSH levels has been 
suggested as one of the important mechanisms through with T-BOOH induces cell 
toxicity (Martin et al., 2001). Therefore, the potential effect of punicalagin against T-
BOOH as radical scavenging activity could maintain the aSH levels and contribute to 
their cytoprotective effects. 
3.3.5 Morphological Changes to Caco-2 Cells Treated with 
Punicalagin 
The protective effect of different concentrations of punicalagin (5 I-lM and 10 I-lM) on 
Caco-2 cells subjected to 3 mM T -BOOH oxidative stress was investigated by 
microscopy for 24 hours. Figure 3.9 shows the morphological changes observed in 
Caco-2 cell lines stressed with T -BOOH compared with control cells. In contrast, cells 
pre-treated with different punicalagin concentrations and then stressed with T -BOOH 
appeared healthy, with morphology appearing the same as the control (Caco-2 cells) as 
well as cells exposed to punicalagin only. These observations confirm the protective 
effect of punicalagin. Trolox was used as the positive control. Trolox and different 
punicalagin treatments showed the same cytotoxic protection of Caco-2 cells stressed by 
T -BOOH. The cells looked healthy which demonstrates the protective effect of that 
antioxidants against oxidative stress. 
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Figure 3.9: Effect of trolox and punicaJagin on a Caco-2 cell line with/without 3 mM 
T-BOOH for 24 hours. Cells were treated with trolox and punicaJagin for 24 hour. The pre-
treated cells incubated with 3 mM T-BOOH for 2 hours. Image were captured u ing light 
microscopy (magnification IOx). 
3.4 Conclusion 
In conclusion, punicalagin at low concentrations has a protective effect aga in t 
oxidative damage induced by 3 mM T-BOOH in a Caco-2 cell line, and may ther fore 
be a useful natural antioxidant. From our experiments, we observed that punicalagin 
strongly protects Caco-2 cells against cell death, by cellular ROS cavenging and 
preventing of lipid peroxidation. Moreover GSH depletion caused by 3 mM T-BO H 
was prevented by treating Caco-2 cells with punicalagin. These finding ugge t that 
punicalagin may afford protection against the development of some di seases that are 
caused by excessive ROS production. This conclusion supports the importance of fruit 
and vegetable intake in our diet. 
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4 Punicalagin Inhibits Angiotensin Converting Enzyme 
and Induces Nitric Oxide (NO) Production in the 
EA.hy926 Endothelial Cell Line 
4.1 Introduction 
High blood pressure is a major risk factor for some chronic diseases such as stroke, 
renal disease, and cardiovascular disease (Mittal and Singh, 2010). In patients with 
hypertension, angiotensin 11 is produced from angiotensin I by the catalytic effect of 
angiotensin converting enzyme in higher amounts than normal (Aviram and Dornfeld, 
2001; Clarke and Turner, 2012). Angiotensin 11 acts as vasoconstrictor, increasing blood 
pressure. For this reason, inhibition of ACE activity is a pharmacological target for the 
treatment of hypertension (Persson et al., 2009). The ACE enzyme has a Zn2+ ion in its 
two active sites (Riordan, 2003). Substrate binding and catalysis of ACE indicate the 
mechanism of Zn2+ ion (Reeves and O'Dell, 1986). One of the mechanisms of ACE 
inhibitors is the ability to bind the Zn2+ ion (Sturrock et 01.,2004). 
High and unregulated production of reactive oxygen species (ROS) is another risk 
factor for heart disease (Lobo et 01.,2010; Sugamura and Keaney, 2011). In endothelial 
cells, enzyme systems involving NADPH oxidase, xanthine oxidase, and the 
mitochondrial respiratory chain are responsible for ROS production (Zhang et al., 
2001). ROS production should be regulated or adverse effects like oxidation will be 
cause to cell macronutrients such as proteins, lipids, and nucleic acids. Balance in ROS 
concentration can be achieve by the antioxidant system that exists in the human body 
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and by antioxidant supplement (Himaya et al., 2012). Moreover, ROS have the ability 
to oxidize nitric oxide (NO) produced from endothelial cells, leading to endothelial 
dysfunction and the initiation and development of cardiac disease (Li et al., 2002). 
Nitric oxide (NO) is known as relaxing factor because it acts as a vasodilator, increases 
blood flow, and inhibits platelet aggregation and adhesion (Kelly et al., 1996). 
Calcium-dependent endothelial nitric oxide synthase (eNOS) is one of the important 
factors responsible for the production of NO in endothelial cells. Increased levels of 
NO in the endothelial cells are often due to the increased protein expression of the 
eNOS enzyme or by scavenging the ROS produced within the cells (Ignarro et al., 
2001; Napoli and Ignarro, 2001). 
Several research groups have reported a significant interaction between biological 
systems and dietary polyphenols from vegetables and fruits. These include benefits such 
as anticancer (Meyers et al., 2003; Zhao et al., 2004), anti-inflammatory (Havstcen, 
2002), antioxidant (ROS scavenging or metal chelating) (KahkOnen and Heinonen, 
2003), and antibacterial properties (Viljanen et al., 2004). Pomegranate is a fruit that 
contains a high quantity of different polyphenols e.g. tannins, ellagic tannins, 
anthocyanins, catechins, gallic, and ellagic acid (Ben Nasr et al., 1996; Gil et al., 2000). 
Punicalagin (of the ellagitannin class) is one of the phenolic compounds present in 
pomegranate. The effect of punicalagin as antioxidant and as an anti-hypertensive was 
investigated in the EA.hy926 cell line. 
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The objectives of this chapter were: 
1. To determine the cell viability of EA.hy926 cells after treatment with different 
concentrations of punicalagin. 
2. To determine NO production of EA.hy926 cells after treatment with different 
concentrations of punicalagin. 
3. To determine the inhibitory effect of punic ala gin on the ACE. 
4. To determine the antioxidant effect of punic ala gin as a ROS scavenger. 
5. To determine the ability of punic ala gin to induce eNOS activity. 
6. To determine the effect of punic ala gin on cellular Ca2+ concentration. 
7. To determine the effect of punicalagin on the eNOS enzyme expression by 
Western blotting. 
4.2 Materials and Methods 
4.2.1 Materials 
The human endothelial-like immortalized cell line Ea.hy926 was kindly donated by Dr. 
Bodman-Smith University of Surrey, UK.. Ethylene glycol tetraacetic acid (EGTA), 
hippuryl-histidyl-Ieucine (H-H-L) and angiotensin 11 were obtained from Sigma-Aldrich 
Chemical Co, Poole, UK.. Griess Reagent Kit for nitrite quantitation, Hanks buffer 
saline solution (HBSS) buffer with calcium and magnesium, o-phthaldialdehyde, high 
purity, fura-2, AM, dihydroethidium dye, foetal bovine serum (FBS), trypsin-EDTA 
solution, Dulbecco's Modified Essential Medium (DMEM), penicillin were obtained 
from Invitrogen, Paisley, UK.. Antibody eNOS and ~-actin mouse mAb were purchased 
from cell signaling technology, Hertfordshire, UK.. EnzyChromTM Nitric Oxide 
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Synthase Assay Kit was obtained from Universal Biological, Cambridge, UK. 
Chemiluminescent Kit-Anti-Rabbit, Chemiluminescent Kit-Anti-Mouse, NuPAGE® 
Novex 4-12% Bis-Tris Gel 1.0 mm (15 well), Novex® Sharp Pre-stained Protein 
Standard -2 x 250 Ill, Invitrolon™ PVDFiFilter Paper Sandwiches, NuPAGE® Transfer 
Buffer (20X) (1 L), NuPAGE® MOPS SDS Buffer Kit (for Bis-Tris Gels), NuPAGE® 
Sample Reducing Agent (lOX) (250 Ill) and NuPAGE® LDS Sample Buffer (4X) (10 
ml) were obtained from Invitrogen, Paisley, UK. Fixer and developer solutions 
champion amfix were obtained from First Call Photography, West Monkton, UK. 
4.2.2 Methods 
4.2.2.1 Cell Viability and Nitric Oxide (NO) Release 
The EA.hy926 cell line was seeded in DMEM with high glucose content (4.5 gIL), and 
supplemented with 10% FBS and 5% penicillin. Different punicalagin concentrations 
(1-100 IlM) were tested on Ea.hy926 cells to measure the cell viability and nitric oxide 
(NO) production. Briefly, a stock solution of punicalagin (l0 mM) was prepared in 
DMSO. Ea.hy926 cells were seeded into 96 well tissue culture plates at a density of 
1 x 104 cells/200 III DMEM serum media. Once the cells reached 60-70% confluence, 
they were treated with punicalagin for 12, 24, or 48 hours. Different incubation times 
were tested to determine the optimal time for nitrite production, as a marker of nitric 
oxide production and cell viability. Nitrite levels in the treated cell supematant were 
measured by Griess kit and cell viability was measured by MTT assay, at each 
experimental time. 
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According to the Griess kit instructions, 100 III of medium supematant was mixed with 
100 III Griess reagent (0.1 % N-naphthylethylethylenediamine dihydrochloride in 5% 
phosphoric acid and 1 % sulfanilamide, mixed in a 1: 1 ratio). The formation of a yellow 
colour was measured at 550 nm using a plate reader (80ehring CO, Marburg, 
Germany); the colour intensity was proportional to nitrite concentration. A sodium 
nitrite standard curve was obtained using a sodium nitrite standard solution supplied 
with the kit. This was used to calculate the NO concentration in the test samples. 
Cells pretreated with different concentrations of punic ala gin were incubated with 20 III 
of MTT dye (5 mg/ml PBS) at 37°C and 5% C02 to measure cell viability after 
different incubation times. At the end of each experimental time, the culture medium 
was aspirated and 100 III of DMSO was added to each well. The formazan crystals 
produced were dissolved completely by shaking the plate for 30 seconds at room 
temperature. The purple colour produced was measured at 492 nm using a plate reader 
(Boehring CO, Marburg, Germany). 
4.2.2.2 Measuring ACE Activity in Ea.hy926 
Angiotensin converting enzyme activity was measured in the Ea.hy926 cell line after 
24 hours of exposure to different concentrations of punicalagin (1, 20, 40 and 60 IlM) 
using a modified fluorometric method (Kapiloff et al., 1984). Briefly, Ea.hy926 cells 
were seeded to confluence in 25cm2 flasks (1 X 106 cells Iml) and then incubated with 
punicalagin (1,20,40 and 60 IlM) for 24 hours. Treated cells were washed three times 
with 3 ml HBSS buffer. The cells were scraped from the flask with 1 ml HBSS and 
frozen at -20 DC until assayed. For the assay, frozen cells were thawed and sonicated 
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then 20 ~l samples were added to 80 ~l ofH-H-L (5 mM prepared in HBSS buffer) and 
incubated at 37°C for 3 hours. The incubated cells were then mixed with 1.4 ml NaOH 
(0.5 N) to stop the reaction. The fluorescent dye, O-phthaldialdehyde (1 00 ~l of 10 
mglml in methanol) was used to detect the histidyl-Ieucine reaction product. The 
reagents were incubated for 5 minutes at room temperature followed by the addition of 
250 III of HCI (6 N). A fluorimeter (Varian, USA) was used to measure the 
fluorescence of the samples using an excitation wavelength of 365 nm and an emission 
wavelength of 495 nm. Captopril (1 ~M) was used as positive control in place of 
punicaIagin. 
4.2.2.3 Measurement of ROS by Flow Cytometry 
DichIorofluorescein dye (non-fluorescent CM-H2DCFDA) has the ability to diffuse 
through the cell membrane (Osseni et al., 1999). In the cytoplasm, this dye is 
hydrolysed enzymatically by intracellular esterases and rapidly converted to fluorescent 
dye (DCF) in the presence of ROS. The fluorescence intensity is proportional to the 
ROS content (Osseni et al., 1999). The ROS level in the Ea.hy926 cell line was 
determined by flow cytometry, using CM-H2DCFDA dye after incubation with 1, 20, 
40, and 60 IlM punicalagin. Ea.hy926 cells were seeded in 25cm1 flasks at 
lx106 cells/m!. The treatments were added when cells reached the desired cell 
confluence (60-70%). After 24 hours incubation time, half of pre-treated cells were 
exposed to 1 0 nM angiotensin 11 for 1 hour, while the other left untreated. The cells were 
trypsinised and centrifuged for 3 minutes at 150 x g using a Beckman GRP centrifuge 
(Shropshire, UK). The supematant was removed, the pellets washed with 2 ml of HBSS 
buffer and centrifuged. The supematant was discarded and the cells re-suspended in 
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1 ml HBSS. Re-suspended cells were then incubated with 5 J.lM CM-H2DCFDA 
(prepared in DMSO) for 30 minutes at 37°C and 5% C02. At the end of the incubation 
time, cells were kept on ice under low light conditions due to the high susceptibility of 
the dye to photo-oxidation. DCFDA florescence was then measured using a BD 
F ACSCanto Flow cytometer (California, USA). At least 10,000 events were acquired in 
the gated regions using an emission wavelength of 520 run. 
4.2.2.4 Measurement of ROS by Fluorometric l\fethod 
The florescent dye, dihydroethidium can penetrate the cell membrane and is oxidized by 
superoxide radicals to fonn 2-hydroxyethidium; a red fluorescent product (Sudheesh 
and Vijayalakshmi, 2005). This intercalates with DNA to enhance intracellular 
fluorescence (Bindokas et al., 1996; Li et al., 2003). Ea.hy926 cells were seeded in 
25cm2 flasks at a density of 1 x 106 cells/ml. Different concentrations of punicalagin (1, 
20, 40 and 60 f..lM) were incubated with the cells once 60-70% confluent. After 
24 hours, a group of treated cells was incubated with angiotensin 11 (10 nM) for 1 hour 
and another group were left untreated (control). All cells were then washed with HBSS 
buffer. Cells were covered with 3 ml HBSS buffer and incubated with 25 f..lM of OBE 
dye for 30 minutes at 37°C and 5% C02. The treated cells were washed with 3 ml 
HBSS and incubated with 5 ml HBSS for 1 hour at 37°C and 5% C02. HBSS buffer 
was discarded and the cells were scraped from the flask with 1 ml cold methanol. The 
cell suspension was sonicated and filtered through a 0.22 f..lM membrane filter. The 2-
hydroxyethidium was detected by fluorimetry (Varian, USA) with excitation and 
emission wavelengths of 480 run and 580 run, respectively. 
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4.2.2.5 Determination of Cellular Calcium Concentration by Fluorescence 
Method 
Intracellular calcium concentrations were measured by fluorometry after loading the 
cells with fura-2/AM dye. Free intracellular calcium will bind with the membrane 
diffusible fluorescent dye fura-2/AM (Grynkiewicz et al., 1985). Briefly, Ea.hy926 
cells were cultured in 25cm2 flasks at 1 x 1 06 cells/ml concentration. Different 
concentrations of punicalagin (I, 20, 40 and 60 J!M) were incubated with the cells after 
they reached 60-70% confluence. Following 24 hours incubation, cells were loaded 
with 5 J!M fura-2/AM dye and incubated for 45 minutes at 37°C and 5% C02. 
Consequently, the dye was removed and the cells were washed and scraped from the 
flask with 2 ml HBSS buffer. The calcium concentration was detected by fluorimetry 
(Varian, USA) with excitation and emission wavelengths of 340 nm and 510 nm, 
respectively. Ethyleneglycoltetraacetic acid (EGTA) at 1 mM was used as negative 
control instead of punicalagin. 
4.2.2.6 Determination of Endothelial Nitric Oxide Synthase Enzyme (eNOS) 
Activity in the Ea.hy926 Cell Line 
Cells treated with different concentrations of punicalagin (1, 20, 40 and 60 J!M) for 
24 hours were lysed as described previously in chapter 3 section 3.2.7, and frozen at 
-20°C until eNOS activity was measured. EGT A (1 mM) was used as a negative 
control in place of punicalagin. 
eNDS synthase activity was measured using a nitric oxide synthase assay colorimetric 
kit (Bioassay System, ENOS-IOO) using a direct and non-radioactive method. 
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According to the manufacturer's instructions, this kit is designed to measure eNOS 
activity in two steps. The first step is an oxidation reaction by an eNDS enzyme that 
oxidises the amino acid arginine to NO. The second step is detection of NO via a 
reduction reaction. NO is rapidly oxidised to nitrite and nitrate after production, thus the 
reduction of nitrate to nitrite by Griess method was used to measure NO production. 
The yellow colour produced was measured at 540 nm using a plate reader (Boehring 
CO, Marburg, Germany). A NO synthase standard curve was obtained using a eNOS 
standard solution supplied with the kit. 
4.2.2.7 Assessment of eNOS Expression by \Vestern Blot 
4.2.2.7.1 Preparation of Whole Cell Lysate 
Ea,hy926 cells at a density of 1 x 106 cells/ml were seeded in 25cm2 tissue culture 
flasks. Once 50% confluence was achieved, cells were treated with 1, 20, 40 and 60 
JlM punicalagin and incubated for 24 hours. After this incubation, the culture media was 
decanted and cells were washed with 5 ml PBS. The cells were then trypsinized and the 
resulting cell suspension centrifuged at 1500 x g for 3 minutes with 5 ml PBS to wash. 
Supernatants were removed and the cell pellets were lysed by adding 300 III of lysis 
buffer (Sigma Aldrich Chemical Company). The last step for ceUlysis was to keep the 
cells on ice for 20 minutes and then store them at -80°C until protein determination and 
western blot experiment were carried out. 
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4.2.2.7.2 Protein Quantification 
The protein concentration for each sample was measured as described previously in 
chapter 3 section (2.3.7.1) with the Bradford method using BioRad assay (Bradford, 
1976). 
4.2.2.7.3 Gel Electrophoresis 
For gel electrophoresis, 4 ~l sample buffer was mixed with each sample containing 
20 ~g of protein this was followed by the addition of 2 ~l of reducing agent and 
completed to a final volume of 20 ~l with distilled water. The prepared samples were 
heated at 70 °C for 10 minutes and then directly put on ice for a few minutes. An 
Invitrogen NuPAGE 4-12% Bis-Tris gel was used for protein electrophoresis. An 
Invitrogen Xcell SureLock Mini-cell chamber was filled with NuPAGE® SOS Running 
Buffer (50 ml 20x MOPS and 950 ml Ra water). In each gel well, 20 J.11 of each 
sample was loaded and the last well was loaded with pre-stained protein ladder. The 
electrophoresis running time was 2.5 hours at 100 V at room temperature. 
4.2.2.7.4 Blotting and Developing 
At the end of the gel electrophoresis running time, the gel cassette was removed, 
washed with water and opened with a gel knife. The gel, together with POVF 
membrane pre-soaked in methanol, was placed in an Invitrogen transfer chamber. The 
chamber was filled with transfer buffer (50 ml of 20x transfer buffer + 100 ml methanol 
to a final volume of 1 L with Ra water). The running time for transfer was 2 hours 
at 30 V. 
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Following transfer, 20 m! sterile water was used to wash the membrane twice for 
5 minutes. After that, transferred membrane was blocked with 10 ml of blocking 
solution (0.5 g BSA, 2 ml blocker/diluent (Part A), 3 ml blocker/diluent (Part B) and 5 
ml RO water) for 1 hour on the rotary shaker. The next step after blocking was adding 
10 ml primary antibody diluents (0.5 g bovine serum albumin, 5 ml RO water 2 ml 
blocker/ diluent (Part A) and 3 ml blocker/ diluent (Part B), and 10 ~l primary antibody) 
and incubated with the membrane on a rotary shaker overnight at 4°C. On the 
following day, 20 ml antibody washing solution (10 ml Ab Wash Solution (l6x) + 150 
ml RO water) was used 3 times to wash the incubated membrane. The PDVF membrane 
was then incubated with a secondary antibody solution (anti-mouse or anti-rabbit) for 1 
hour to allow binding of the secondary antibody to the primary antibody. Using a 
Chemiluminescent Western Blot Kit Immunodetection the presented band of protein on 
the PDVF membrane was developed. In a dark room, 2.5 ml chemiluminescent 
substrate was applied to the membrane surface and incubated for 5 minutes. The excess 
of chemiluminescent reagent was removed with a filter paper and cling film was used to 
cover the membrane. The membrane was then inserted into a cassette with Amersham 
film paper placed on top of the membrane and the cassette closed. 
The exposure time for membrane to film was different depending on the antibody used 
and ranged from 30 seconds to 15 minutes. At the end of this exposure, the film was 
developed and fixed using developing and fixing solutions (Champion Amfix. First call 
Photography, West Monkton, UK), respectively. 
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4.2.2.8 Statistical Analyses 
All experiments were performed at least in triplicate. For the 96-well microtiter tissue 
culture plates, 4 replicate wells were used per category. The data were analyzed by 
Graphpad Prism version 6. For significant differences between control and experimental 
values, the P-value between groups was determined by one-way analysis of variance 
followed by Bonferroni test. The significance level was set at P ~0.05. 
4.3 Results and Discussion 
4.3.1 Cell Viability and NO Production 
Cell viability and nitric oxide production was measured over a time course to determine 
the optimal experimental exposure time. The data in Figure 4.1 A show that cell 
viability increased significantly (p ~ 0.05) after treatment with 1, 20, 40, and 60 f.lM 
punicalagin for 12 hours, but that NO production is similar compared with the untreated 
control (Figure 4.1 B). In contrast, there was a significant decrease in cell viability at 80 
and 100 f.lM punicalagin concentrations (p < 0.0001) with a corresponding significant 
decrease in NO production at 12 hours (p < 0.0001). After 24 hours incubation time 
with the same range of punicalagin concentrations, cell viability and NO production 
were significantly increased (p ~ 0.05) compared with untreated cells (control) as shown 
in Figures 4.2 A and B. As for the 12-hours incubation, concentrations of 80 and 100 
f.lM punicalagin caused a significant decrease in cell viability and NO production 
compared with untreated cells (p ~ 0.05). 
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After 48 hours incubation significant decreases in cell viability (p :S 0.05) and N 
production (p < 0.001) were observed at all punicalagin concentrations (I , 20, 40, 60, 
80 and 100 !AM) Figure 4.3 A and B. Based on the previous cell viability and NO 
production results, punicalagin concentrations in the range 1 - 60 !AM were selected for 
exposure to cells for 24 hours in future experiments because higher punicaJagin 
concentrations 80-100 !AM produced a toxic effect on Ea.hy926 cell s. The significantly 
enhanced release of NO due to the activation of eNOS enzyme is described below in 
section 4.3.5. 
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Figure 4.1: Cell viability and NO production after exposure of Ea.hy926 cells to different 
concentrations of punicalagin (1-100 IlM) for 12 hours. A) Cell viability; B) NO production . 
Data represent mean ± SD ofthree individual experiments. Comparisons of mean were made 
using a one-way AN OVA followed by Bonferroni's test (*= p < 0.05; **= p < 0.001 · ... = P < 
0.0001 versus control). 
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Figure 4.2: Cell viability and NO production after exposure of Ea.hy926 cell to d iff rent 
concentrations of punic a la gin (1-100 J.tM) for 24 hours. A) Cell viabili ty; B) N production. 
Data represent mean ± SD of more than three experiments. Compari on of mean were made 
using a one-way ANOV A fo llowed by Bonferroni's te t (*= p < 0.05; **= p < 0.00 I ' *** = P < 
0.0001 versus control). 
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Figure 4.3: Cell viability and NO production after exposure of Ea.hy926 cell to di fferen t 
concentrations of punic ala gin (1-100 J.t M) for 48 hours. A) Cell viability; B) NO production. 
Data represent mean ± SD of more than three experiments. Comparisons of mean were made 
using a one-way AN OVA fo llowed by Bonferroni's test (*= p < 0.05 ; **= p < 0.001 ; *** = p < 
0.000 1 versus control). 
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Several research studies the effect of polyphenol to produce NO in agreement with our 
findings. Leikert et al.,(2002) examined the effect of red wine polyphenol extract on 
EA.hy926 cell line. EA.hy296 cell line incubated with different concentrations of 
extract (100-600 ~g/ml) for 18 hours produced a significant increase in NO production 
(Leikert et al., 2002). Dihydrocaffeic acid (caffeic acid metabolite) at different 
concentrations (0-200 ~M) significantly increased the production of NO after being 
added to EA.hy926 cells for 18 hours in a dose-dependent manner (Huang et al., 2004). 
Another study was performed on NO production after incubating the bovine pulmonary 
artery endothelial cellline with 50 and 1 00 ~M pomegranate juice for 24 and 48 hours. 
The observed result showed an increased NO production (lgnarro et al., 2006). 
Punicalagin and o-galloyl punicalagin extracted from Terminalia calamansanai plant 
leaves (50 ~M each) produced a significant increase in NO production in bovine aortic 
cell line (Chen et al., 2008). NO production was also significantly increased in a dose-
dependent manner after incubating the EA.hy926 cell line for 24 hours with different 
polyphenols (resveratrol, epicatechin gallate and epigallocatechin gallate) (Appeldoom 
et al., 2009). Different concentrations (0.1-1 0 ~M) of polyphenols extracted with 70 % 
acetone from black currant were exposed to EA.hy926 cell line for 10 minutes and 
produced a significant increase in NO production a dose-dependent manner (Edirisinghe 
et al., 2011). 
4.3.2 Measuring ACE Activity in Ea.hy926 Cells 
In this study, incubation of Ea.hy926 with different concentrations of punicalagin (1, 
20, 40 and 60 ~M) for 24 hours caused significant and dose-dependent inhibition of 
ACE activity compared with the control (Figure 4.4) (P < 0.0001). The inhibition 
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percent was 62, 30, 41 , 44 and 51 % achieved from 1 ~M captopril , and I, 20, 40 and 60 
IlM punicalagin, respectively. 
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Figure 4.4: ACE activity in Ea,hy926 cell exposed to punicalagin (1-60 IlM) for 24 hour, 
A) Represent florescence intensity for negative control (untreated cell ), po itive control ( I /lM 
captopril) and treated cells with different punicalagin concentrations, the fluore cent inten ity 
proportional to enzyme activity. B) Represent the ACE inhibition activity for po itiv c nt! 
and treated cells with different punicaJagin concentrations in relative to negati e control 
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activity was observed in a dose dependent manner. Data represent mean ±SD of more than thr e 
experiments, Comparisons of means were made using a one-way A NOY A fo llowed by 
Bonferroni's test (*=p< 0.05 , **p<O.OO 1 and *** = p < 0.000 I). Captopri l wa u ed a a 
positive control. 
Numerous studies have been conducted on endothelial cell lines to examine the effect of 
polyphenols as ACE inhibitors , Black tea, green tea and rooibos tea epicatechi n 
epigallocatechin, epicatechin gallate and epigallocatechin gallate were incubated with 
HUVEC cell line at different concentrations for 10 min. All experimental component 
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inhibited the activity of ACE at all concentrations except rooibos tea. Rooibos tea did 
not contain any catechin compounds (Persson et al., 2006). In 2009, another study was 
performed on HUVEC cell line to investigate the inhibition of ACE enzyme after 
exposure to aqueous phenolic extract from Vaccinium myrtillus (bilberry). The bilberry 
extract contained several polyphenols such as quercetin, stillbene, resveratrol, ferulic 
acid and coumaric acid; these components (0.000625-0.1 mg/ml) significantly inhibited 
ACE activity in a dose dependent manner in HUVEC cell line treated for 10 minutes 
(Persson et al., 2009). 
A viram and Dornfeld (2001) found that serum ACE enzyme activity was significantly 
inhibited by 36% in seven-hypertensive patients who consumed pomegranate juice for 2 
weeks. Each treated patient's serum was incubated with pomegranate juice (50-350 
J.lM) for 15 minutes at 37°C. The enzyme activity was significantly inhibited in a dose 
dependent manner (A viram and Domfeld, 2001). Thus, all the previous research results 
show similar effects to punicalagin in the present study as an inhibitor for ACE activity 
on EA.hy926 cell line. The ACE inhibitory activity may be due to metal chelation by 
punicalagin as zinc ion is present in the active site of ACE. This metal chelating activity 
of punic ala gin is discussed in Chapter 2, Section 2.3.5. 
4.3.3 Measurement of ROS by Flow Cytometry and Fluorometric 
Methods 
Angiotensin (Ang) 11 has the ability to stimulate ROS production in endothelial cells 
through activation of a redox-sensitive signaling system. In an endothelial cell line, 
NADPH oxidase was considered as a source of ROS, responding to Ang 11 with the 
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donation of an electron to reduce a molecule of oxygen to produce the superoxide anion, 
e_ 
O2 (Rey et al., 2001). ROS production in the Ea.hy926 cell line, treated with 
different concentrations of punicalagin for 24 hours, in the absence of Ang II 
stimulation, was not significantly different to ROS production in cells not treated with 
punicalagin. This was true using either flow cytometry (Figure 4.5A) or fluorimetry 
(Figure 4.6 A) as the ROS determination method. 
The ability of different concentrations of punicalagin added to Ea.hy296 cells for 
24 hours to reduce ROS production was assessed by flow cytometer analysis after 
treating cells with 10 nM Ang 11 for 1 hour (Figure 4.5 B). As described in the methods 
section, the non-fluorescent CM-H2DCFDA dye is converted to fluorescent DCF in the 
presence of ROS. The cells treated with Ang 11 showed a significant decrease in 
fluorescence intensity as the concentration of punicalagin increased compared with cells 
treated with Ang II alone (positive control) (Figure 4.5 B: p =:; 0.001). The percent of 
inhibition was 75, 60, 51,49 and 48% for the positive control, and 1,20,40 and 60 ~M 
punicalagin, respectively. 
The results were confirmed by a second method, measuring the conversion of DHE 2-
hydroxyethidium in the presence of ROS, by fluorimetry (Figure 4.6 B). The 
fluorescence intensity in Ea.hy926 cells incubated for 24 hours with punicalagin (1, 20, 40 
and 60 J-lM) and then treated with 10 nM Ang 11 also decreased in a dose-dependent 
manner compared with cells treated with Ang 11 only (positive control). The 
fluorescence intensity was 0.83, 0.59, 0.54, 0.48 and 0.46 for positive control, and 1,20, 
40 and 60 J-lM punic algin, respectively. These findings are in contrast with cells not 
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stimulated with Ang II, in which no significant difference was found in ROS leve l 
between punicalagin-treated cells and control by flow cytometry or fluor scence 
methods (Figure 4.5 A and 4.6 A, respectively). These results illustrate that punica lagi n 
has the ability to scavenge ROS and thereby protect cellular macromolecules from 
ROS-mediated damage. The antioxidant properties of punicalagin showing radical 
scavenging activity were examined previously in Chapter 2, Section 2.3.3 and Section 
2.3 .4 and Chapter 3, Section 3.3.3. 
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Figure 4.5: R OS production measurement by flow cytometery in the Ea.hy926 cell line 
incubated with different punicaJagin concentrations with/without 10 nM an gioten in 11 for 
1 hour . A) ROS production in the Ea.hy926 cell line treated wi th different punicalagi n 
concentrations (1-60 ""M); B) pre-treated cells with punicalagin incubated with lO nM 
angiotensin 11 for 1 hour. Values are mean ± SD, n=3. Comparisons of mean were made u ing 
a one-way ANOVA followed by Bonferroni 's test (ns= non significant, **= p <0.00 I and .. * = 
P < 0.0001 when compared with control). 
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Figu re 4.6: ROS pr oduction measurement by DHE fluo rescence method in the a.hy926 
cell line incubated with different punicaJagin concentration with/without to nM 
angiotensin II for 1 hou r. A) ROS production in the Ea.hy926 cell line treated wi th different 
punicaJagin concentrations (1-60 ~M) ; B) pre-treated cells with punicalagin incubated wi th 
10 nM angiotensin II for 1 hour. Values are mean ± SD, n=3. Comparison of mean were 
made using a one-way ANOV A fo llowed by Bonferroni's test (ns= non ignificant , .... = p < 
0.001 and ***p < 0.0001 when compared with control). 
As reported previously from several in vitro studies, the presence of the OH group in 
phenolic compounds plays an important role in scavenging ROS (Chen and Ho 1997 ' 
Bouchet et al., 1998; Khan et al. , 2007). The Chinese medicine, Seabuckthom contain 
different flavonoids e.g. quercetin, isorhamnetin and kaempherol. Seabuckthom at 
different concentrations (9.38-37.5 !-tglml) and 15 !-tg/ml quercetin was incubated with 
EA.hy926 cell line for 20 minutes separately before adding 100 !-tglml oxidized LDL a 
a ROS inducer for a 24 hours incubation time. A protective effect again t superoxide 
anion in EA.hy926 cells was found (Bao and Lou, 2006). ROS production was 
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significantly decreased in liver cell line (HepG2) exposed to different concentrations of 
quercetin and rutin (1-100 IlM) for 24 hours followed by incubation with 200 IlM H202 
for 3 hours (Alia et al., 2006). Pomegranate juice, concord juice and blueberry juice 
antioxidant activities were examined and showed scavenging of superoxide anion and 
protection of NO destruction from ROS action. Pomegranate juice, diluted 6-fold and 
using a small volume of 3 Ill, showed very high antioxidant activity while the same 
effect was only possible from 300 III undiluted blueberry or 1000 III undiluted concord 
grape (Ignarro et al., 2006). In this study, punicalagin concentrations (1-60 IlM) 
showed a significant reduction of ROS levels in Ea.hy926 cell line after stimulation by 
Ang 11 (p < 0.001). 
4.3.4 Determination of Cellular Calcium Concentration by 
Fluorescence Method 
Different concentrations of punic ala gin (1, 20, 40 and 60 IlM) exposed to Ea.hy926 cell 
line for 24 hours caused a significant dose-dependent increase in intracellular Ca2+ 
concentration p < 0.001 (Figure 4.7). Since eNOS activity is dependent on Ca2+, the 
cytoplasmic Ca2+ concentration was investigated in response to different punicalagin 
concentrations. EGTA (a Ca2+ inhibitor) was used as the negative control. 
This study demonstrates that the punicalagin from pomegranate (1-60 IlM) produced a 
significant increase in calcium concentration in EA.hy926 cell line after incubation for 
24 hours. Polyphenols can affect intracellular Ca2+ store and release it or increase the 
entrance of Ca2+ through the cell membrane (Martin et al., 2002). This suggestion 
could explain the significant induction of Ca2+ concentration by different punicalagin 
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concentrations In the endothelial cell line (p < 0.00 1). Previous research re ults on 
polyphenols as calcium inducer were similar to our findings. 
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Figure 4.7: Calcium concentr ation in Ea.hy926 cells exposed to p unicalagin (1-60 I-lM) for 
24 hours. Calcium concentration was increased in a dose-dependent manner. ura 2/AM dye 
was used to measure calcium concentration. Data represent mean ± SD of more than thr e 
experiments. Comparisons of means were made using a one-way A OV followed by 
Bonferroni's test (*=p< 0.05; **=p <0.001 and *** = p < 0.001. EGTA I mM wa u d a a 
negative control. 
As eNOS enzyme is calcium-dependent, several researchers measured the ca lcium 
concentration in EA.hy926 cell line after incubation with different polyphenol . 
EA.hy926 cell line was incubated for 20 hours with 100-600 ~g/ml red wine 
polyphenols water extract. The experimental dose showed a significant increa e in 
calcium concentration in EA.hy926 cell line, which increased the eNOS protein level 
and showed a significant release of NO (Leikert et af. , 2002). Another study wa 
performed on calcium concentrations in EA.hy926 after incubation with punica lagin 
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and o-galloylpunicalagin extracted from Terminalia Calamansanai plant leave; 
EA.hy926 cell line, exposed to 50 !-lM of each component for 12 hours produced a 
significant increase in calcium concentration (Chen et al., 2008) . 
4.3.5 Determination of eNOS Enzyme Activity in Ea.hy926 Cell Line 
The effects of punicalagin at different concentrations (1, 20, 40, and 60 !-lM) on 
activation of the eNOS enzyme were detemlined in Ea.hy926 cell s after a 24 hour 
exposure time. As shown in Figure 4.8, punicalagin caused a significant incrca e in 
eNOS enzyme activity that was dose-dependent p ~ 0.05. EGTA (\ mM) wa u ed a 
the negative control. 
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Figure 4.8: Effect of different concentrations ofpunicaJagin (1 -60 ~M) incubated for 
24 hours on eNOS activity in the Ea.hy926 cell line. The enzyme activity wa mea ured by 
using eNOS activity detection kit. Enzyme activity was increased in a dose-dependent manner. 
Data represent mean ± SO of more than three experiments. Compari ons of mean were made 
using a one-way ANOVA followed by Bonferroni's test (*= p < 0.05; **=p < 0.001 ; and *u = 
p < 0.0001). EGTA 1 mM incubated for 3 hours was used as a negative control. 
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Western blot analysis using a specific antibody against eNOS revealed no change in 
eNOS protein expression in Ea.hy926 cells treated with punicalagin compared with 
untreated control cells (Figure 4.9). The calcium concentration for I mM EGT A 
(negative control) was significantly decreased (p ~ 0.05); therefore, the protein 
expression level of eNOS enzyme was down regulated and eNOS enzyme ac tivity 
decreased. Punicalagin may increase eNOS activity via eNOS phosphorylation, which i 
enhanced by the activation of redox-sensitive phosphatidylinositol-3 (PI3)/ protein 
kinase B (AKT) pathways (Edirisinghe et al., 2011; Hidalgo et al. , 201 2). 
Punicalagin 
c 
eNOS 
Jl- actin 
A 
ImM 
Figure 4.9: Western blot of eNOS expression in Ea.hy926 cells treated with differ ent 
punicaIagin concentrations. Protein was extracted from Ea.hy926 cells after treatment with 
1-60 IlM punicalagin for 24 hours. EGT A 1 mM incubated for 3 hour wa u ed a a negative 
control. Cells were harvested and lysates were prepared. 20 Ilg protein per lane was ubj ected 
to 4-12% SDS gel electrophoresis followed by Western bot analysis and chemi lum ine cence 
detection . Loading of protein was confirmed using ~-actin expression. MW= 140 kDa. 
Similar to this research outcome, pomegranate juice (50 and 100 ~M) was xamined on 
bovine pUlmonary artery endothelial cell line for 24 and 48 hours. The treatment did 
not show any significant effect on protein expression on eNOS enzyme at any 
concentration (Ignarro et al., 2006). Chen et al., (2008) examined the effect of 
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punicalagin and o-galloylpunicalagin extracted from Terminalia Calamansanai leaves 
on eNDS expression. Protein expression of eNOS enzyme in bovine aorteic cell line 
was not affected after incubation for 12 hours with 50 J..tM of punicalagin and 
0- gaUoylpunicalagin extracted from Terminalia Calamansanai leaves (Chen et al., 
2008). 
In contrast, Leikert et al., (2002) found that red wine polyphenols water extract (100-
600 J..tglml) had increased eNOS protein levels after incubation in EA.hy926 cell line for 
20 hours. Huang et al., (2004) found a significant increase in protein expression and 
activity of eNDS enzyme in EA.hy926 cell line after incubation with dihydrocaffeic 
aicd (caffeic acid metabolite) at different concentrations (0-200 J..tM) for 18 hours. The 
effect of resveratrol, epigallocatechingallate and epicatechingallate on eNOS enzyme 
was investigated on EA.hy926 cell line at different concentrations (0-100 J..tM) for 
24 hours. The protein level of eNDS enzyme was significantly increased in a dose 
dependent manner (Appeldoorn et al., 2009). Edirisinghe et al., (2011) studied the 
black currant polyphenols 70% acetone extract on protein expression of eNOS. 
Different extract concentrations (0.1-10 J..tM) were applied on EA.hy926 cell line for 10 
minutes. The treated cells produced a significant increase in eNOS enzyme expression 
associated with the concentration increase (Edirisinghe et al., 2011). 
4.4 Conclusion 
In conclusion, all of the results presented in this chapter support the proposition that 
punicalagin is a type of polyphenol that could play a role in reducing the risk of 
cardiovascular disease. As observed previously, punicalagin incubated with EA.hy926 
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cells at different concentrations for 24 hours produced a significant inhibition of ACE 
enzyme activity and increased NO production. Increased NO production was via 
increased eNOS activity due to an increase in calcium concentration. There was no 
induction of eNOS enzyme expression observed. This NO level is protected from 
destruction by ROS through punicalagin scavenging activity. The above findings 
indicate that punicalagin may be helpful for lowering blood pressure; this could be 
achieved through dietary intervention or by the production of new anti-
hypertensive treatments from a natural product. 
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5 The Effect of Pomegranate Active Component 
(Punicalagin) on Caco-2 Human Colon Cancer Cells 
5.1 Introduction 
Reactive Oxygen Species (ROS) are produced from several physiological processes in 
the body. Overproduction of these species can damage cellular components such as 
lipids, proteins and DNA. There are several diseases related to the high production of 
ROS like cardiovascular and inflammatory diseases and cancer (Syed et al., 2007). The 
carcinogenesis process (initiation, promotion and progression) is enhanced due to high 
ROS level in the organs (Khan et al., 2008). Xenobiotics, toxins and ingested food are 
some sources for ROS production in the small intestine (Herring et al., 2007). 
Cancer is one of the diseases associated with ROS overproduction. Cancer is a major 
health concern in terms of morbidity and mortality. It is a fatal disease, which can be 
metastasised to another organ of the body, specially if undiagnosed at early stages 
(Surh, 2003). The third most common type of cancer incident in the world is colorcctal 
cancer. However, in terms of morbidity, colorectal cancer is the fourth most common 
type of cancer death globally (Parkin et 01.,2001). Around 610,000 people have been 
estimated to die due to colorectal cancer in 2008 (FerIay et 01.,2011). According to the 
International Agency for Research on Cancer (2010), the United Kingdom colorectal 
cancer mortalities were 47th highest of male and 48th highest for females out of 184 
countries worldwide (Ferlay et al., 2011). In Saudi Arabia, according to the tumor 
registry annual report (2011) from King Faisal Special Hospital and Research Center, 
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colorectal cancer was the most common cancer among male population and the third 
most common among female population; males were more affected by this disease than 
females (Mehmood et al., 2012). Some risk factors of this type of cancer are human 
lifestyle (smoking and heavy alcohol drink) and dietary factors. This risk is associated 
with an increased fat consumption and decreased consumption of cereal grains and 
dietary fibre (Potter et al., 1993). Therefore, the incidence of colorectal cancer all over 
the world is varied depending on the dietary style in each country (Parkin et al., 2001; 
Bingham et al., 2005; Moghaddam et al., 2007). 
Due to concerns for general health, chronic disease prevention and aging have 
increased the consumers interest in phytonutrients because of their potential curative, 
preventive and nutritive values (Guhr and Lachance, 1997). Phytonutrients have 
functionally been demonstrated as antioxidants, as well as modulators of enzyme 
activity, cell proliferation and apoptosis (Balentine et al., 1999). Phytochemicals, like 
fruits and vegetable phenolics, may be responsible for the bioactivity in plant food diets 
that provide the health benefits. Numerous studies have shown that consumption of 
fruits and vegetables can reduce the risk of several cancer types due to their polyphenols 
content. The suggested mechanisms of polyphenol action as anticancer agents include 
antioxidant, anti-inflammatory and anti-proliferative activities as well as their effect on 
subcellular signaling pathways, stimulation of cell cycle arrests and apoptosis 
(Middleton et al., 2000; Yang et al., 2001). Pomegranate is widely consumed as fruit, 
juice and as wine (Gil et al., 2000). Pomegranate contains pectin, sugars, fib er and 
several tannins. It is also a rich source of anthocyanins such as delphinidin, cyanidin 
and pe1argonidin, and hydrolysable tannins such as punicalin, gallie acid, ellagic acid 
120 
Chapter 5: The Effect of Pomegranate Active Component (Punicalagin) on Caco-2 Human Colon 
Cancer Cells 
and punicalagin. Around 92% of pomegranate antioxidant activity is due to the 
presence ofhydrolysable tannins (Khan et al., 2010). 
One of the anticancer properties of polyphenols is their ability to induce cell cycle arrest 
and apoptosis (type of cell death). Cell death is a normal feature in our body; in healthy 
cases there is a balance between cell division and cell death (Khan et al., 20 I 0). 
Apoptosis is a programmed cell death process that normally eliminates damaged cells 
through the activation of caspase enzymes. Apoptosis has been characterised by cell 
shrinkage (nuclear chromatin condenses and cytoskeleton collapses) and engulfs by 
macrophage. In contrast to apoptosis, necrosis is uncontrolled cell death and 
characterised by cell swellings and bursting. It is caused by external factors that affect 
cells such as toxins, infection and trauma. In necrosis, cellular contents are spilled into 
the intracellular cell space and elicit an inflammatory response (Edinger and Thompson, 
2004). Some dietary polyphenols such as EGCG and genistein have the ability to 
induce apoptosis in various cancer cell1ines but not to normal cell lines (Ahmad et al., 
1997; Chang et al., 2009). 
According to a number of studies on the anticancer properties of polyphenols, 
increasing the consumption of fruits, vegetables and dietary fibre may reduce the risk of 
colon cancer (Steinmetz and Potter, 1996; Briviba et al., 2002; Larrosa et al., 2006a). It 
is, therefore, the purpose of this study to investigate the mechanism in which 
pomegranate active component (punicalagin) acts as an anticancer agent. To achieve 
this goal, the colon carcinoma cell culture model (Caco-2) was used and the results were 
compared with a normal colon cell line (HCEC). 
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The objectives of this chapter are therefore: 
• To detennine the cytotoxicity of punicalagin at different concentrations 
(1-500 J!M) on Caco-2 cells and the HCEC cell line by MTT method. 
• To study the morphological changes in Caco-2 cell line and HCEC cells induced 
by punicalagin. 
• To detennine the level ofROS by flow cytometry using CM- H2DCFDA. 
• To detennine the cell death type on Caco-2 cell line by Annexin V-FITC. 
• To examine the effect of punicalagin treatment on the Caco-2 cell cycle at a 
range of concentrations. 
5.2 Materials and Methods 
5.2.1 Materials 
The human colorectal carcinoma cell line Caco-2 was obtained from the European 
Collection of Cell Cultures (ECACC), Salisbury, UK. The nonnal colon cell line 
(HCEC) was gratefully received from Dr. Karen Brown, University of Leicester, UK. 
Phosphate buffered saline tablets (PBS) were obtained from Oxoid, Hampshire, UK. 
Punicalagin, 2 amino-7-dimethylamino-2-methylphenazine hydrochloride (MTT dye), 
dimethyl sulphoxide (DMSO) and cell lytic buffer were obtained from Sigma-Aldrich 
Chemical Co, Poole, UK. The Annexin V-FITC apoptosis detection kit was obtained 
from Merck Chemicals Ltd. Staurosporine was purchased from Calbiochem, 
Nottingham, UK. Foetal bovine serum (FBS), trypsin-EDTA solution, L-glutamine 
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(200 mM), non-essential ammo acids (NEAAs), Dulbecco's Modified Essential 
Medium (DMEM), collagen and fibronectin, CM-H2DCFDA, Mitosox WestemBreeze 
Antibody were obtained from Invitrogen, Paisley, UK. PARP, caspase 9,8 and 3 were 
purchased from Cell Signaling Technology, UK. 
5.2.2 Methods 
5.2.2.1 Cytotoxicity of Punicalagin on Colon Cells 
Colon cancer cell line (Caco-2) was grown in DMEM media with high glucose content 
without sodium pyruvate. Media was supplemented with 20% FBS, 5% penicillin and 
5% glutamine. The cytotoxic effect of different concentrations ranging from 1-500 J.1M 
of punicalagin on Caco-2 cells was studied. In brief, a stock solution of 10 mM 
punicalagin was prepared in DMSO. Caco-2 cells were seeded into 96 well tissue 
culture plates at 1 x 104 cells/200 ,.11 DMEM serum media. After 24 hours, punicalagin 
of different concentration was added to each well. The MTT determination was 
performed after 24 hours of incubation at 37°C and 5% C02. The plate was removed 
from the incubator and the sample (20 J.11) from the MTT dye was added to each well. 
The plate was incubated for 2 hours at 37°C. At the end of the incubation time, the 
culture media was aspirated and 50 J.11 of DMSO was added to each well. The produced 
formazan crystals were dissolved completely by shaking the plate for 30 seconds at 
room temperature. The colour intensity was measured at 492 nm using a plate reader 
(Boehring CO, Marburg, Germany). 
The HCEC cell line was seeded in DMEM with high glucose content without sodium 
pyruvate, supplemented with 10% ofFBS. Tissue culture plates (96 wells) were coated 
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for 15 minutes with a coating solution before seeding HCEC cells. The coating solution 
contained 50 ml serum-free media (without FBS), 65 III BSA (lOO mg BSA in 2 ml 
H20), 0.5 ml collagen (250 III from stock + 9.75 ml H20) and 125-~1 fibronectin. After 
15 minutes, the coating solution was collected and reused for 5 times only. The HCEC 
seeding density was 1 x 104 cells per well. The same concentrations of punicalagin were 
examined using HCEC as with Caco-2 cells and cytotoxicity was assessed by the MTT 
method as described above. Experiments were carried out in triplicate and repeated 
three times to ensure reproducibility. 
5.2.2.2 Morphological Change in Caco-2 and HCEC Treated with 
Punicalagin 
Caco-2 cells and HCEC cell line were seeded at concentrations of 1 x 106 cells/ml in 
25cmz flasks. After 24 hours, two different concentrations of punicalagin (50 flM and 
75 flM) were applied to each cell line. Cellular morphology was dctennincd by 
microscopy after 24 and 48 hours. Pictures of the cells were taken using a phase 
contrast microscope (Zeiss Telaval inverted microscopy) fitted with a camera (Nikon, 
Japan) at 10 x magnification. 
5.2.2.3 Measurement of Cellular Reactive Oxygen Species (ROS) 
Dichlorofluorescein dye (non-fluorescent CM-H2DCFDA) has the ability to diffuse 
across cell membranes (Osseni et al., 1999). In the cytoplasm, this dye is hydrolysed 
enzymaticalIy by intracellular esterases and is rapidly converted to fluorescein dye 
(DCF) in the presence of ROS (Osseni et al., 1999). The fluorescence intensity was 
proportional to the ROS content (Osseni et al., 1999). The ROS levels in Caco-2 cell 
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line incubated with 50 JlM and 75 JlM punicalagin concentration were measured by 
flow cytometry using CM-H2DCFDA dye. Caco-2 cells were seeded in 25cm1 flasks at 
1 x 106 cells/m!. The treatments were applied once the cells reached 60-70% confluence. 
Following that, the cells were trypsinised and centrifuged for 3 minutes at 150 x g using 
a Beckman GRP centrifuge. The supernatant was discarded and the cells were washed 
and centrifuged with 3 ml PBS. Again, the supematant was discarded and 1 ml PBS was 
added. The cells were incubated with 5 JlM of DCFDA (prepared in DMSO) for 30 
minutes at 37°C and 5% C02. At the end of the incubation time, the cells were kept on 
ice under low light conditions due to the high susceptibility of the dye to photo-
oxidation until DCFDA florescence was measured using a BD F ACSCanto flow 
cytometer (California, USA). At least 10,000 events were acquired in the gated regions 
using an emission wavelength of 520 nm. Experiments were carried out in triplicate 
and repeated three times to ensure reproducibility. 
5.2.2.4 Measurement of l\litochondrial Oxygen Species 
Mitosox red fluorogenic dye is a selective dye for the superoxide free radical in the 
mitochondria. The superoxide radical is generated as a by-product of oxidative 
phosphorylation occurs in living cells. Only once this dye is oxidised by superoxidc 
ion, does it produce red fluorescence that can be determined by flow cytometry (Uu et 
al.,201O). The superoxide levels, in Caco-2 cell line incubated with 50 JlM and 75 JlM 
punicalagin concentrations, were measured by flow cytometry using Mitosox dye. 
Caco-2 cells were seeded in 25cm1 flasks at a density of 1 xl 06 cells/ml. The treatments 
were applied after 24 hours of seeding. Following incubation for 24 hours with 
treatments, the cells were trypsinised and centrifuged for 3 minutes at 150 x g using a 
Beckman GRP centrifuge. The supernatant was removed and cells were washed by 
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centrifugation with PBS for 3 minutes at 150 x g. The supernatant was discarded and 
1 ml Hank's Buffered Salt Solution (HBSS) containing calcium and magnesium was 
added. The cells were then incubated with 5 J.lM of Mitosox (prepared in DMSO) for 
10 minutes at 37 °C and 5% C02. At the end of the incubation time, the cells were kept 
on ice under low light conditions, due to the high susceptibility of the dye to photo-
oxidation, until measurements were taken. Red florescence was measured using BD 
F ACSCanto flow cytometer (California, USA). At least 10,000 events were acquired in 
the gated regions using an emission wavelength of 620 nm. Experiments were carried 
out in triplicate and repeated three times to ensure reproducibility. 
5.2.2.5 Determination of Apoptosis by Annexin-V Assay 
Phosphatidylserine is a phospholipid located in the inner surface of the cell membrane. 
It is expressed on the cell surface during cell death by apoptosis programme and was 
measured by using annexin V-FITC apoptosis detection kit from Merck Millipore. To 
detect early and late apoptosis, Caco-2 cells were cultured in 25cm1 flasks at a 
concentration of lx1Q6 cells/ml and incubated in 5% C02 at 37°C. Treatments were 
added 24 hours later and cells were incubated for 24 hours while exposed to diffcrent 
concentrations of punic ala gin (50 IlM and 75 IlM). Before trypsinisation, the media was 
collected in falcon tubes from each flask; this media contained floating cells produced 
during the cell death process; the trypsin was inhibited by re-suspending the dctached 
cells in the collected media. All cells were then centrifuged for 3 minutes at 150 x g 
using a Beckman GRP centrifuge. Chilled binding buffer (500 Ill) was added to each 
tube followed by 1.25 III conjugated Annexin V-FITC. The cells were then incubated 
for 15 minutes in the dark at room temperature. At the end of this incubation, the cells 
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were centrifuge for 3 minutes at 150 x g using a Beckman GRP centrifuge. Supernatant 
was removed and 500 III cold binding buffer was added with 10 III from propidium 
iodide (PI) and mixed gently. The cells were kept on ice until analysed by BD 
F ACSCanto flow cytometry (California, USA). A minimum of 10,000 events was 
acquired in the gated regions. The emission was 520 nm for cells labelled with Annexin 
V -FIre and 620 nm for cells labelled with PI. The PI dye was used to distinguish the 
cells that had lost their membrane integrity. Staurosporine at 1 IlM was used as a 
positive control for apoptosis. Experiments were carried out in triplicate and repeated 
three times to ensure reproducibility. 
5.2.2.6 Cell Cycle and DNA Fragmentation 
To study the effect of punic ala gin, 50 IlM and 75 IlM on the cell proliferation ofCaco-2 
cells. Cells were seeded in 25 cm2 flasks at a concentration of 1 x 106 cells/ml. Each 
punicalagin concentrations were added once the cells reached 50-60% confluence using 
a 24 hours exposure time. The cells were trypsinised and centrifuged for 3 minutes at 
150 x g using a Beckman GRP centrifuge. The pellets were washed twice with PBS and 
re-centrifuged at the same speed. The cells were then re-suspended with 200 ~l cold 
PBS. Cells were vortexed vigorously and fixed in 1 ml ice-cold fixing buffer (70% 
ethanol in PBS), then vortexed again for 2 minutes to achieve (1) full fixation and (2) 
complete dissociation of clumped cells. The cells were incubated at 4 °C for 24 hours. 
On the following day, the cells were centrifuged to remove the fixation buffer. Next, the 
cells were re-suspended in PBS with 10 IlM of RNAse and incubated for 30 minutes at 
37 °C. At the end of this incubation, the cells were then stored on ice and 10 ~l of 
Img/ml PI was added to each sample and analysed by BD FACSCanto flow cytometry 
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(California, USA). At least 10,000 events were acquired in list mode, using an emission 
wavelength of 620 nrn. The experiments were performed at least in triplicate for each 
treatment. 
5.2.2.7 Assessment of Caspases Family by Westren Blot 
5.2.2.7.1 Preparation of Whole Cell Lysate 
Caco-2 cells at a density of Ix 106 cells/ml were seeded in 25 cm2 tissue culture flasks. 
Once 50% confluence was achieved, cells were treated with 50 ~M and 75 J.1M 
punicalagin and incubated for 24 hours. After this incubation, the culture media was 
decanted and cells were washed with 5 ml PBS. The cells were then trypsinized and the 
reSUlting cell suspension centrifuged at 1500 x g for 3 minutes with 5 ml PBS to wash. 
Supematants were removed and the cell pellets were lysed by adding 300 ,.d of lysis 
buffer from (Sigma Aldrich Chemical Co.). The last step for ceUlysis was to keep the 
cells on ice for 20 minutes and then store them at -80 °C until which time for protein 
determination and western blot experiment were determine. 
5.2.2.7.2 Protein Quantification and Western Blot 
The protein concentration for each sample was measured, as described previously in 
Chapter 3 Section 3.2.2.6.1, with Bradford method using BioRad assay (Bradford, 
1976). The Western blot technique was performed as described previously in Chapter 
4, Section 4.2.2.7.3. 
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5.2.2.8 Statistical Analyses 
All experiments were performed in triplicate. For the 96-well microtiter ti sue culture 
plates, 4 replicate wells were used per category. The data were analyzed by Graphpad 
Prism software 6. Significant differences between the control and the experimental 
values were evaluated using P-values determined by one way analysis of vari ance 
followed by Bonferroni test. Significance was set at a cut-off level of ~O .05 . 
5.3 Results and Discussion 
5.3.1 Dose Response Curve for Punicalagin 
To measure the effect of punic ala gin on the Caco-2 cellline , cell viability wa a c cd 
by the MTT assay as shown in Figure 5.1. 
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Figure 5.1: Dose response curve for different concentrations of punicaJagin incubated for 
24 hours in Caco-2 cell Line. Punicalagin concentrations were (1 5 10, 25 50, 100, 150, 200 
and 500 IlM) incubated for 24 hours in Caco-2 cell Line. Cell viability was measured by the 
MTT assay. Log concentrations were plotted in Graphpad Prism to obtain a sigmoidal do e 
response curve and the curve was fitted using a standard IC50 equation. The data rep re ent are 
the mean of three independent experiments (n=3 ± SD). 
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Punicalagin doses of 1-500 ~M cause a significant dose-dependent inhibition of ce ll 
survival. The IC5o, detennined after a 24-hour incubation time, was 75 f!M. 
5.3.2 Comparison of the Effect of Punicalagin on Caco-2 and HCEC 
Cells 
Figure 5.1 revealed that a concentration of 75 !AM was the 1Cso of punica\ag in 
concentration on caco-2 cell line. Consequently, this concentration was used to induce 
an anti-cancer effect on Caco-2 cells. However, a lower dose of 50 f!M punicalag in wa 
also tested in Caco-2 cells to ascertain the efficacy of a lower concentration. 
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Figure 5.2: The effect of different punicalagin concnetrations on Caco-2 and H E cell 
for 24 hours. Cells were treated with punicalagin 50, 100, 150,200 and 500 1lM. The cell 
viability was monitored for 24 hours by the MTT assay. The data represents the mean of three 
independent experiments (n=3 ± SD). Comparisons of means were made using a one-way 
ANOV A followed by Bonferroni test (** = p < 0.001 ; *** = p < 0.0001) . 
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The cell viability for Caco-2 cells was 152%, 141%, 131%, 95%, 67%, 53%, 46%, 
37%, and 19% at punicalagin concentrations of 1, 5, 10, 25, 50, 100, 150, 200, and 
500 IlM respectively. Different punicalagin concentrations (50-500 flM) were also 
tested on nonnal colon HCEC cells. The 50 flM and 75 flM concentrations showed no 
significant effect on the cell viability of the HCEC cell line as presented in Figure 5.2. 
In contrast to Caco-2 cells, the cell viability for HCEC cells was 95%, 93%, 70%, 62%, 
and 43% at 50, 100, 150,200 and 500 flM punicalagin concentrations, respectively. 
Several studies have shown that the polyphenolic compounds have the ability to inhibit 
cell proliferation in different cancer cell lines (Seeram et al., 2005; Khan et al., 2007). 
Seeram et al., (2005) observed a greater anti-proliferative effect for pomegranate juice 
at 100 flglml, compared with ellagic acid, punicalagin and total pomegranate tannin 
when using different human tumour cell lines (oral, colon and prostate). In their 
research, the cell proliferation in all tumour cell lines tested was inhibited by 30% to 
100% at 12.5 flglml to 100 flglml in a dose-dependent manner (Seeram et al., 2005). 
Similarly, Larrosa et al., (2006) found that the cell viability of Caco-2 cells exposed to 
ellagic acid (1, 10 and 30 flM) or punicalagin (1, 10 and 100 flM) for 24 hours was 
significantly reduced in a dose dependent-manner, by both compounds. Additionally, 
another research study perfonned on a 70% acetone extract of pomegranate, similarly 
showed anti-proliferative effects on a lung cancer cell line (A549) at different 
concentrations (50, 100 and 150 flg/ml) in a dose-dependent manner (Khan et al., 
2007). However, this extract exhibited an insignificant effect on the cell viability of 
nonnal human bronchial epithelial cell at the same doses (Khan et al., 2007). 
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5.3.3 Morphological Changes of Caca-2 and HCEC Cells Induced by 
Punicalagin 
The anti-proliferative effect of various punicalagin concentrations (50 !J.M and 75 !J.M) 
on Caco-2 and HCEC cells was investigated by microscopy at 24 and 48 hours. Figure 
5.3 shows a morphological change in the Caco-2 cell line in response to punicalagin 
treatments compared with the control. Conversely, the same concentrations of 
punicalagin had little effect on HCEC comparable to the control, i.e. the cells appeared 
as healthy as the control (Figure 5.4). This confirms the anti-proli ferative ffect of 
punicalagin on the colon cancer cell line but not on normal colon cell line. 
24 Hours 
48 Hours 
Figure 5.3: Effect of different punicaJagin concentrations on the Caco-2 Cell line for 24 
and 48 hours. Caco-2 cells were treated with 50 I-lM and 75 I-lM punicalagin for 24 and 4 
hours. Images were captured using light microscopy at 10x magnification . 
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Figure 5.4: Effect of different punicalagin concentrations on the HCEC cell line for 24 
and 48 hours. HCEC cells were treated with 50 IlM and 75 IlM punicalagin for 24 and 4 h ur . 
Images were captured using light microscopy at !Ox magnification. 
5.3.4 Cellular and Mitochondria ROS Measurement 
Mitochondrial ROS (superoxide anion) generation was significantly induced by 50 ~M 
and 75 ~M) concentrations of punicalagin (60%, 66%) compared with the c ntr 1 
(30%) (Figure 5.5 A) (p < 0.001). Mitochondrial dysfunction may have been cau ed by 
different punicalagin concentrations; this may be the reason for the increa ed producti n 
of superoxide anion. In section 5.4 we show the activation of caspase 9 which upp rt 
the hypothesis that punicalagin caused mitochondrial dysfunction. Wh n mitochondria 
lose their function they release cytochrome C which activates caspase 9 (Larro a t al. 
2006a). In contrast to mitochondrial ROS production discussed above, reduction in 
cytoplasmic ROS production was observed with 50 ~M and 75 ~M punicalagin 
compared with the control (Figure 5.5 B). The percent ROS inhibition wa 69% at 
50 ~M and 54% for 75 ~M, while the control ROS production was 81 %. 
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Figure 5.5: Measurements of mitochondria and cellular ROS in Caco-2 cell trea ted, ith 
different punicalagin concentrations for 24 hours. A) Punicalagi n-Induced mtR 
Production in Caco-2 Cells. Caco-2 cells were treated with 50 f-lM and 75 f-lM punicalag in for 
24 hours. Cells were loaded with Mitosox stains and the fluorescence mea ured by fl w 
cytometry to monitor mtROS formation. B) Punicalagin Cellular ROS Inhibition in aco-2 
Cells. Caco-2 cells were treated with 50 IlM and 75 IlM punicalagin for 24 hour . e ll werc 
loaded with CM-H2DCFDA and DCF and fluorescence was measured by flow cytom try t 
monitor ROS formation. The data represent the mean of three independent experiment n= 
± SD). Comparison of means was made using a one-way ANOV A followed by Bonferr ni' t 
(** = P < 0.001 *** = P < 0.0001). 
In this research, the DCF assay method was applied to asses ROS production r 
scavenging activity by phenolic compounds to induce cell death . According to e eral 
studies in which ROS levels in tumour cell lines after exposing them to polyphenol r 
flavonoids were measured, the induction or reduction of ROS levels lead to cell death 
(Yamarnoto et al. , 2003; Qanungo et al. , 2005 ; Renis et al. , 2008; Singh et al. 2011). 
Mertens-Talcott et aI. , (2006) reported that tannins namely ellagic acid (0.4 1lJ110l/g) and 
ellagitannine (0.8 Ilmol/g) from red muscadine grapes, caused a significant incr a e in 
ROS production when applied to the Caco-2 cell line at different dilutions (1 : 10 1: 1 00 
and 1: 1000). However, the total red muscadine grapes phenolic extract (7.45 Ilmol/g) 
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caused a significant reduction in ROS level at the lowest dilution (1: 1 0), while the other 
dilutions from red muscadine grapes (1: 100 and 1: 1000) did not change the generation 
of ROS (Mertens-Talcott et al., 2006). 
In contrast, cellular ROS levels in Caco-2 cells was decreased significantly by 
anthocyanins, cyanidin at 25, 50, 100 and 200 J.lM, while, cyanidin-3-0-~-
glucopyranoside had the ability to decrease ROS level only at the lowest concentration 
(25 J.lM) (Renis et al., 2008). In a different study, also on anthocyanins, ROS levels 
decreased significantly in Caco-2 cells and in a metastatic colorectal cell line (lovo cell 
line) after exposure to different concentrations (25, 50 and 100 J.lM) of cyanidin and 
delphinidin (Cvorovic et al., 2010). The above results are in agreement with our 
findings, and the high anti oxidation potential of punicalagin due to the presence of 
phenolic groups may explain this decrease in cytoplasmic ROS (Mertens-Talcott et al., 
2006). 
5.3.5 Apoptosis in Caco-2 Cells 
In the presence of 50 ~M and 75 ~M punicalagin concentrations for 24 hours, apoptosis 
was significantly induced in the Caco-2 cell line. Compared with the negative control, 
the percentage of apoptotic cells, in both the early apoptotic (single Annexin V) and the 
late apoptotic (Annexin V plus PI) stages were significantly increased (p <0.0001). The 
proportion of cells in the early apoptotic stage was 5%, 18%, 20%, and 28% for control, 
50 ~M, 75 IlM punicalagin, and staurosporine (positive control) while the proportion in 
the late apoptotic stage was 6%, 17%, 19 %, and 50% respectively. The cell population 
stained with PI only (necrotic cells) did not change significantly with treatment 
compared with the negative control p value >0.05. The proportion of cells undergoing 
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necrosis was 6.5%, 7.5%, and 8% for negative control , 50 f-lM and 75 f-lM punica lagin, 
and staurosporine respectively (Figure 5.6 A & B). 
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Figure 5.6: Detection of Caco-2 cell death treated with different punicalagin 
concentrations for 24 hours by flow cytometric analysis. A) flow cytometric analy i f 
Annexin V in Caco-2 Cells treated with 50 f-lM and 75 f-lM punicalag in for 24 hour . re 
harvested and stained with propidium iodide (PI) and Annexin V (A V). Q 1- Q4 quadrant 
indicate: QI = Healthy cells; Q2 = Cells conjugated with AV; Q3 = Cell conjugat d wi th 
and stained with PI; Q4 = Cells stained with PI. Staurosporine 1 f-lM wa a ayed a p itive 
control. B) Percentage of Caco-2 cells in early Apoptosis, late Apoptotic/Necrotic cell d ath 
and necrotic cell death pathways after treatment with 50 f-lM and 75 f-lM punicalagin 
concentrations for 24 hours. Represented values are the mean of three independent experi ment 
(n=3 ± SEM). Comparisons of means were made using a one-way ANOV A fo llowed by 
Bonferroni's test ( *** = p < 0.0001) . 
Several studies have been conducted using the Annexin V assay to determine the type 
of cell death programme induced by polyphenols and anthocyanins as chemo-pr enti e 
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agents in different cell lines (Seeram et al., 2005; Larrosa et al., 2006a; Hafeez et al., 
2008). In a study conducted by Seeram et al., (2005), significant induction of apoptosis 
in a colon cancer cell line (HT -29) was observed mostly by pomegranate juice followed 
by ellagic acid, punicalagin, and lastly by total pomegranate tannins at 100 Jlglml. 
However, pomegranate juice did not have any apoptotic effect on a different colon 
cancer cell line (HCT 116), although ellagic acid, punicalagin and total pomegranate 
tannins induced apoptosis at the same concentration 100 Jlglml (Seeram et al., 2005). 
Larrosa et al., (2006) found that both ellagic acid at 1, 10 and 30 JlM and punicalagin at 
1, I 0 and 100 J.1M significantly induced apoptosis in Caco-2 colon cancer cells in a dose-
dependent manner. In contrast, no apoptotic effect was observed in a normal colon cell 
line (CCD 112) at the tested concentrations (Larrosa et al., 2006a). Hafeez et al., 
(2008) found the significant effect of delphinidin at 60, 120 and 180 JlM as a cell 
inhibitor in a prostate cancer cell line (PC3) (Hafeez et al., 2008). 
In this research, Annexin V and morphological changes to the Caco-2 cell line in the 
presence of 50 J.1M and 75 J.1M punicalagin concentrations confirmed the apoptosis cell 
death pathway. 
5.3.6 Effect of Punicaiagin on Cell Cycle 
Figure 5.7 illustrates Caco-2 cell cycle phases after treatment with 50 J.1M and 75 JlM 
punicalagin. Arrest in the S-phase was observed by noting a significant decrease in the 
cell popUlation, with an associated increase in the G 1 population in cells treated with 
both concentrations of punicalagin. Consequently, the G21M phase cell popUlation was 
not affected by the treatment. The percentage of cells in the G I-phase was 45%, 54%, 
and 60% for control, 50 Jl.M and 75 Jl.M, (p :s 0.01), respectively. The percentage of 
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cells in the S-phase was 26%, 19% and 14%, while in the G2-phase, the percentage wa 
7%, 7.4% and 7.5 % for the control and 50 ~ and 75 ~M (p ~ 0.001), respectively. 
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Figure 5.7: Cell cycle arrest in Caco-2 cells treated with different punicalagin 
concentrations for 24 hours by flow cytometry. A) Caco-2 cells were treated with SO J.lM 
and 75 JlM Punicalagin and fixed in 70% ethanol for 24 hours. Fixed cells were treated with 
RNase (10 JlM) and stained with 10 Jll of 1 mg/ml propidium iodide stock. B) Effect of SO JlM 
and 75 JlM Punicalagin concentrations at 24 hours on the Caco-2 cell cycle di tribution. 1-
phase (growth phase), S-phase (DNA synthesis phase), and G2-phase (growth 2 pha e). In each 
phase, cells percentages were measured by flow cytometry. Represented values are the mean 
of three independent experiments (n=3 ± SO). Comparisons of means were made using one-way 
ANOVA followed by Bonferroni's test (*=p < 0.01 , **= P < 0.001 and *** = p < 0.0001 ). 
In the present research, punicalagin at different concentrations may down-regulat 
cyelin E. eyelin E is involved as a checkpoint for the cells to transfer from G 1- to S-
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phase; thereby any alteration in cyclin E may arresting the cell cycle (Lazze et al., 
2004). Caco-2 cells significantly reduced in the S-phase and consequently increased 
significantly in the G I-phase. 
Cell cycle arresting has been considered as a target for cancer therapy (Hartwell and 
Kastan, 1994; Dickson and Schwartz, 2009). Phenolic compounds showed different 
arresting phases in different cancer cell lines (Lazze et al., 2004). In this research, the 
significant reduction of Caco-2 cells in to S-phase and the accumulation the G I-phase 
caused by 50 JlM and 75 J.1M punicalagin is in agreement with the findings of another 
study conducted by Larrosa et al., (2006). In their research, punic ala gin at I, 10 and 
lOO JlM and ellagic acid at 1,10 and 30 J.1M caused arresting in the S-phase on Caco-2 
cell line (Larrosa et al., 2006a). In a separate study, ellagic acid at 10 J1M and urolithins 
(A and B) at 40 J.1M have individually been shown to cause accumulation of Caco-2 
cells in the S-phase (Gonzalez-Sarrias et al., 2009). An extract of pomegranate 70% 
acetone extract has also been shown to have a chemotherapeutic potential against a lung 
cancer cell line (A549) (Khan et al., 2007). Arresting of A549 cells was observed in the 
G I-phase of the cell cycle; the cell distributions were 65%, 70% and 72% for 50, 100 
and 150 Jlglml extract concentrations, respectively (Khan et al., 2007). 
Anthocyanins delphinidin, as a class of flavonoid, have also shown efficacy in arresting 
the cell cycle of prostate cancer cell line (PC3) (Hafeez et al., 2008). The PC3 cell line 
was exposed to 60, 120 and 180 J.1M delphinidin concentrations. Delphinidin induced 
apoptosis and arrested cells in the G2-M-phase in a dose-dependent manner (Hafeez et 
al., 2008). 
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5.3.7 Punicaiagin Induced Apoptosis in the Caco-2 Cell Line via the 
Activation of Caspases and P ARP 
Induction of the apoptosis process by punicalagin through caspase activation has been 
studied. Western blotting of caspase 3, 8 and 9 (Figure 5.8) illustrated a dose dependent 
increase in the levels of these proteins. Caspase 9 is activated due to the release of 
cytochrome C from the mitochondria and is involved in the intrinsic apoptosis pathway. 
On the other hand, caspase 8 is activated by transmembrane death receptors and is 
involved in the extrinsic apoptosis pathway. Activation of caspase 9 and caspase 8 both 
lead to the activation of caspase 3. Subsequently, the poly (ADP-ribose) polymerase 
protein (P ARP) is activated by caspase 3 during the process of apoptosis. Thus, P ARP 
is an important downstream biomarker of apoptosis occurring by either the intrinsic or 
extrinsic pathways. Cells treated with different concentrations of punicalagin showed a 
cleavage of P ARP protein as represented by Western blotting (Figure 5.8). Therefore, 
the effect of punic ala gin as an inhibitor of colon cancer cell growth is mediated by the 
activation of the caspase family. 
The caspase activation results confirm the findings of previous research conducted on 
100 IlM punicalagin and 30 IlM ellagic acid (Larrosa et al., 2006a), except for the 
activation of caspase 8 which was only demonstrated in the present research wherein 
neither punicalagin nor ellagic acid activated caspase 8. Other polyphenols like 
pomegranate delphinidin (60, 120, and 180 IlM) also induced apoptosis through the 
activation of caspase9 and 3 enzymes in prostate cancer cell line (PC3). (Hafeez et al., 
2008). 
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Figure 5.8: Western blot of caspases 3, 8, and 9 and PARP-l expression in Caco-2 11 
treated with different punicalagin concentrations. Protein was extracted from aco-2 cell 
after treatment with 50 flM and 75 J1M punicalagin for 24 hours. Cells were harve led and 
lysates were prepared. For each treatment 20 flg protein was subjected to 4-12% SD gel 
electrophoresis followed by Western blot analysis and chemiluminescence detection . Loading 
of protein was confirmed using ~-actin expression (MW=45 kDa). Panel A protein expre ion 
for caspase 9 (MW=47 kDa). Panel B protein expression for caspase 8 (MW= 57 kDa) panel 
protein expression for caspase 3 (MW= 35 kDa) and panel D protein expres ion for PARP- I 
(MW= 116, 89 kDa). 
5.4 Conclusion 
According to the results obtained from all the previous experiments punicalagin at 
50 ~ and 75 ~ was found to be an effective agent for apoptosis when used in the 
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Caco-2 cell line, but not in normal colon cell line HCEC, when compared to the control. 
Cytoplasmic ROS production was decreased in cytoplasm and superoxide radical 
release from mitochondria was increased. Cell morphology changes, 
phosphatidylserine exposure and activation of caspases and P ARP cleavage; support the 
induction of the apoptosis pathway. The cell cycle was arrested by punicalagin in the 
G liS-phase at the examined concentrations. Punicalgin may be a potential anticancer 
agent. 
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6 General Discussion and Conclusions 
6.1 General Discussion 
In recent years there has been increased attention on phenolic compounds and 
flavonoids due to evidence from several research groups that diets rich in vegetables 
and fruits can reduce the risk of developing several diseases (Borges et al., 2010). In 
particular, pomegranate fruit has received attention because it contains many different 
phytochemical compounds. Pomegranates are a rich source of phenolic compounds 
that include hydrolysable tannins, condensed tannins, and flavonoids (flavonols, 
flavanols and anthocyanins) (Malik et al., 2005). Punicalagin, ellagic acid, and gallic 
acid are polyphenolic tannins found in pomegranate (Gil et al., 2000). Punicalagin 
(eUagitannin) is the main polyphenol in pomegranate husk (Ch en and Li, 2006; 
Kulkami et al., 2007; Lee et al., 2008); this compound is reported to have anti-cancer, 
anti-inflammatory, and anti-atherosclerotic properties (Chen et al., 2000; Seeram et 
al., 2005; Kulkami et al., 2007). Therefore, this research aimed to study the detection 
of commercial punicalagin in pomegranate husk and juice and to determine some of 
the bioactive properties of punicalagin. 
6.1.1 PunicaIagin Detection in Pomegranate (busk and juice) and its 
Antioxidant Activity 
In this study, the presence of punicalagin in pomegranate husk (US) and pomegranate 
juice (US & UK) was compared with a punicalagin standard using high performance 
liquid chromatography (HPLC) and liquid chromatography- mass spectroscopy (LC-
MS) which are highly sensitive and selective analytical methods for the separation 
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and identification of phenolic compounds and anthocyanins (Gil et al., 2000; Fischcr 
et al., 2011; Qu et al., 2012). The present study shows a high degree of similarity of 
HPLC and LC-MS results between the punicalagin commercial standard (Sigma 
Aldrich) and US pomegranate husk extracted with methanol. In contrast, in the 
methanol juice extract obtained from US and UK pomegranates, punicalagin was not 
detected using the same detection methods. Most research on pomegranate has 
established that phenolic compounds such as punicalagin, gallic acid, and ellagic acid 
are in high quantities in pomegranate husk, whereas the concentration of anthocyanins 
like delphinidin, cyanidin and pelargonidin is high in pomegranate juice (Gil et al., 
2000; Fischer et al., 2011; Qu et al., 2012). 
6.1.2 Punicaiagin Antioxidant Activity 
In the present work, the antioxidant mechanism of punicalagin and pomegranate 
water extract was investigated. The DPPH radical scavenging activity assay has 
previously been used to measure the free radical scavenging effectiveness of different 
polyphenols (Bersuder et al., 1998; Murcia et al., 2001; Gill'rin et al., 2010). In the 
present study, inhibition of DPPHe by pomegranate juice or punicalagin was 
increased with increasing concentration (0.05-0.15 mg/ml). Pomegranate juice 
showed significant inhibition of DPPH- compared with punicalagin at concentrations 
between 0.1 and 0.15 mg/ml (p < 0.05). Thus, pomegranate juice exhibits greater 
ability to donate hydrogen atoms to reduce the stable radical DPPH- to its non-radical 
form (DPPH-H) than punicalagin. The inhibition of DPPH radical activity caused by 
natural (trolox) and synthetic (BHT) antioxidants (positive controls) at 0.1 mg/ml was 
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compared with pomegranate and punicalagin at the same concentration. Compared 
with BRT, pomegranate juice and punicalagin inhibited the DPPH- radical activity to 
a similar extent. In contrast, an equivalent concentration of trolox 0.1 mg/ml 
significantly inhibited DPPR- grater degree than punicalagin or pomegranate juice (p 
< 0.0001 for both examples components). Several polyphenols such as tannins and 
anthocyanins have demonstrated antioxidant properties through scavenging the 
DPPH- radical (Ozcelik et aI., 2003). 
The second radical scavenging mechanism for punicalagin and pomegranate juice as 
H20 2 scavenger was examined. H202 has an effect on lipid peroxidation; however, it 
can sometimes cause cytotoxicity if it generates hydroxyl radicals (Namiki, 1990). 
The hydroxyl radical is a very reactive free radical, which can initiate lipid 
peroxidation (Halliwell and Gutteridge, 1984). In this study, both punicalagin and 
pomegranate juice showed scavenging activity towards H20 2• which was dose 
dependent. Pomegranate juice demonstrated significant scavenging of 1120 2 
compared with punicalagin at 0.15 mg/ml (p <0.001); the percent inhibition was 30% 
and 18% for pomegranate juice and punicalagin, respectively. In addition, 
pomegranate juice and punic ala gin showed significant inhibition of IhOz at 0.1 
mg/ml compared with BHT at the same concentration (p <0.001 for both experimental 
components). However, no significant difference was observed when punicalagin and 
juice were compared with trolox. The percent of inhibition was 19%, 17%, and 17% 
for trolox, pomegranate juice, and punicalagin, respectively. 
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The ability of punicalagin and pomegranate juice to act as ferrous chelating agents 
was examined in order to study their antioxidant effects further. Ferrous metal (Fe2+) 
ions are reactive and can induce free radical formation via the Fenton reaction: 
Fe2+ + H20 2 - Fe3+ + OH + • OH (Halliwell and Gutteridge, 1984). Consequently, this 
radical can initiate lipid peroxidation (Yu et al., 1988). The amount of Fe2+-ferrozin 
complex was significantly reduced in a dose-dependent manner in the presence of 
punicalagin and pomegranate juice at concentrations of 0.05-0.15 mg/m!. At 0.15 
mg/ml concentration ferrous chelating activity of punicalagin was significantly higher 
than for pomegranate juice (p :S0.05). The positive control (EDTA) showed 97% 
complex inhibition, while punicalagin and pomegranate juice showed 18% and 14% 
inhibition at 0.1 mg/ml, respectively. It has been established that, due to the presence 
of several hydroxyl groups, many phenolic compounds can bind with metal ions such 
as Fe2+ or Cu2+ and prevent free radical formation (Yoshino and Murakami, 1998). 
Moreover, moderate free-radical scavenging components often have strong metal 
chelation capacity (Wu et al., 2006). 
The potential of pomegranate juice and punicalagin to act as reducing agents was also 
tested. Punicalagin and pomegranate juice appeared to have reducing activity 
associated with increased concentrations (0.05-0.15 mg/ml). Reduction of ferric 
(Fe3+) to ferrous (Fe2+) iron by pomegranate juice and punicalagin has been 
demonstrated in this study. Both compounds have the ability to reduce Fe3+ to Fe2+ in 
a dose-dependent manner. Punicalagin was a more powerful reducing agent than 
pomegranate juice at all concentrations (0.05-0.15 mg/ml; p :s 0.05). As reported by 
Gill et al., (2000) punicalagin contains 16 phenolic hydroxyls per molecule, while the 
manual extract of pomegranate juice contains higher concentrations of anthocyan ins 
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than the tannin compounds. This may help to explain the high reducing activity of 
punicalagin compared with the pomegranate juice extract. 
Increased levels of ROS in the cells, results in the phenomena of oxidative stress that 
can lead to cell death. Oxidative stress can be involved in the initiation of different 
diseases such as cancer (Zhao et al., 2004; Hafeez et al., 2008) and cardiovascular 
diseases (Paravicini and Touyz, 2006; Tabassum and Ahmad, 2011). Therefore, in 
vitro cyto-protective effects of punicalagin against T-BOOH damage were 
investigated through different mechanisms such as MDA, glutathione and ROS levels. 
6.1.3 Protective Effect of Punicalagin on Caco-2 Intestine Cell Line 
under Oxidative Stress caused by Tert-butylhydroperoxide 
Antioxidants are compounds that have the ability to scavenge ROS and reduce 
oxidative stress. The damaging effects of ROS on cell macronutrients such as lipids. 
proteins and nucleic acids can be prevented by antioxidants (Lima et al., 2006). Our 
data from experiments using the Caco-2 cell line incubated with different 
concentrations of punicalagin (1-200 IlM) for 24 hours showed non-significant 
decreases in cell viability at 1,3,5 and 10 IlM punicalagin concentration. However, 
even at these concentrations, cell viability was >95%. A concentration of 3 mM T-
BOOH exposed to cells for 2 hours was used as an oxidative inducer. The protective 
effect of punicalagin (after a 24-hour incubation period) was observed on Caco-2 cell 
viability after exposure to T-BOOH. Cell viability was significantly greater at 5 and 
10 IlM concentrations of punicalagin, compared with 1 and 3 IlM concentrations (P 
<0.001). The percent cell viability was 55, 62, 65 and 72% for 1. 3, 5 and 10 IlM 
respectively, versus 58 % for 3 mM T -BOOH only. This protective effect of 
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punicalagin was confinned by microscopy, where adverse morphological cell changes 
were less apparent with antioxidant treatment. 
Malondialdehyde levels (MDA) were measured as an indicator of lipid peroxidation 
(Suttnar et al., 2001). In several diseases that are associated with free radical damage, 
the MDA level is increased (Suttnar et al., 1997). In this study, the effectiveness of 
punicalagin to reduce the level of MDA under oxidative stress induced by T-BOOn 
was tested. The level of MD A after induction by T-BOOH was significantly reduced 
when Caco-2 cells were pretreated for 24 hours with 5 and 10 J.lM punicalagin 
concentrations (p <0.0001). Therefore, the protective effect of punic ala gin against T-
BOOH is assumed to be due to its ability to scavenge ROS that would otherwise 
oxidize the polyunsaturated fatty acids in cell membranes (Mora et al., 1990). This 
effect is similar to the effects of other polyphenols that protect cell membrane lipids 
from the effects ofROS (Alia et al., 2006b). 
Several studies reported that polyphenols could decrease the level of ROS in a liver 
cell line (HepG2) (Alia et al., 2006a). The effect of punicalagin as a ROS scavenger 
was studied in the current research. Caco-2 cells were incubated with punicalagin at 5 
and 10 IlM for 24 hours and then treated with 3 mM of T -BOOH for 2 hours. In the 
presence of 3 mM T-BOOH, the cells pretreated with trolox (positive antioxidant 
control) or punicalagin showed a significant decrease in ROS levels compared with 
cells treated only with T-BOOH (p< 0.0001). Punicalagin clearly showed antioxidant 
activity by inhibiting ROS generation induced by T -BOOH. The presence of several 
hydroxyl groups in the chemical structure of punicalagin may account for this 
property (Dziedzic and Hudson, 1983). 
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Glutathione (a non-enzymatic antioxidant) has an important protective role against 
ROS in the cell (Dringen, 2000). Increased intracellular oxidation leads to depletion 
of glutathione (Buc-Calderon et al., 1991; Martin et al., 2001). Conversely, an 
increased level of glutathione protects the cell from the harmful effect of ROS. 
Therefore, the level of glutathione in Caco-2 cells pretreated with punicalagin under 
T-BOOH oxidative stress conditions was measured. Our data showed that glutathione 
significantly increased to 0.3 IlM in pretreated cells compared with untreated cells 
under oxidative stress conditions. Untreated cells had a glutathione level of 0.18 IlM, 
which indicates significant depletion due to increased ROS levels. From this point of 
view, the protective effect of polyp he no Is as radical scavengers could help to maintain 
glutathione levels under oxidative stress conditions as demonstrated in other 
published research concerning the effect of polyphenols on human health (Alia et al., 
2006a; Lima et al., 2007), 
Several studies have shown that high intakes of polyphenols may protect the human 
body from cardiovascular diseases (Aviram and Dornfeld, 2003; Adams et al., 2006). 
Possible protection against cardiovascular diseases could be mediated by polyphenol 
effects, namely anti-platelet aggregation (Appeldoorn et al., 2009), vasodilator 
properties (Leikert et al., 2002; Acharya et al., 2003), and prevention of LDL 
oxidation. In this study, the ability of punicalagin to act as an antihypertensive agent 
has been studied because hypertension is a potential risk for cardiovascular disease. 
Different pathways have been investigated as follows. 
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6.1.4 Punicalagin Inhibits Angiotensin Converting Enzyme and 
Induces Nitric Oxide Production in Endothelial Cell Line 
EA.hy926 
Major research indicates that polyphenols have the ability to reduce the risk of cardiac 
disease such as atherosclerosis as well as hypertension (Leikert et al., 2002; Huang et 
al., 2004; Persson et al., 2009). A wide concentration range of punicalagin 
(1-100 ~M) was examined using an exposure time of 24 hours on EA.hy926 cells. At 
concentrations of 1-60 f.,tM, no cytotoxicity was observed, while NO production 
increased dose-dependently. In contrast, at 80 and 100 f.,tM punicalagin, a reduction in 
cell viability and consequently reduction in NO was observed, indicating toxicity at 
high levels of punicalagin on EA.hy926 cells. 
To investigate whether punicalagin has the potential to reduce hypertension via ACE 
inhibition, the activity of ACE was examined. This research showed significant 
inhibition of ACE activity associated with increasing punicalagin dose (p < 0.0001 for 
all concentrations 1-60 ~M). As a consequence of enzyme inhibition, levels of 
angiotensin 11 were decreased. Angiotensin 11 acts as a vasoconstrictor leading to 
increased blood pressure (A viram and Domfeld, 200 I), thus reduction of angiotensin 
11 levels should decrease blood pressure. The mechanism of inhibition has been 
suggested by Persson et al., (2009) to involve polyphenol binding to Zn2+ ions in the 
active site of ACE. As reported by Kulkami et al., (2004) punicalagin has the ability 
to chelate- metal ions like Fe2+ and Zn2+. 
151 
Chapter 6: General Discussion and Conclusions 
Protection of endothelial NO from ROS destruction is important since the NO acts as 
a vasodilator. Therefore, the antioxidant activity of punicalagin (1-60 IlM) was 
studied in the EAhy926 cell line after a 24-hour incubation period. The superoxide 
production that was induced after incubation of cells with angiotensin 11 was 
significantly inhibited at all concentrations of punicalagin when investigated by flow 
cytometry and fluorescence methods. This result, Le. inhibition of superoxide levels 
was expected due to the presence of several hydroxyl groups within the chemical 
structure of punicalagin (Dziedzic and Hudson, 1983). The structure-activity 
relationship of polyphenols as radical scavengers has been well demonstrated (8ao 
and Lou, 2006; Alia et al., 2006b). 
The NO-release response in endothelial cells after exposure to punicalagin (1-60 IlM) 
was also studied. The NO level significantly increased in a dose-dependent manner in 
response to punicalagin treatment. As seen in other research on polyphenols, the 
increase in NO can be mediated by increased activity and protein expression of the 
eNOS enzyme (Leikert et al., 2002; Chen et al., 2008) or by scavenging of ROS that 
would normally degrade it (Ignarro et al., 2006; Edirisinghe et al., 2011; Hidalgo et 
al., 2012). 
Punicalagin, at experimental doses, showed a significant increase in eNOS enzyme 
activity but there was no increase in the protein expression level of the eNOS enzyme. 
Punicalagin may have increased the eNOS activity via eNOS phosphorylation. which 
enhances activity via the activation of the redox-sensitive phosphatidylinositol-3 
(PI3)/ protein kinase B (AKT) pathways (Edirisinghe et al., 2011; Hidalgo et al., 
2012). 
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eNOS enzyme activity is calcium-dependent (Leikert et al., 2002), therefore, the 
calcium concentration in EA.hy926 cells treated with punicalagin was measured. At 
the same examined concentrations (1-60 ~M), punicalagin caused a significant 
• • 2+ h I rr Increase In Ca concentrations measured by flow cytometry. Polyp eno scan auect 
intracellular Ca2+ levels by releasing ions from intracellular stores or by increasing the 
entrance of Ca2+ through the cell membrane (Martin et al., 2002). One or both of 
these mechanisms may help to explain the significant increase of Ca2+ concentration 
caused by punic ala gin in the endothelial cell line (p < 0.001). 
Under the harmful effects of oxidative stress, high levels of intracellular ROS are 
produced in living cells that cause chronic diseases like cancer. Therefore, ROS 
scavenging is necessary in order to prevent cancer and protect the human body from 
ROS damage. The dietary antioxidants such as polyphenols are reported to have anti-
carcinogenic (Malik et al., 2005, Zhang et al., 2008) and cardiovascular diseases 
prevention properties (Ignarro et al., 2006; Edirisinghe et al., 2011; Hidalgo et al., 
2012) due to their antioxidant effects. In this research, the anti-carcinogenic effect of 
pomegranate punicalagin was investigated to determine the potential mechanism and 
pathways involved as discussed below. 
6.1.5 The Effect of Punicalagin on Human Colon Cancer Cell Line 
Caco-2 
Several studies on polyphenols have indicated that they can inhibit the proliferation of 
cancer cell lines obtained from various tissues such as lung (Khan et 01.,2007), cervix 
(McDougaU et al., 2008), colon (Seeram et al., 2005) and prostate (Malik et al., 
2005). In this study, the anti-proliferative effect of punicalagin was investigated in 
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Caco-2 cells as a model for colon cancer. The cytotoxicity of punicalagin was 
measured by the MTT assay. The concentration of punicalagin that reduced cell 
viability to 50% was 75 I-lM. A similar dose of 50 and 100 I-lM was also tested on a 
normal colon cell line (HCEC) and showed no significant reduction of cell viability. 
Cell morphology for both caco-2 and HCEC cell lines treated with 50 I-lM and 75 I-lM 
punicalagin had a selective effect on colon cancer cells but not on normal colon 
cells. 
The ROS level in the Caco-2 cell line was investigated to assess whether ROS played 
a significant role in the induction of apoptosis after exposure to punicalagin. The data 
demonstrated that mitochondrial ROS formation was induced while cytoplasmic ROS 
was inhibited. This phenomenon was observed at all different punicalagin 
concentrations used in this experiment. In agreement with this finding, the high 
antioxidant potential of punicalagin due to the presence of phenol groups may explain 
the decrease in cytoplasmic ROS (Mertens-Talcott et al., 2006). On the other hand, 
the increased amount of superoxide anion released from the mitochondria may be due 
to mitochondrial dysfunction caused by different punicalagin concentrations. This 
result was confirmed by the activation of caspase 9, which supports our hypothesis 
that punicalagin causes mitochondrial dysfunction in Caco-2 cancer cells. 
Many studies conducted on cancer cell lines treated with polyphenols have found that 
different cancer cell lines (from liver, colon, breast, and prostate tissue: HepG2, Caco-
2, Mcf-7 and LNCap, respectively) died via the apoptosis pathway (Malik et a/., 
2005; Zhang et al., 2008). In the present study, Caco-2 cells incubated with 
punicalagin, 50 and 75 I-lM, for 24 hours showed apoptotic responses as measured by 
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flow cytometry using an Annexin V kit. Annexin V dye binds with phosphatidyl 
serine that has been externalized from the inner surface of the cell membrane to the 
outer surface during apoptosis. As shown by Western blotting, the activation of 
apoptotic pathways was confinned with caspase activation. The poly (ADP-ribose) 
polymerase protein (P ARP) cleavage, which is an important apoptosis marker, was 
detected in treated Caco-2 cells via a significant activation of caspase 3. Caspase 3 
activation can occur via the intrinsic (caspase 9) or extrinsic pathways (caspase 8). 
Caspase 9 is activated due to the release of cytochrome C from the mitochondria 
while caspase 8 is activated by transmembrane death receptors. In this study, the 
significant increase in protein expression of caspase 9 and 8 were indicative that both 
pathways are involved in the mechanism of cell death by apoptosis. 
To investigate the possibility of cell growth arrest, cell cycle phases were explored 
when punicalagin (50 and 75 ~M) was exposed to the Caco-2 cell line for 24 hours. 
Flow cytometry assays showed that cells were arrested in the S-phase, and 
accumulated in the G I-phase. The percentage of cells in the G I-phase was 45%, 
54%, and 60% for control, 50 and 75 ~M punicalagin, respectively. The percentage of 
cells in the S-phase was 26%, 19% and 14% for the treatments (stated in the same 
order). It has been reported that arresting cells in G I-S-phase is due to the down 
regulation of cyclin E (Lazze et al., 2004). This cyclin is involved as a checkpoint for 
the transition from G I-to S-phase, the down-regulation of which leads to cell cycle 
arrest (Lazze et al., 2004). Therefore, the arresting effect of different punicalagin 
concentrations could be due to cyclin E down regulation. Other polyphenols have 
shown different cell cycle arrest mechanisms in different cancer cell lines, arresting 
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the cell cycle in G 1·, S·, S·G2 and G2·phases (Fresco et al., 2006; Renis et al., 2008; 
Hafeez et al., 2008). 
6.2 General Conclusions 
Characterisation 
• Commercial punicalagin standard used in this study and analysed by IIPLC and 
LC·MS, revealed an identical peak in samples extracted from a methanol extract 
of pomegranate husk (US), whilst no punicalagin peak was observed in a 
methanol extract of pomegranate juice (US and UK). 
Antioxidant Activity and Mechanisms 
• In vitro experimental solutions of punicalagin and pomegranate juice (0.05, 0.1 
and 0.15 mg/ml) showed antioxidant activity by radical scavenging, hydrogen 
peroxide scavenging, metal chelating, and reducing power mechanisms. These 
antioxidant properties were similar to the standard synthetic antioxidant DlIT. 
Antioxidant Activity in Cells 
• Punicalagin at 5 and 10 IlM concentrations significantly scavenged ROS in Caco· 
2 cells produced by added tert butyl hydroperoxide (T·BOOH). 
• The formation of malondialdehyde (MDA) as a secondary metabolitc product of 
lipid peroxidation was significantly inhibited by 5 and 10 IlM punicalagin in 
Caco·2 cells stressed with T·BOOH. 
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• Punicalagin at 5 and 10 IlM minimized the depletion of glutathione levels in 
Caco-2 cells treated with T -BOOH. 
• Morphological changes indicating decrease in viability of Caco-2 cells stressed 
with T-BOOH were protected in the presence of 5 and 10 IlM punicalagin. 
• Therefore 5 and 10 IlM punicalagin have good antioxidant properties. 
Antihypertensive Effect 
• Punicalagin at I, 20, 40 and 60 IlM concentrations showed a significant inhibition 
of ACE activity in the EA.hy926 cell line after a 24 hours incubation period; ACE 
inhibition is important for reducing hypertension, a risk factor for cardiovascular 
disease. 
• Punicalagin caused a significant decrease in ROS levels in EA.hy926 cells under 
oxidative stress induced by angiotensin 11. ROS scavenging can prevent 
destruction of NO which is a vasodilator. 
• The cytoplasmic calcium concentration was significantly increased in EA.hy926 
cells treated with different concentrations of punicalagin, thereby increasing 
activity of calcium dependent eNOS. 
• The significant increased activity of eNOS was confirmed in EA.hy926 cells 
treated with punicalagin. Therefore the level of NO production was significantly 
increased. 
• The above findings indicate that punicalagin is a potential antihypertensive agent. 
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Anticancer Effect 
• Cytotoxicity in the Caco·2 cell line was induced by punicalagin with an ICso value 
of 75 IlM. In contrast, there was no cytotoxicity observed in the normal colon cell 
line (HCEC) at the same concentration. Morphological changes observed in cells 
incubated with punicalagin confirmed these results. Therefore, punicalagin (SO. 
100 f.lM) killed Caco·2 cancer cells but not normal colon cells. 
Mechanism of Cell Death in Cancer Cells 
• As markers of apoptosis, caspase (9, 8 and 3) protein expression was significantly 
increased in the Caco·2 cell line following incubation with 50 and 75 J.lM 
punicalagin for 24 hours; consequently PARP cleavage was detected. Therefore, 
the apoptosis mechanism of cell death in the Caco·2 cancer cell line was 
confirmed. 
• Increased mitochondrial superoxide anions were detected in the Caco·2 cell line 
following incubation with different concentrations of punicalagin. 
• A decreased proportion of the Caco·2 cell populations were In the S-phase 
because more remained in the G l·phase after incubation with different 
punicalagin concentrations. 
• The above findings indicate that punicalagin arrested the cell cycle and caused 
cell death by apoptosis in Caco·2 cancer cells 
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6.3 Future Work 
• To study the effect of punicalagin as antihypertensive agent in vim in animal 
models. 
• To study the effect of punicalagin as a colon cancer treatment agent in vim in 
animal studies. 
• To study the effect of punicalagin as an anticancer agent for different types of 
cancer cell lines, such as breast, liver, pancreas and prostate cancer cell lines. 
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